id.exposure	id.outcome	outcome	exposure	method	Q	Q_df	Q_pval
07WJuW	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	81.1444438318328	55	0.0124797277690839
07WJuW	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	79.8371119415599	54	0.0127024972657432
07WJuW	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	81.1576262365616	55	0.0124483263870491
07WJuW	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0616213350407545	55	1
07WJuW	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	67.4288549702497	55	0.12130874491447
07WJuW	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	66.6684211109488	54	0.115464627665967
07WJuW	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	67.4446561134621	55	0.121043815888461
07WJuW	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0751412767629847	55	1
07WJuW	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	72.255592358684	54	0.0491673900943414
07WJuW	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	72.0925331169447	53	0.0416029041421414
07WJuW	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	72.3264554290351	54	0.0485980263836689
07WJuW	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.48409682839019	54	1
0hsEf2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	60.1102980724289	51	0.179186748814121
0hsEf2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_P_int_imputed.txt_snps.txt	MR Egger	59.6551388663273	50	0.164714017174684
0hsEf2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	60.1164146572536	51	0.179044817172582
0hsEf2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0773172863825081	51	1
0hsEf2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	54.2579795114475	51	0.35134497833418
0hsEf2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_P_int_imputed.txt_snps.txt	MR Egger	54.1647201192215	50	0.318563192950681
0hsEf2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	54.2618396485564	51	0.351209090385366
0hsEf2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0931045863649401	51	1
0hsEf2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	56.4646801426242	50	0.246174517237815
0hsEf2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_P_int_imputed.txt_snps.txt	MR Egger	56.427698711117	49	0.217097632474181
0hsEf2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	56.5472800291722	50	0.243783009020251
0hsEf2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.816301277585998	50	1
0JkIhz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	82.8675786573403	58	0.0177409568107488
0JkIhz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	82.8255493966607	57	0.0143444004376286
0JkIhz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	82.881882384855	58	0.0176951173863586
0JkIhz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0567241457147755	58	1
0JkIhz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	83.1015500434483	58	0.0170043598305102
0JkIhz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	82.8364202774551	57	0.0143154223527969
0JkIhz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	83.102081741278	58	0.0170027176589012
0JkIhz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0558125708305881	58	1
0JkIhz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	49.8010773881704	58	0.76965031467575
0JkIhz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	49.8496935005763	57	0.737862433415895
0JkIhz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	49.8640560314486	58	0.767679939670349
0JkIhz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.332313377530971	58	1
0jTx40	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	86.2092448440624	46	0.000302564525198931
0jTx40	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	85.8026666734168	45	0.00023663204292922
0jTx40	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	86.2155024756843	46	0.000302081793607732
0jTx40	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.148886679552099	46	1
0jTx40	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	72.1049369736592	46	0.00827071403943901
0jTx40	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	71.3255633691843	45	0.007474119667873
0jTx40	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	72.1962309521131	46	0.00811223668487973
0jTx40	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.154099493696377	46	1
0jTx40	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	52.8088547455386	41	0.102304458014913
0jTx40	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	45.9412399319191	40	0.239567760168845
0jTx40	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	52.8257429409808	41	0.102023541188305
0jTx40	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.453025766999279	41	1
0RFzS9	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	72.3909399079804	54	0.0480848163630365
0RFzS9	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_CE_int_imputed.txt_snps.txt	MR Egger	69.3852937094343	53	0.0648631918693714
0RFzS9	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	72.4248544192785	54	0.0478167661333013
0RFzS9	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0573049633649566	54	1
0RFzS9	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	66.0347253503905	54	0.126144467464999
0RFzS9	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_CE_int_imputed.txt_snps.txt	MR Egger	64.0083877803452	53	0.143028794135791
0RFzS9	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	66.1032940590465	54	0.124953398033761
0RFzS9	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0821420891617305	54	1
0RFzS9	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	60.3661257916071	53	0.226970357667842
0RFzS9	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_CE_int_imputed.txt_snps.txt	MR Egger	55.448054538645	52	0.346055580441219
0RFzS9	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	60.3767913803968	53	0.226684363414431
0RFzS9	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.447591933964865	53	1
0v83Sg	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	43.4026528090109	25	0.0126379918665138
0v83Sg	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	41.9569984233135	24	0.0130485644341538
0v83Sg	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	43.4303057854694	25	0.0125492960542092
0v83Sg	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.037012566639736	25	1
0v83Sg	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	37.091347941191	25	0.0565947225018114
0v83Sg	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	36.9175838319129	24	0.044595380274419
0v83Sg	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	37.1168241839717	25	0.056279703253703
0v83Sg	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0488312327534495	25	1
0v83Sg	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	26.1121724209254	25	0.401632012128557
0v83Sg	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	25.7921646152125	24	0.36379429821073
0v83Sg	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	26.1121945890623	25	0.401630836856059
0v83Sg	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.231217558566367	25	1
0XsbI2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	73.8118386352241	55	0.0460710677129499
0XsbI2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	72.7546845103816	54	0.0452758874449523
0XsbI2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	73.9139033732847	55	0.0453029309925451
0XsbI2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.115224140447613	55	1
0XsbI2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	73.1082111548215	55	0.0516759808841901
0XsbI2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	73.0546361666708	54	0.0430666643548471
0XsbI2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	73.1549587071977	55	0.051286393957501
0XsbI2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.154364772225031	55	1
0XsbI2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	62.5526443026839	52	0.149998248918778
0XsbI2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	62.5858062705717	51	0.128153549468367
0XsbI2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	62.8057670267552	52	0.14494721159999
0XsbI2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.685846565656407	52	1
14Jprq	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	76.715804783246	46	0.0030029943285869
14Jprq	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_CE_int_imputed.txt_snps.txt	MR Egger	76.4495697477631	45	0.00237189021233474
14Jprq	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	76.71580812297	46	0.00300299204774496
14Jprq	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0755560728228634	46	1
14Jprq	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	58.810237653328	46	0.0973857647758599
14Jprq	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_CE_int_imputed.txt_snps.txt	MR Egger	58.8096005616565	45	0.0811320275308817
14Jprq	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	58.8106170548725	46	0.0973799822719021
14Jprq	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.11097169733592	46	1
14Jprq	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	57.5549963645066	43	0.0679863378541243
14Jprq	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_CE_int_imputed.txt_snps.txt	MR Egger	54.5210826584477	42	0.093220210643078
14Jprq	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	57.6726285699205	43	0.0666253609602739
14Jprq	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.379097994799003	43	1
1m41fZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_PL_int_imputed.txt_snps.txt	Maximum likelihood	80.0404836993662	48	0.00253202490238381
1m41fZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_PL_int_imputed.txt_snps.txt	MR Egger	75.6406635672177	47	0.00506961868777972
1m41fZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_PL_int_imputed.txt_snps.txt	Inverse variance weighted	80.0670109251227	48	0.00251686117382996
1m41fZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_PL_int_imputed.txt_snps.txt	Unweighted regression	0.051990425014121	48	1
1m41fZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_PL_int_imputed.txt_snps.txt	Maximum likelihood	65.8017871499563	48	0.0448210597317986
1m41fZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_PL_int_imputed.txt_snps.txt	MR Egger	64.018802543205	47	0.049846802872884
1m41fZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_PL_int_imputed.txt_snps.txt	Inverse variance weighted	65.8161581149929	48	0.044708704736089
1m41fZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0571272434007919	48	1
1m41fZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_PL_int_imputed.txt_snps.txt	Maximum likelihood	57.2435546390699	46	0.123709514686939
1m41fZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_PL_int_imputed.txt_snps.txt	MR Egger	57.2550077046426	45	0.103996113671382
1m41fZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_PL_int_imputed.txt_snps.txt	Inverse variance weighted	57.2555761213398	46	0.123488253801965
1m41fZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_PL_int_imputed.txt_snps.txt	Unweighted regression	0.306713034545555	46	1
24vjyw	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Pyruvate_int_imputed.txt_snps.txt	Maximum likelihood	13.5463365993779	13	0.406550152335519
24vjyw	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Pyruvate_int_imputed.txt_snps.txt	MR Egger	13.3721009301514	12	0.342584741529006
24vjyw	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Pyruvate_int_imputed.txt_snps.txt	Inverse variance weighted	13.5881551150213	13	0.403473574967015
24vjyw	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Pyruvate_int_imputed.txt_snps.txt	Unweighted regression	0.00834731973997534	13	1
24vjyw	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Pyruvate_int_imputed.txt_snps.txt	Maximum likelihood	14.8396345092037	13	0.317470785470812
24vjyw	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Pyruvate_int_imputed.txt_snps.txt	MR Egger	14.566897635208	12	0.26597982007989
24vjyw	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Pyruvate_int_imputed.txt_snps.txt	Inverse variance weighted	14.8666393089017	13	0.315752051189783
24vjyw	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Pyruvate_int_imputed.txt_snps.txt	Unweighted regression	0.015665610452856	13	1
24vjyw	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Pyruvate_int_imputed.txt_snps.txt	Maximum likelihood	5.71839391061273	13	0.955804018037889
24vjyw	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Pyruvate_int_imputed.txt_snps.txt	MR Egger	4.96135026053697	12	0.959257424262927
24vjyw	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Pyruvate_int_imputed.txt_snps.txt	Inverse variance weighted	5.7190780192735	13	0.95578201142646
24vjyw	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Pyruvate_int_imputed.txt_snps.txt	Unweighted regression	0.0262722027742059	13	1
2K1bQt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	73.0755183279428	62	0.158666438942856
2K1bQt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_C_pct_int_imputed.txt_snps.txt	MR Egger	72.8752780073523	61	0.141896052904221
2K1bQt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	73.2576701242944	62	0.15514835543257
2K1bQt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0671078955693158	62	1
2K1bQt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	75.1913466585207	62	0.121278081879681
2K1bQt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_C_pct_int_imputed.txt_snps.txt	MR Egger	75.1625489433816	61	0.104940227025908
2K1bQt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	75.2766831575799	62	0.119925654559302
2K1bQt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.110586650924362	62	1
2K1bQt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	74.1218002796973	59	0.0887524487546481
2K1bQt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_C_pct_int_imputed.txt_snps.txt	MR Egger	74.4301365694454	58	0.0718708603740731
2K1bQt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	74.5332372684356	59	0.0836447497428047
2K1bQt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.569185348141605	59	1
2lj1XQ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	83.0624894540972	49	0.00170567446299114
2lj1XQ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_PL_int_imputed.txt_snps.txt	MR Egger	80.4253126749892	48	0.0023202276174433
2lj1XQ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	83.0697430234736	49	0.00170283090247353
2lj1XQ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0825986822477377	49	1
2lj1XQ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	78.7947738243121	49	0.00442689439614916
2lj1XQ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_PL_int_imputed.txt_snps.txt	MR Egger	76.5457847084288	48	0.00547790870187448
2lj1XQ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	78.8142881657146	49	0.00440820705771553
2lj1XQ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.115324287742743	49	1
2lj1XQ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	60.3972555178193	48	0.10803284633756
2lj1XQ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_PL_int_imputed.txt_snps.txt	MR Egger	55.5657722775286	47	0.183333187559596
2lj1XQ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	60.4359257715938	48	0.107405568607215
2lj1XQ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.44970245592515	48	1
2TemtU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	61.5283952214775	58	0.350923490560122
2TemtU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_C_int_imputed.txt_snps.txt	MR Egger	61.5006087975328	57	0.318105754152996
2TemtU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	61.5301310540377	58	0.350866095383046
2TemtU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0665118934747559	58	1
2TemtU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	62.0796265661766	58	0.332926865408254
2TemtU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_C_int_imputed.txt_snps.txt	MR Egger	62.0611493620801	57	0.300585310658577
2TemtU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	62.0797930108285	58	0.332921502351003
2TemtU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.109468880407716	58	1
2TemtU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	69.9831855337474	55	0.0840200323004236
2TemtU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_C_int_imputed.txt_snps.txt	MR Egger	69.4513756754142	54	0.0767039967822533
2TemtU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	70.0149120880153	55	0.0836231614976395
2TemtU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.474653182125158	55	1
2viv8j	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	71.4505028097751	51	0.0308747371047504
2viv8j	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	66.9483408461663	50	0.054897631563375
2viv8j	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	71.5046446686616	51	0.0305770450725814
2viv8j	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0600185501449865	51	1
2viv8j	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	64.0051388774144	51	0.104398870446352
2viv8j	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	61.5137085105533	50	0.12739664384345
2viv8j	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	64.0200461013039	51	0.104169270160605
2viv8j	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0845892949963432	51	1
2viv8j	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	58.7886774644485	49	0.159609525303933
2viv8j	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	57.7656779196105	48	0.157887960819562
2viv8j	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	58.9031542081024	49	0.157136376163206
2viv8j	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.338216554003795	49	1
33lkXK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	66.9127305850969	51	0.0667014360468658
33lkXK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_PL_int_imputed.txt_snps.txt	MR Egger	66.8906299785583	50	0.0554281292877342
33lkXK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	66.9142814878008	51	0.0666848470602642
33lkXK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0635716080072298	51	1
33lkXK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	64.6495809646273	51	0.0948343451764035
33lkXK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_PL_int_imputed.txt_snps.txt	MR Egger	64.6433090314983	50	0.0797187536180361
33lkXK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	64.6537961849474	51	0.0947741831965673
33lkXK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.106323691217688	51	1
33lkXK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	69.5013333480846	50	0.0353832181830529
33lkXK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_PL_int_imputed.txt_snps.txt	MR Egger	68.0830452477907	49	0.0369020292005835
33lkXK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	69.5126600592686	50	0.0353122472824554
33lkXK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.70185294232538	50	1
3aVL36	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	58.693342201842	35	0.00729727325425292
3aVL36	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_PL_int_imputed.txt_snps.txt	MR Egger	58.6770031820508	34	0.00536262649593241
3aVL36	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	58.7018601041033	35	0.00728262215216367
3aVL36	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0521160942069831	35	1
3aVL36	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	53.5822322411568	35	0.0230623488070477
3aVL36	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_PL_int_imputed.txt_snps.txt	MR Egger	53.3983388587591	34	0.0183017187712604
3aVL36	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	53.5851032474773	35	0.0230481958346112
3aVL36	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.086064804973794	35	1
3aVL36	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	30.5578127000102	34	0.637113040768314
3aVL36	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_PL_int_imputed.txt_snps.txt	MR Egger	26.8696455962655	33	0.765353369843848
3aVL36	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	30.6469914137958	34	0.632758018361728
3aVL36	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.236276171282512	34	1
3EGOyZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	74.663889202916	39	0.000508154029557161
3EGOyZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	74.5156097934283	38	0.000366213263091278
3EGOyZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	74.668752302186	39	0.000507503615892178
3EGOyZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0889712632305199	39	1
3EGOyZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	79.3749855132803	39	0.000142407183323557
3EGOyZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	79.1500801536292	38	0.000102125963406469
3EGOyZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	79.375203997974	39	0.000142398582281417
3EGOyZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.234521071228802	39	1
3EGOyZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	42.5464267356597	36	0.209920790823
3EGOyZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	41.5441596979557	35	0.207033027274449
3EGOyZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	42.5723485189584	36	0.209134968892899
3EGOyZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.426452340072855	36	1
3JPynM	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	55.0647663070864	34	0.0125830898010376
3JPynM	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_CE_int_imputed.txt_snps.txt	MR Egger	52.9334114606716	33	0.0153109945615708
3JPynM	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	55.077813671644	34	0.0125456254071012
3JPynM	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0499135527680208	34	1
3JPynM	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	52.5375482635735	34	0.0220999691007329
3JPynM	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_CE_int_imputed.txt_snps.txt	MR Egger	50.6257457725673	33	0.025543594048926
3JPynM	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	52.5771378371106	34	0.0219107762932441
3JPynM	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0849930360178252	34	1
3JPynM	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	35.0397747772824	32	0.325856314950979
3JPynM	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_CE_int_imputed.txt_snps.txt	MR Egger	27.4929166368631	31	0.647204692359976
3JPynM	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	35.0868251006093	32	0.323868043156558
3JPynM	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.237467682921637	32	1
3l2YuP	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_size_int_imputed.txt_snps.txt	Maximum likelihood	85.536069181706	70	0.0998828725667446
3l2YuP	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_size_int_imputed.txt_snps.txt	MR Egger	84.7319203002749	69	0.0959632992505414
3l2YuP	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_size_int_imputed.txt_snps.txt	Inverse variance weighted	85.5826509196807	70	0.0992801486409855
3l2YuP	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_size_int_imputed.txt_snps.txt	Unweighted regression	0.0815701746652443	70	1
3l2YuP	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_size_int_imputed.txt_snps.txt	Maximum likelihood	84.2447246033769	70	0.117766662012764
3l2YuP	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_size_int_imputed.txt_snps.txt	MR Egger	84.2892979293625	69	0.101690891148007
3l2YuP	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_size_int_imputed.txt_snps.txt	Inverse variance weighted	84.3062817197745	70	0.116861519058267
3l2YuP	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_size_int_imputed.txt_snps.txt	Unweighted regression	0.10792922070697	70	1
3l2YuP	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_size_int_imputed.txt_snps.txt	Maximum likelihood	77.6634784675882	66	0.154307951574804
3l2YuP	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_size_int_imputed.txt_snps.txt	MR Egger	70.5290868597664	65	0.298077435770321
3l2YuP	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_size_int_imputed.txt_snps.txt	Inverse variance weighted	77.6830772505664	66	0.153944688051328
3l2YuP	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_size_int_imputed.txt_snps.txt	Unweighted regression	0.456404041358728	66	1
3zWZil	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	66.2064250360619	58	0.214773885739669
3zWZil	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_P_int_imputed.txt_snps.txt	MR Egger	65.8131052692328	57	0.198198168777098
3zWZil	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	66.2097151869973	58	0.214692262960056
3zWZil	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0614137851036062	58	1
3zWZil	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	59.4519558637054	58	0.42249166207294
3zWZil	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_P_int_imputed.txt_snps.txt	MR Egger	58.5191827928137	57	0.41941368671434
3zWZil	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	59.4542403065624	58	0.422410082933254
3zWZil	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0821795849030758	58	1
3zWZil	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	80.7001069532799	56	0.0170142239189487
3zWZil	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_P_int_imputed.txt_snps.txt	MR Egger	79.9044960610727	55	0.015775132468999
3zWZil	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	80.7135815681264	56	0.0169720537737067
3zWZil	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.609030493543494	56	1
48uKRB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	68.995479038308	40	0.0029603208758504
48uKRB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_CE_int_imputed.txt_snps.txt	MR Egger	68.9281008906123	39	0.00218821005249505
48uKRB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	69.0181273797991	40	0.00294433812070025
48uKRB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0606111749092141	40	1
48uKRB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	65.890044149916	40	0.00611337202877778
48uKRB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_CE_int_imputed.txt_snps.txt	MR Egger	65.8304991612638	39	0.00460177181638325
48uKRB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	65.890519255016	40	0.0061127101046641
48uKRB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.114996002496198	40	1
48uKRB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	39.3780217027276	38	0.408060167614514
48uKRB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_CE_int_imputed.txt_snps.txt	MR Egger	34.479152299802	37	0.587816568089499
48uKRB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	39.5196107814326	38	0.401929252945898
48uKRB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.295868622139556	38	1
4Ahcrm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	64.6385365342468	51	0.0949921230878077
4Ahcrm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_L_int_imputed.txt_snps.txt	MR Egger	64.6321357245464	50	0.0798585475095614
4Ahcrm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	64.6453487579058	51	0.0948947804830373
4Ahcrm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0711361199646715	51	1
4Ahcrm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	52.9616062494244	51	0.398336590215274
4Ahcrm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_L_int_imputed.txt_snps.txt	MR Egger	51.9081109747635	50	0.399377959970251
4Ahcrm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	52.9616623790373	51	0.398334500900806
4Ahcrm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0908189837308826	51	1
4Ahcrm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	65.9644650113621	51	0.0775081489250343
4Ahcrm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_L_int_imputed.txt_snps.txt	MR Egger	65.6616323914652	50	0.0677977954454706
4Ahcrm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	65.9780984620178	51	0.0773431236871201
4Ahcrm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.895208964991405	51	1
4oyrSR	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_L_int_imputed.txt_snps.txt	Maximum likelihood	66.7043390888063	31	0.000203524060309861
4oyrSR	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_L_int_imputed.txt_snps.txt	MR Egger	64.5342288802493	30	0.000251529263511673
4oyrSR	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	66.7319389106964	31	0.000201887304229085
4oyrSR	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0386556283277175	31	1
4oyrSR	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_L_int_imputed.txt_snps.txt	Maximum likelihood	66.5116238161813	31	0.000215315276150161
4oyrSR	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_L_int_imputed.txt_snps.txt	MR Egger	65.7645745504879	30	0.000174963316566981
4oyrSR	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	66.5375951513077	31	0.000213688592207571
4oyrSR	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0504418872888965	31	1
4oyrSR	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_L_int_imputed.txt_snps.txt	Maximum likelihood	40.9245670983967	30	0.088163116782319
4oyrSR	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_L_int_imputed.txt_snps.txt	MR Egger	40.1345822606242	29	0.0817604201804478
4oyrSR	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	40.9293550153121	30	0.0880827188968265
4oyrSR	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.21078966426126	30	1
4PPW4h	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	57.6133595652767	35	0.00939267729382612
4PPW4h	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_PL_int_imputed.txt_snps.txt	MR Egger	54.0517209344339	34	0.0158248942404369
4PPW4h	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	57.6144568327768	35	0.00939029148158196
4PPW4h	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.037618902681893	35	1
4PPW4h	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	66.0051844936742	35	0.00117556841258146
4PPW4h	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_PL_int_imputed.txt_snps.txt	MR Egger	64.2955843500843	34	0.00128742681614905
4PPW4h	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	66.0081962392479	35	0.00117463907651241
4PPW4h	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0523044605580799	35	1
4PPW4h	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	47.6670687255128	34	0.060003906243076
4PPW4h	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_PL_int_imputed.txt_snps.txt	MR Egger	46.9464016001325	33	0.0547123049959457
4PPW4h	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	47.6694729632701	34	0.0599761420680884
4PPW4h	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.24966109784596	34	1
4VDymZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	59.6889071376335	52	0.216411219004232
4VDymZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_L_int_imputed.txt_snps.txt	MR Egger	59.6728975959565	51	0.189544949166891
4VDymZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	59.7021486969478	52	0.216064211146433
4VDymZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0501211620953235	52	1
4VDymZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	41.9487191969945	52	0.839121730628947
4VDymZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_L_int_imputed.txt_snps.txt	MR Egger	41.926007713015	51	0.81352544744522
4VDymZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	41.9536278976292	52	0.838986036128502
4VDymZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0593997561197772	52	1
4VDymZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	69.8220765088913	50	0.0334209923240625
4VDymZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_L_int_imputed.txt_snps.txt	MR Egger	69.5385566737643	49	0.0283696709035514
4VDymZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	69.8276918504394	50	0.0333875046446868
4VDymZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.553566808960583	50	1
4yAMb6	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	80.7884349815304	48	0.00213575256274248
4yAMb6	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_P_int_imputed.txt_snps.txt	MR Egger	79.8003083917468	47	0.00199049573351358
4yAMb6	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	80.8108459686466	48	0.00212483200287713
4yAMb6	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0727455686445239	48	1
4yAMb6	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	72.8186227591636	48	0.011924003231083
4yAMb6	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_P_int_imputed.txt_snps.txt	MR Egger	72.0916196868607	47	0.0107521160086911
4yAMb6	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	72.8477097281511	48	0.0118540939440705
4yAMb6	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0957384609833892	48	1
4yAMb6	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	64.7425947620811	48	0.0537987660648935
4yAMb6	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_P_int_imputed.txt_snps.txt	MR Egger	59.2659421235364	47	0.10809152770008
4yAMb6	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	64.8172176664533	48	0.0531195487818502
4yAMb6	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.536276659834041	48	1
4yP3Ta	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_size_int_imputed.txt_snps.txt	Maximum likelihood	45.0600157258959	54	0.801718626619075
4yP3Ta	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_size_int_imputed.txt_snps.txt	MR Egger	44.482836812905	53	0.791184284430685
4yP3Ta	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_size_int_imputed.txt_snps.txt	Inverse variance weighted	45.0787464298949	54	0.801151924493785
4yP3Ta	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_size_int_imputed.txt_snps.txt	Unweighted regression	0.0479021000557115	54	1
4yP3Ta	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_size_int_imputed.txt_snps.txt	Maximum likelihood	36.9896827036013	54	0.962734084762571
4yP3Ta	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_size_int_imputed.txt_snps.txt	MR Egger	36.3652992508117	53	0.96061900691257
4yP3Ta	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_size_int_imputed.txt_snps.txt	Inverse variance weighted	37.0068163250405	54	0.962560679140926
4yP3Ta	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_size_int_imputed.txt_snps.txt	Unweighted regression	0.0504557808175482	54	1
4yP3Ta	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_size_int_imputed.txt_snps.txt	Maximum likelihood	62.2068519268876	54	0.207152316266945
4yP3Ta	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_size_int_imputed.txt_snps.txt	MR Egger	60.7262975020687	53	0.217443635700947
4yP3Ta	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_size_int_imputed.txt_snps.txt	Inverse variance weighted	62.2069212031122	54	0.207150582855652
4yP3Ta	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_size_int_imputed.txt_snps.txt	Unweighted regression	0.526119155361123	54	1
4ySJC6	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	48.0368758973203	46	0.390265399393894
4ySJC6	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_TG_int_imputed.txt_snps.txt	MR Egger	44.9249332647224	45	0.475106609345954
4ySJC6	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	48.0439593396475	46	0.389990424683929
4ySJC6	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0445461240409899	46	1
4ySJC6	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	43.1638677064218	46	0.591752011191637
4ySJC6	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_TG_int_imputed.txt_snps.txt	MR Egger	38.0110367059142	45	0.760347612919748
4ySJC6	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	43.1646895811916	46	0.591717330810317
4ySJC6	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0704231937954229	46	1
4ySJC6	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	62.3040970113122	46	0.0547815914625401
4ySJC6	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_TG_int_imputed.txt_snps.txt	MR Egger	61.4606952752544	45	0.0517515273642319
4ySJC6	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	62.3141012871461	46	0.0546870521109676
4ySJC6	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.730331505143835	46	1
51xcbE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	65.5227780384568	51	0.0830130604309258
51xcbE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	65.329056807895	50	0.0715163682213454
51xcbE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	65.5253876610104	51	0.0829796210714926
51xcbE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0747237444443062	51	1
51xcbE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	63.2894693058772	51	0.115901146708564
51xcbE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	63.2883009197492	50	0.098192687000739
51xcbE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	63.2896668695435	51	0.115897839816798
51xcbE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.126507278952098	51	1
51xcbE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	57.8195680721818	49	0.181699496959662
51xcbE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	57.4795369585722	48	0.164203597476962
51xcbE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	57.8644912247149	49	0.180629499387194
51xcbE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.402633323398675	49	1
5Bs9x8	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	77.2748774177326	60	0.0659782935012077
5Bs9x8	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_FC_int_imputed.txt_snps.txt	MR Egger	72.9841002943636	59	0.104191853034713
5Bs9x8	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	77.2751427631248	60	0.0659756665580985
5Bs9x8	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0845759563290761	60	1
5Bs9x8	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	78.0412474375593	60	0.0587456858168478
5Bs9x8	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_FC_int_imputed.txt_snps.txt	MR Egger	77.2973409855554	59	0.0552167464069634
5Bs9x8	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	78.0429679550445	60	0.0587302285485501
5Bs9x8	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.134409341350093	60	1
5Bs9x8	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	80.8444816763725	56	0.0165672504428541
5Bs9x8	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_FC_int_imputed.txt_snps.txt	MR Egger	75.7070709719618	55	0.033497551124692
5Bs9x8	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	80.8740321557808	56	0.0164770765482726
5Bs9x8	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.459017103510443	56	1
5PvxLQ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	67.4431566705741	49	0.0413120296980752
5PvxLQ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_TG_int_imputed.txt_snps.txt	MR Egger	66.2826895102438	48	0.0411908805880254
5PvxLQ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	67.4461896769391	49	0.0412900943084764
5PvxLQ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0593938768602479	49	1
5PvxLQ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	60.2344435827375	49	0.1304317732783
5PvxLQ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_TG_int_imputed.txt_snps.txt	MR Egger	56.6116192823111	48	0.184485625102916
5PvxLQ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	60.2383958937474	49	0.13035801756761
5PvxLQ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.10044132724752	49	1
5PvxLQ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	39.15955442581	49	0.84159932897534
5PvxLQ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_TG_int_imputed.txt_snps.txt	MR Egger	39.1805788423478	48	0.814027361520503
5PvxLQ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	39.2007626386394	49	0.840428205804523
5PvxLQ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.674754654110854	49	1
664f84	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	62.1683561012997	51	0.135879544503
664f84	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_L_int_imputed.txt_snps.txt	MR Egger	61.464978104268	50	0.1282844128627
664f84	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	62.1747453706094	51	0.13575868024096
664f84	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0823003459520045	51	1
664f84	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	59.7956033174666	51	0.186597529456093
664f84	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_L_int_imputed.txt_snps.txt	MR Egger	59.755396951822	50	0.162515480034799
664f84	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	59.7990197342592	51	0.186515931170443
664f84	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.119517976762286	51	1
664f84	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	61.1470736048273	51	0.156266062258594
664f84	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_L_int_imputed.txt_snps.txt	MR Egger	61.1072925319503	50	0.134946905361102
664f84	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	61.184117287147	51	0.155489043863968
664f84	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.917331706451362	51	1
6HbaSm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	55.4117256218469	31	0.00450802012667238
6HbaSm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	53.3936676526046	30	0.00536719513859982
6HbaSm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	55.4142519483267	31	0.00450512758763357
6HbaSm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0388465322444655	31	1
6HbaSm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	51.6536263404604	31	0.0113735648830916
6HbaSm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	50.0965457567004	30	0.0121186050779647
6HbaSm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	51.674402885157	31	0.0113174209096134
6HbaSm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0596769727807763	31	1
6HbaSm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	35.2236496325117	31	0.275023250136377
6HbaSm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	32.1886906416889	30	0.358803941465926
6HbaSm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	35.2396714661722	31	0.274400972787008
6HbaSm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.313759446600406	31	1
6tHSci	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	73.9625214331166	44	0.00312568866126693
6tHSci	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	73.9185072858323	43	0.00233226661037162
6tHSci	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	74.0176939825208	44	0.00308618651411183
6tHSci	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0913222732075893	44	1
6tHSci	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	72.6848665570661	44	0.0041842941017494
6tHSci	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	71.9678729774428	43	0.00367560488051484
6tHSci	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	72.7088094950884	44	0.00416169546745608
6tHSci	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.148895101685493	44	1
6tHSci	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	41.7190545217651	41	0.439378233740531
6tHSci	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	37.3737659642313	40	0.589114869747306
6tHSci	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	41.9481847411335	41	0.429566325793381
6tHSci	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.305561973761812	41	1
6zPugv	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_L_int_imputed.txt_snps.txt	Maximum likelihood	68.9830558203196	58	0.153224135558217
6zPugv	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_L_int_imputed.txt_snps.txt	MR Egger	68.4396964536353	57	0.142617510460487
6zPugv	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	68.98306597467	58	0.153223936972046
6zPugv	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0570905889822519	58	1
6zPugv	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_L_int_imputed.txt_snps.txt	Maximum likelihood	68.3211436186872	58	0.166574802120126
6zPugv	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_L_int_imputed.txt_snps.txt	MR Egger	67.9765073741006	57	0.15147033096604
6zPugv	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	68.3211946257355	58	0.16657374185561
6zPugv	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.075683963726523	58	1
6zPugv	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_L_int_imputed.txt_snps.txt	Maximum likelihood	87.1975823704313	56	0.00479545594901382
6zPugv	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_L_int_imputed.txt_snps.txt	MR Egger	81.8444442774381	55	0.0109082184498352
6zPugv	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	87.258327351872	56	0.00473601526176932
6zPugv	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.49402839742561	56	1
7g2xCE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	53.506354703105	39	0.0608588920744886
7g2xCE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_PL_int_imputed.txt_snps.txt	MR Egger	53.3273004947349	38	0.0505337870170477
7g2xCE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	53.5141754312664	39	0.0607724388262908
7g2xCE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0364296319330573	39	1
7g2xCE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	46.0804902747058	39	0.20263169315159
7g2xCE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_PL_int_imputed.txt_snps.txt	MR Egger	46.0870060834914	38	0.172517333679538
7g2xCE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	46.0958854290897	39	0.202192228898974
7g2xCE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0576636255318792	39	1
7g2xCE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	37.9400233719597	39	0.518096255441055
7g2xCE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_PL_int_imputed.txt_snps.txt	MR Egger	35.9456415831075	38	0.56478886960582
7g2xCE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	37.9803797169857	39	0.516244472906695
7g2xCE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.266504122564399	39	1
7hbbkU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	68.6409381553878	56	0.119643622454798
7hbbkU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	67.907513158295	55	0.113480484268228
7hbbkU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	68.7060830841743	56	0.118574309682815
7hbbkU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0635489940337881	56	1
7hbbkU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	72.8624999811771	56	0.0644660710966686
7hbbkU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	72.8706668680738	55	0.0536947132970287
7hbbkU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	72.8711959967792	56	0.0643791806127082
7hbbkU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.117684147328815	56	1
7hbbkU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	82.548522201371	54	0.00745213156284325
7hbbkU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	82.6589491294414	53	0.00565666251961666
7hbbkU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	82.7128501187501	54	0.00720950006069661
7hbbkU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.969408629845985	54	1
7ulVhJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	74.8150265107379	48	0.00790851057443643
7ulVhJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_C_pct_int_imputed.txt_snps.txt	MR Egger	74.6125511112148	47	0.00633168482342463
7ulVhJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	74.817075814518	48	0.00790512078345793
7ulVhJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.092454026536091	48	1
7ulVhJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	61.9064185176487	48	0.0856267428726944
7ulVhJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_C_pct_int_imputed.txt_snps.txt	MR Egger	61.3379007742979	47	0.0781186389018877
7ulVhJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	61.9064400849323	48	0.085626452006552
7ulVhJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.113662055008275	48	1
7ulVhJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	51.5592083310964	44	0.20214493106101
7ulVhJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_C_pct_int_imputed.txt_snps.txt	MR Egger	50.8792782406984	43	0.191166143672939
7ulVhJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	51.6071587835165	44	0.200852778133485
7ulVhJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.483881695769933	44	1
7uxmJU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	SFA_pct_int_imputed.txt_snps.txt	Maximum likelihood	14.2644049663025	13	0.355490375996352
7uxmJU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	SFA_pct_int_imputed.txt_snps.txt	MR Egger	13.7613267728105	12	0.316208544995321
7uxmJU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	SFA_pct_int_imputed.txt_snps.txt	Inverse variance weighted	14.331370252464	13	0.350928088119319
7uxmJU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	SFA_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0113226980876586	13	1
7uxmJU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	SFA_pct_int_imputed.txt_snps.txt	Maximum likelihood	13.3256764655049	13	0.422981917973375
7uxmJU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	SFA_pct_int_imputed.txt_snps.txt	MR Egger	13.4181185585054	12	0.339396267990658
7uxmJU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	SFA_pct_int_imputed.txt_snps.txt	Inverse variance weighted	13.4954255323368	13	0.410312008696136
7uxmJU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	SFA_pct_int_imputed.txt_snps.txt	Unweighted regression	0.00988031771614126	13	1
7uxmJU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	SFA_pct_int_imputed.txt_snps.txt	Maximum likelihood	24.7629553219339	13	0.024795163656504
7uxmJU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	SFA_pct_int_imputed.txt_snps.txt	MR Egger	23.7504868017695	12	0.02198962201246
7uxmJU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	SFA_pct_int_imputed.txt_snps.txt	Inverse variance weighted	24.9315905819549	13	0.0235660682886161
7uxmJU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	SFA_pct_int_imputed.txt_snps.txt	Unweighted regression	0.202082016754587	13	0.999999999834384
7ySKLK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	82.1704370567283	43	0.000298769000544607
7ySKLK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	82.067178730801	42	0.000213628284708024
7ySKLK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	82.1719945767615	43	0.000298647622362324
7ySKLK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.110418073837329	43	1
7ySKLK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	56.9131686453893	43	0.0758283255953314
7ySKLK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	56.8820766115861	42	0.0624170715804923
7ySKLK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	56.9191779375152	43	0.0757515592780131
7ySKLK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.120597546189956	43	1
7ySKLK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	52.7467276894628	41	0.103343224352573
7ySKLK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	50.8020529169026	40	0.117707573363482
7ySKLK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	52.7470344557227	41	0.103338074500786
7ySKLK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.397359966147093	41	1
83Y90V	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	64.120777240859	40	0.00909586261923605
83Y90V	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	61.4046239599055	39	0.0125191187818574
83Y90V	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	64.190075685037	40	0.00895741265771026
83Y90V	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0442678018160537	40	1
83Y90V	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	57.8211295192214	40	0.0337905587639541
83Y90V	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	56.1505308869123	39	0.0369992764979016
83Y90V	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	57.8316245008477	40	0.0337215597861241
83Y90V	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0670896291377164	40	1
83Y90V	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	47.2428568003869	40	0.200719616186709
83Y90V	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	44.7901195535138	39	0.24184068854606
83Y90V	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	47.2550715331542	40	0.200377116026438
83Y90V	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.458699889346184	40	1
8GYfcc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	ApoB_int_imputed.txt_snps.txt	Maximum likelihood	69.0981509705976	45	0.0119618160431704
8GYfcc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	ApoB_int_imputed.txt_snps.txt	MR Egger	67.9003010448891	44	0.0118565738195057
8GYfcc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	ApoB_int_imputed.txt_snps.txt	Inverse variance weighted	69.1164829532505	45	0.011916500172769
8GYfcc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	ApoB_int_imputed.txt_snps.txt	Unweighted regression	0.0377345048764985	45	1
8GYfcc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	ApoB_int_imputed.txt_snps.txt	Maximum likelihood	59.1899495270587	45	0.0762162106895151
8GYfcc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	ApoB_int_imputed.txt_snps.txt	MR Egger	58.7236695579191	44	0.0678960775054616
8GYfcc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	ApoB_int_imputed.txt_snps.txt	Inverse variance weighted	59.2207829082124	45	0.0758287392430513
8GYfcc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	ApoB_int_imputed.txt_snps.txt	Unweighted regression	0.0659613458725423	45	1
8GYfcc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	ApoB_int_imputed.txt_snps.txt	Maximum likelihood	60.5331215155058	45	0.0607909825621103
8GYfcc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	ApoB_int_imputed.txt_snps.txt	MR Egger	57.1168133005997	44	0.0886824775749926
8GYfcc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	ApoB_int_imputed.txt_snps.txt	Inverse variance weighted	60.6382270637603	45	0.0597037868837351
8GYfcc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	ApoB_int_imputed.txt_snps.txt	Unweighted regression	0.538210032167523	45	1
8Kaos1	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_P_int_imputed.txt_snps.txt	Maximum likelihood	122.431817770701	73	0.000259473729408183
8Kaos1	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_P_int_imputed.txt_snps.txt	MR Egger	121.296220308242	72	0.000250906353845745
8Kaos1	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	122.471507394401	73	0.000257219941588603
8Kaos1	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.151303823736524	73	1
8Kaos1	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_P_int_imputed.txt_snps.txt	Maximum likelihood	109.390936631742	73	0.00375570753733183
8Kaos1	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_P_int_imputed.txt_snps.txt	MR Egger	109.435024313387	72	0.00294609566443433
8Kaos1	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	109.440582481127	73	0.0037205985110313
8Kaos1	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.226258213204181	73	1
8Kaos1	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_P_int_imputed.txt_snps.txt	Maximum likelihood	78.6004452927234	68	0.178231597510462
8Kaos1	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_P_int_imputed.txt_snps.txt	MR Egger	74.26929887297	67	0.253432330458305
8Kaos1	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	78.6263966775222	68	0.177705388233814
8Kaos1	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.519094872483069	68	1
8NOPDu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_L_int_imputed.txt_snps.txt	Maximum likelihood	74.6296199662696	50	0.0135520256518981
8NOPDu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_L_int_imputed.txt_snps.txt	MR Egger	69.2324262888984	49	0.0300039070507839
8NOPDu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	74.6302036760685	50	0.0135504697856433
8NOPDu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.066388500868186	50	1
8NOPDu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_L_int_imputed.txt_snps.txt	Maximum likelihood	61.4088463938426	50	0.129312907842222
8NOPDu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_L_int_imputed.txt_snps.txt	MR Egger	58.0451624347266	49	0.176371632422987
8NOPDu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	61.4140863460601	50	0.129216629522412
8NOPDu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0606067873669792	50	1
8NOPDu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_L_int_imputed.txt_snps.txt	Maximum likelihood	65.4236969935548	48	0.0478656399381769
8NOPDu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_L_int_imputed.txt_snps.txt	MR Egger	61.8625377117958	47	0.0717253018494719
8NOPDu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	65.4508316239052	48	0.0476413723525439
8NOPDu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.405896432882982	48	1
8oXIZY	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Acetoacetate_int_imputed.txt_snps.txt	Maximum likelihood	0.887623768110654	3	0.828413405154782
8oXIZY	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Acetoacetate_int_imputed.txt_snps.txt	MR Egger	0.874499216971855	2	0.645810211581433
8oXIZY	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Acetoacetate_int_imputed.txt_snps.txt	Inverse variance weighted	0.887772856717594	3	0.828377452912637
8oXIZY	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Acetoacetate_int_imputed.txt_snps.txt	Unweighted regression	0.000349756516398577	3	0.999998260509905
8oXIZY	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Acetoacetate_int_imputed.txt_snps.txt	Maximum likelihood	1.17861972916073	3	0.758136617765863
8oXIZY	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Acetoacetate_int_imputed.txt_snps.txt	MR Egger	1.12919144018977	2	0.568589969797029
8oXIZY	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Acetoacetate_int_imputed.txt_snps.txt	Inverse variance weighted	1.17866446157566	3	0.758125870833753
8oXIZY	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Acetoacetate_int_imputed.txt_snps.txt	Unweighted regression	0.000485722279531084	3	0.999997153327142
8oXIZY	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Acetoacetate_int_imputed.txt_snps.txt	Maximum likelihood	4.92758402796217	3	0.177177248407063
8oXIZY	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Acetoacetate_int_imputed.txt_snps.txt	MR Egger	1.49379583659075	2	0.473834147504705
8oXIZY	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Acetoacetate_int_imputed.txt_snps.txt	Inverse variance weighted	4.92975152726805	3	0.177013948022421
8oXIZY	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Acetoacetate_int_imputed.txt_snps.txt	Unweighted regression	0.0267819929144074	3	0.998843631021252
8ru6L4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	78.6428754743846	42	0.000523248058516771
8ru6L4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_C_int_imputed.txt_snps.txt	MR Egger	78.2717127628592	41	0.000404632560083767
8ru6L4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	78.6429127852913	42	0.000523243044525795
8ru6L4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0808164575224486	42	1
8ru6L4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	81.312890927973	42	0.000260947525728771
8ru6L4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_C_int_imputed.txt_snps.txt	MR Egger	81.1545067791323	41	0.000188139474165677
8ru6L4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	81.313792404206	42	0.000260885371862892
8ru6L4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.162284388643415	42	1
8ru6L4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	41.5660431249875	41	0.445971821741488
8ru6L4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_C_int_imputed.txt_snps.txt	MR Egger	34.8223208771434	40	0.702109420750961
8ru6L4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	41.6710075816258	41	0.441445220834107
8ru6L4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.321929878541686	41	1
90qqPa	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	80.5175501982905	64	0.0795322196152419
90qqPa	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	78.1356149178099	63	0.0948058143073164
90qqPa	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	80.5178789086792	64	0.0795285275713759
90qqPa	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.144462471041485	64	1
90qqPa	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	72.762988242384	64	0.211826071034725
90qqPa	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	72.6289727008926	63	0.190418574815221
90qqPa	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	72.7631017661156	64	0.211823403885072
90qqPa	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.221551831546295	64	1
90qqPa	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	80.2469003324583	59	0.0343407263537832
90qqPa	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	69.8280071982139	58	0.13735032905224
90qqPa	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	80.2574261667894	59	0.0342806248660887
90qqPa	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.79027739683418	59	1
92b9p2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_P_int_imputed.txt_snps.txt	Maximum likelihood	77.7146246669321	44	0.0012871237807883
92b9p2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_P_int_imputed.txt_snps.txt	MR Egger	76.8844960470374	43	0.00114073425132615
92b9p2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	77.818442879061	44	0.00125512461185899
92b9p2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.051004964255762	44	1
92b9p2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_P_int_imputed.txt_snps.txt	Maximum likelihood	64.7412648040258	44	0.0224979815342257
92b9p2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_P_int_imputed.txt_snps.txt	MR Egger	63.9740396044271	43	0.0205751149057356
92b9p2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	64.8228945870474	44	0.0221397608259456
92b9p2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0704881279435774	44	1
92b9p2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_P_int_imputed.txt_snps.txt	Maximum likelihood	57.335792907637	43	0.0705846330285472
92b9p2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_P_int_imputed.txt_snps.txt	MR Egger	45.9437929678083	42	0.312138496232829
92b9p2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	57.5584449793448	43	0.0679461091418305
92b9p2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.368354652801616	43	1
9Ai83a	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	62.603022444136	58	0.316282057106925
9Ai83a	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_FC_int_imputed.txt_snps.txt	MR Egger	61.7134161973189	57	0.311390824213702
9Ai83a	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	62.6039124682594	58	0.316254133229386
9Ai83a	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.056156167295528	58	1
9Ai83a	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	52.7465214891944	58	0.670358410117463
9Ai83a	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_FC_int_imputed.txt_snps.txt	MR Egger	51.6004980463253	57	0.677107696486584
9Ai83a	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	52.7590818695591	58	0.669908897832336
9Ai83a	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0761306046048104	58	1
9Ai83a	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	87.9885082191339	58	0.00673061731326336
9Ai83a	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_FC_int_imputed.txt_snps.txt	MR Egger	87.9753975220985	57	0.00527186303452674
9Ai83a	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	88.0131804931936	58	0.00669790661977006
9Ai83a	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	1.04814510028659	58	1
9pVrvx	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_CE_int_imputed.txt_snps.txt	Maximum likelihood	71.0699673809266	42	0.00335446529374738
9pVrvx	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_CE_int_imputed.txt_snps.txt	MR Egger	71.0792600121867	41	0.00245958724541967
9pVrvx	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_CE_int_imputed.txt_snps.txt	Inverse variance weighted	71.0798956000416	42	0.00334670781442413
9pVrvx	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0744148742392781	42	1
9pVrvx	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_CE_int_imputed.txt_snps.txt	Maximum likelihood	61.8422471273841	42	0.0246780611800696
9pVrvx	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_CE_int_imputed.txt_snps.txt	MR Egger	61.8580695098702	41	0.0192263990306068
9pVrvx	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_CE_int_imputed.txt_snps.txt	Inverse variance weighted	61.8626740596269	42	0.024578406596204
9pVrvx	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0907397028746831	42	1
9pVrvx	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_CE_int_imputed.txt_snps.txt	Maximum likelihood	53.3209735920318	41	0.094058205124785
9pVrvx	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_CE_int_imputed.txt_snps.txt	MR Egger	45.9089246748868	40	0.240591423296706
9pVrvx	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_CE_int_imputed.txt_snps.txt	Inverse variance weighted	53.3430164841912	41	0.0937157329348227
9pVrvx	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_CE_int_imputed.txt_snps.txt	Unweighted regression	0.253260054982948	41	1
9X8zTi	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_C_int_imputed.txt_snps.txt	Maximum likelihood	72.3330314201875	40	0.00130869485136132
9X8zTi	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_C_int_imputed.txt_snps.txt	MR Egger	72.3627973741635	39	0.000924164346148768
9X8zTi	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	72.376901244036	40	0.00129441609267217
9X8zTi	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0867853686911449	40	1
9X8zTi	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_C_int_imputed.txt_snps.txt	Maximum likelihood	71.799177666593	40	0.00149487401696368
9X8zTi	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_C_int_imputed.txt_snps.txt	MR Egger	71.7365130174929	39	0.00108449872456939
9X8zTi	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	71.801661808225	40	0.00149395222809774
9X8zTi	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.153685145169642	40	1
9X8zTi	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_C_int_imputed.txt_snps.txt	Maximum likelihood	37.3030410063107	39	0.547421998531552
9X8zTi	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_C_int_imputed.txt_snps.txt	MR Egger	35.9966965139264	38	0.562399584755906
9X8zTi	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	37.4418175926194	39	0.541021034251251
9X8zTi	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.210904621917071	39	1
a0oD2i	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_P_int_imputed.txt_snps.txt	Maximum likelihood	54.6909360594396	30	0.00384689794402358
a0oD2i	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_P_int_imputed.txt_snps.txt	MR Egger	54.3015376041909	29	0.0029864691992715
a0oD2i	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	54.880361750775	30	0.00366222673037432
a0oD2i	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0643574115307689	30	1
a0oD2i	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_P_int_imputed.txt_snps.txt	Maximum likelihood	50.6206688230411	30	0.0106811582254799
a0oD2i	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_P_int_imputed.txt_snps.txt	MR Egger	49.357787094352	29	0.0105815879695484
a0oD2i	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	50.7119927371923	30	0.0104474083556024
a0oD2i	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0830402000612417	30	1
a0oD2i	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_P_int_imputed.txt_snps.txt	Maximum likelihood	44.6695432836423	27	0.01761449565074
a0oD2i	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_P_int_imputed.txt_snps.txt	MR Egger	44.7261404645594	26	0.012611797491947
a0oD2i	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	44.7623103259722	27	0.0172243745603725
a0oD2i	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.284530966416612	27	1
AcRhqJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	49.5410904843058	22	0.000676234871764331
AcRhqJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_C_pct_int_imputed.txt_snps.txt	MR Egger	49.5460130404205	21	0.000421764841721332
AcRhqJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	49.546225302839	22	0.00067516077299614
AcRhqJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.029116908061601	22	1
AcRhqJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	34.6620914049361	22	0.0420107999622395
AcRhqJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_C_pct_int_imputed.txt_snps.txt	MR Egger	34.6191157581292	21	0.0310736298180135
AcRhqJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	34.663051399	22	0.0420011860181804
AcRhqJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0342061055322123	22	1
AcRhqJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	28.9123894853262	21	0.116120813061646
AcRhqJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_C_pct_int_imputed.txt_snps.txt	MR Egger	27.8824453214106	20	0.11221147252736
AcRhqJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	28.9129788897307	21	0.116106448508055
AcRhqJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.203932513018117	21	1
AfAEGp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_P_int_imputed.txt_snps.txt	Maximum likelihood	97.3534226346256	47	2.25098253223064e-05
AfAEGp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_P_int_imputed.txt_snps.txt	MR Egger	95.787340770929	46	2.34440203112729e-05
AfAEGp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_P_int_imputed.txt_snps.txt	Inverse variance weighted	97.359301928274	47	2.24732336677955e-05
AfAEGp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_P_int_imputed.txt_snps.txt	Unweighted regression	0.0819304064786462	47	1
AfAEGp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_P_int_imputed.txt_snps.txt	Maximum likelihood	89.1272927055103	47	0.000202948420190828
AfAEGp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_P_int_imputed.txt_snps.txt	MR Egger	86.5904105958995	46	0.000274470952134241
AfAEGp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_P_int_imputed.txt_snps.txt	Inverse variance weighted	89.1297765116743	47	0.000202818700988906
AfAEGp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_P_int_imputed.txt_snps.txt	Unweighted regression	0.0969715553304926	47	1
AfAEGp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_P_int_imputed.txt_snps.txt	Maximum likelihood	65.4547978485319	46	0.031121688078996
AfAEGp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_P_int_imputed.txt_snps.txt	MR Egger	62.1329356558889	45	0.0459416367259934
AfAEGp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_P_int_imputed.txt_snps.txt	Inverse variance weighted	65.470100672754	46	0.0310331450341301
AfAEGp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_P_int_imputed.txt_snps.txt	Unweighted regression	0.456547754875882	46	1
AGoBQl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	59.2735358338916	36	0.00860613863443318
AGoBQl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_PL_int_imputed.txt_snps.txt	MR Egger	59.3028838218945	35	0.00631513358994044
AGoBQl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	59.3079975627797	36	0.00853795451708682
AGoBQl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0492702866696282	36	1
AGoBQl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	51.3564138134295	36	0.0466459895553666
AGoBQl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_PL_int_imputed.txt_snps.txt	MR Egger	50.9329400197427	35	0.0399611472217518
AGoBQl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	51.3901867354856	36	0.0463398445565667
AGoBQl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0808033567963144	36	1
AGoBQl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	27.1539284234548	34	0.791363948969471
AGoBQl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_PL_int_imputed.txt_snps.txt	MR Egger	23.1667867682793	33	0.898439329211878
AGoBQl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	27.2304194389441	34	0.788260270165846
AGoBQl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.149755290494554	34	1
aGyRvY	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_P_int_imputed.txt_snps.txt	Maximum likelihood	77.8594787727501	44	0.00124268566469044
aGyRvY	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_P_int_imputed.txt_snps.txt	MR Egger	73.6345447160215	43	0.00249388371661384
aGyRvY	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	77.8616945022102	44	0.00124201736315949
aGyRvY	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0700790383815116	44	1
aGyRvY	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_P_int_imputed.txt_snps.txt	Maximum likelihood	75.0660945096613	44	0.00241901485612531
aGyRvY	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_P_int_imputed.txt_snps.txt	MR Egger	70.6522345169188	43	0.0049592310830294
aGyRvY	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	75.0686038609693	44	0.00241759461338882
aGyRvY	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0783704012113233	44	1
aGyRvY	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_P_int_imputed.txt_snps.txt	Maximum likelihood	52.8020018599654	43	0.145348498190156
aGyRvY	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_P_int_imputed.txt_snps.txt	MR Egger	49.7501619989454	42	0.192058924549499
aGyRvY	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	52.8133363520442	43	0.145105358103465
aGyRvY	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.365603216296797	43	1
ajr14i	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	78.5524868422528	39	0.000178604112717492
ajr14i	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_TG_int_imputed.txt_snps.txt	MR Egger	77.6375388424072	38	0.000155924342345543
ajr14i	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	78.6935725759104	39	0.000171820543524127
ajr14i	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0928762425949959	39	1
ajr14i	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	66.5688058626248	39	0.00386643271492734
ajr14i	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_TG_int_imputed.txt_snps.txt	MR Egger	64.3831993526447	38	0.00476776088547178
ajr14i	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	66.7055895765035	39	0.00374290066452416
ajr14i	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.125312719400963	39	1
ajr14i	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	51.4782969262054	38	0.0710166984773997
ajr14i	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_TG_int_imputed.txt_snps.txt	MR Egger	51.4798963062435	37	0.0572139862663322
ajr14i	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	51.4826310845195	38	0.0709615266632932
ajr14i	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.428433245289411	38	1
AQey12	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	59.0244548847804	41	0.0337963761169799
AQey12	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_TG_int_imputed.txt_snps.txt	MR Egger	56.7740400897941	40	0.0413295683855699
AQey12	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	59.0374792786142	41	0.0337115765761546
AQey12	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0430126113653073	41	1
AQey12	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	54.5272396718727	41	0.0767577840432249
AQey12	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_TG_int_imputed.txt_snps.txt	MR Egger	50.0613887085978	40	0.13230466579916
AQey12	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	54.5374511121242	41	0.0766234195073634
AQey12	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0626868806628493	41	1
AQey12	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	59.400753898736	41	0.0314206000158616
AQey12	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_TG_int_imputed.txt_snps.txt	MR Egger	59.3184913416034	40	0.0251172056306976
AQey12	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	59.4225512104597	41	0.0312876118268496
AQey12	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.494077457835365	41	1
as4H97	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	64.1753468499654	52	0.119813114210826
as4H97	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_PL_int_imputed.txt_snps.txt	MR Egger	62.6052076847351	51	0.127802854122266
as4H97	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	64.1832097426187	52	0.119679246971772
as4H97	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0627020622454587	52	1
as4H97	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	62.7258375223109	52	0.146528235136475
as4H97	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_PL_int_imputed.txt_snps.txt	MR Egger	60.948176696447	51	0.16048713320633
as4H97	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	62.7330773892141	52	0.146384499422364
as4H97	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.079957762830887	52	1
as4H97	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	67.5317564152197	50	0.0497725919539534
as4H97	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_PL_int_imputed.txt_snps.txt	MR Egger	65.4865620210339	49	0.0577290982224722
as4H97	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	67.5561059244829	50	0.0495678869158014
as4H97	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.525569075251002	50	1
aXHsS6	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	non_HDL_C_int_imputed.txt_snps.txt	Maximum likelihood	56.9884680960495	38	0.0245264970986354
aXHsS6	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	non_HDL_C_int_imputed.txt_snps.txt	MR Egger	56.7763153243392	37	0.0198060950811477
aXHsS6	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	non_HDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	56.9944753861235	38	0.0244961718382405
aXHsS6	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	non_HDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.06257336266584	38	1
aXHsS6	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	non_HDL_C_int_imputed.txt_snps.txt	Maximum likelihood	56.2684564261173	38	0.0284133541270971
aXHsS6	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	non_HDL_C_int_imputed.txt_snps.txt	MR Egger	56.012783574958	37	0.0232665512444265
aXHsS6	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	non_HDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	56.271257424451	38	0.0283972282876168
aXHsS6	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	non_HDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.119559986219948	38	1
aXHsS6	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	non_HDL_C_int_imputed.txt_snps.txt	Maximum likelihood	39.8220493915719	35	0.264106742517001
aXHsS6	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	non_HDL_C_int_imputed.txt_snps.txt	MR Egger	34.6202683793657	34	0.438173747164096
aXHsS6	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	non_HDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	39.919088528409	35	0.26064534540654
aXHsS6	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	non_HDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.196867610861474	35	1
azn3mg	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	57.1219209662447	54	0.359906274671255
azn3mg	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	57.124047688269	53	0.324546480542304
azn3mg	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	57.1249462733205	54	0.359801485485868
azn3mg	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0642382400841662	54	1
azn3mg	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	62.7905738788697	54	0.192896095546571
azn3mg	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	62.8009011851548	53	0.167835643641534
azn3mg	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	62.8009725742855	54	0.192648460691142
azn3mg	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.108091381619407	54	1
azn3mg	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	66.5532406541227	53	0.0999261254441844
azn3mg	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	66.4084137708641	52	0.0862617651526479
azn3mg	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	66.6230666262596	53	0.0989078453683189
azn3mg	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.652486486604012	53	1
B3hFgI	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	60.7437399083707	36	0.00610381762010657
B3hFgI	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_CE_int_imputed.txt_snps.txt	MR Egger	59.8113502063187	35	0.00559146658711602
B3hFgI	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	60.7711451572638	36	0.00606436224850284
B3hFgI	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0614235463011564	36	1
B3hFgI	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	58.0335307998356	36	0.0114209772794759
B3hFgI	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_CE_int_imputed.txt_snps.txt	MR Egger	57.5567727923547	35	0.00951647591324389
B3hFgI	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	58.0726391324218	36	0.0113206024460264
B3hFgI	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0978041177844098	36	1
B3hFgI	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	31.3535888504273	34	0.597994866268309
B3hFgI	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_CE_int_imputed.txt_snps.txt	MR Egger	25.368441638146	33	0.826288410021959
B3hFgI	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	31.4470409311797	34	0.593372022515976
B3hFgI	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.179022948025896	34	1
bGTCfY	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Remnant_C_int_imputed.txt_snps.txt	Maximum likelihood	73.2375921598053	41	0.0014553774182511
bGTCfY	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Remnant_C_int_imputed.txt_snps.txt	MR Egger	72.537067525591	40	0.00124353086504938
bGTCfY	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Remnant_C_int_imputed.txt_snps.txt	Inverse variance weighted	73.2375929762568	41	0.00145537712523403
bGTCfY	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Remnant_C_int_imputed.txt_snps.txt	Unweighted regression	0.0866583694656919	41	1
bGTCfY	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Remnant_C_int_imputed.txt_snps.txt	Maximum likelihood	66.2339192072747	41	0.00753927517287036
bGTCfY	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Remnant_C_int_imputed.txt_snps.txt	MR Egger	66.2398403893522	40	0.00564364987100949
bGTCfY	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Remnant_C_int_imputed.txt_snps.txt	Inverse variance weighted	66.2423349926801	41	0.00752517369777376
bGTCfY	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Remnant_C_int_imputed.txt_snps.txt	Unweighted regression	0.146048433438193	41	1
bGTCfY	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Remnant_C_int_imputed.txt_snps.txt	Maximum likelihood	43.4924394634113	39	0.285957651488992
bGTCfY	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Remnant_C_int_imputed.txt_snps.txt	MR Egger	33.0723840594624	38	0.69647147927794
bGTCfY	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Remnant_C_int_imputed.txt_snps.txt	Inverse variance weighted	43.6250208998446	39	0.281239532631546
bGTCfY	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Remnant_C_int_imputed.txt_snps.txt	Unweighted regression	0.308840468307477	39	1
BLXt6H	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	PUFA_int_imputed.txt_snps.txt	Maximum likelihood	81.0157428904706	47	0.00149923315745669
BLXt6H	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	PUFA_int_imputed.txt_snps.txt	MR Egger	80.2489464532941	46	0.00131844984425039
BLXt6H	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	PUFA_int_imputed.txt_snps.txt	Inverse variance weighted	81.0345130028638	47	0.00149263302410245
BLXt6H	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	PUFA_int_imputed.txt_snps.txt	Unweighted regression	0.0650841757972994	47	1
BLXt6H	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	PUFA_int_imputed.txt_snps.txt	Maximum likelihood	73.3585882673266	47	0.00826289296680822
BLXt6H	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	PUFA_int_imputed.txt_snps.txt	MR Egger	73.2629458982458	46	0.00645675476411895
BLXt6H	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	PUFA_int_imputed.txt_snps.txt	Inverse variance weighted	73.3635743278188	47	0.00825424120306261
BLXt6H	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	PUFA_int_imputed.txt_snps.txt	Unweighted regression	0.0758675838594369	47	1
BLXt6H	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	PUFA_int_imputed.txt_snps.txt	Maximum likelihood	54.0375987067677	45	0.167352618597863
BLXt6H	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	PUFA_int_imputed.txt_snps.txt	MR Egger	52.0798054470388	44	0.18842349849943
BLXt6H	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	PUFA_int_imputed.txt_snps.txt	Inverse variance weighted	54.0820331383999	45	0.166316713006778
BLXt6H	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	PUFA_int_imputed.txt_snps.txt	Unweighted regression	0.373725460449265	45	1
bP6Cly	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_P_int_imputed.txt_snps.txt	Maximum likelihood	93.0865411650097	63	0.00817966377741818
bP6Cly	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_P_int_imputed.txt_snps.txt	MR Egger	92.7112950740119	62	0.00696911952054992
bP6Cly	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	93.0892202975493	63	0.00817553877766016
bP6Cly	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.105138538288573	63	1
bP6Cly	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_P_int_imputed.txt_snps.txt	Maximum likelihood	87.0833581327996	63	0.02395100635015
bP6Cly	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_P_int_imputed.txt_snps.txt	MR Egger	87.0840744961893	62	0.0195484900272793
bP6Cly	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	87.1063072592886	63	0.0238580889793855
bP6Cly	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.140766323179285	63	1
bP6Cly	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_P_int_imputed.txt_snps.txt	Maximum likelihood	87.587279735273	60	0.0115992726764453
bP6Cly	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_P_int_imputed.txt_snps.txt	MR Egger	85.7713727897706	59	0.0129885025511783
bP6Cly	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	87.5948939331124	60	0.0115828531664177
bP6Cly	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.732766100835721	60	1
BRQTEp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	103.285694697527	63	0.0010345188884146
BRQTEp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_CE_int_imputed.txt_snps.txt	MR Egger	98.7579640472495	62	0.00207102802361829
BRQTEp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	103.310682208816	63	0.00102893933209384
BRQTEp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.110380396289429	63	1
BRQTEp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	89.8510500900578	63	0.014803022179057
BRQTEp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_CE_int_imputed.txt_snps.txt	MR Egger	88.8992433566976	62	0.0141694854374381
BRQTEp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	89.8577901966902	63	0.0147852416045071
BRQTEp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.130214024426099	63	1
BRQTEp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	72.6920275596927	61	0.145234706708849
BRQTEp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_CE_int_imputed.txt_snps.txt	MR Egger	68.048720317178	60	0.222285213112673
BRQTEp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	72.835526266629	61	0.142615375595487
BRQTEp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.472388335949823	61	1
bWur4l	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	48.60196346199	39	0.139384489934317
bWur4l	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	48.3178397045064	38	0.12186783486133
bWur4l	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	48.6023792607267	39	0.139375469242969
bWur4l	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.049135543049264	39	1
bWur4l	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	51.3555415898713	39	0.0889157614727011
bWur4l	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	49.9799440113126	38	0.0923578457347346
bWur4l	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	51.3618235960722	39	0.0888204570687911
bWur4l	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0721586219739568	39	1
bWur4l	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	59.8641984739595	38	0.0133224518065938
bWur4l	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	58.9450003809375	37	0.012363109152715
bWur4l	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	59.9417497289371	38	0.0130985863637378
bWur4l	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.424145085134225	38	1
CWNa35	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	60.1028102853471	41	0.0273795996445606
CWNa35	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_PL_int_imputed.txt_snps.txt	MR Egger	59.4650719481337	40	0.0243853394269714
CWNa35	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	60.1270045294095	41	0.0272489620635018
CWNa35	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0689157723351037	41	1
CWNa35	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	57.1892213509949	41	0.0477814724853047
CWNa35	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_PL_int_imputed.txt_snps.txt	MR Egger	57.1167594550318	40	0.0387145888209625
CWNa35	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	57.1962407433917	41	0.0477196435731584
CWNa35	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.131782788372735	41	1
CWNa35	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	47.6698892598564	38	0.13521219637868
CWNa35	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_PL_int_imputed.txt_snps.txt	MR Egger	41.2026207011492	37	0.291819842158301
CWNa35	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	47.7308954764577	38	0.13390947912465
CWNa35	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.324426993429014	38	1
cXXYjV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	57.5585181216583	47	0.139100927760911
cXXYjV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_C_pct_int_imputed.txt_snps.txt	MR Egger	57.1301284104675	46	0.125812363788579
cXXYjV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	57.5945166344589	47	0.13838354850457
cXXYjV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0667044234781142	47	1
cXXYjV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	68.7597751164274	47	0.0208916183898023
cXXYjV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_C_pct_int_imputed.txt_snps.txt	MR Egger	68.7452269974606	46	0.0165022476184998
cXXYjV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	68.795129600129	47	0.0207494926767745
cXXYjV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.110900513534319	47	1
cXXYjV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	46.6792635294755	45	0.403233530669542
cXXYjV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_C_pct_int_imputed.txt_snps.txt	MR Egger	41.9592011994965	44	0.559454814089877
cXXYjV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	46.7827737960946	45	0.399124682373864
cXXYjV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.378162308760403	45	1
Cy2SBE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_3_int_imputed.txt_snps.txt	Maximum likelihood	39.9225752366152	32	0.158522272612603
Cy2SBE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_3_int_imputed.txt_snps.txt	MR Egger	36.0518640612548	31	0.24402280890381
Cy2SBE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_3_int_imputed.txt_snps.txt	Inverse variance weighted	39.9274825337706	32	0.158394354649374
Cy2SBE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_3_int_imputed.txt_snps.txt	Unweighted regression	0.0387400486793993	32	1
Cy2SBE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_3_int_imputed.txt_snps.txt	Maximum likelihood	41.7295595480602	32	0.116519763629101
Cy2SBE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_3_int_imputed.txt_snps.txt	MR Egger	40.2488110573843	31	0.123524637450948
Cy2SBE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_3_int_imputed.txt_snps.txt	Inverse variance weighted	41.7371377127598	32	0.116364327669404
Cy2SBE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_3_int_imputed.txt_snps.txt	Unweighted regression	0.0542129868720497	32	1
Cy2SBE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_3_int_imputed.txt_snps.txt	Maximum likelihood	27.6824116406204	31	0.637509271146447
Cy2SBE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_3_int_imputed.txt_snps.txt	MR Egger	26.1088171751484	30	0.669565711505611
Cy2SBE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_3_int_imputed.txt_snps.txt	Inverse variance weighted	27.68402219635	31	0.637426670931548
Cy2SBE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_3_int_imputed.txt_snps.txt	Unweighted regression	0.193401820006769	31	1
CZlA55	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	38.8691488929353	28	0.0830506141716799
CZlA55	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_C_pct_int_imputed.txt_snps.txt	MR Egger	34.3936745432326	27	0.15489944662373
CZlA55	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	38.8732773557554	28	0.0829827756030227
CZlA55	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0391857277623186	28	1
CZlA55	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	31.3653420393032	28	0.301098719277423
CZlA55	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_C_pct_int_imputed.txt_snps.txt	MR Egger	28.656970303045	27	0.377726560323693
CZlA55	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	31.3751342294332	28	0.300677070821937
CZlA55	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0407391437330747	28	1
CZlA55	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	24.4598185304576	25	0.492949306504934
CZlA55	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_C_pct_int_imputed.txt_snps.txt	MR Egger	24.4601568646927	24	0.435551700974891
CZlA55	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	24.4981512130762	25	0.490761292215392
CZlA55	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0995487510149824	25	1
DgYLKv	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	91.804626305654	51	0.0004002473106122
DgYLKv	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_CE_int_imputed.txt_snps.txt	MR Egger	90.9393130116514	50	0.000356771843847744
DgYLKv	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	91.8240919349774	51	0.00039835246130513
DgYLKv	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0762617098665212	51	1
DgYLKv	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	87.4606858657094	51	0.00112531595771433
DgYLKv	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_CE_int_imputed.txt_snps.txt	MR Egger	87.2987783027375	50	0.000860265132979149
DgYLKv	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	87.4799824468455	51	0.00112028837807543
DgYLKv	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.114683702183765	51	1
DgYLKv	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	62.9696984469906	50	0.103001241821735
DgYLKv	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_CE_int_imputed.txt_snps.txt	MR Egger	55.8239058455947	49	0.233811089867452
DgYLKv	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	63.0357273091886	50	0.101989579372856
DgYLKv	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.401376328674923	50	1
dOhV4U	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	67.2572782568548	54	0.106185502644166
dOhV4U	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	67.3318790291084	53	0.0890341572809101
dOhV4U	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	67.3467711574207	54	0.104828304953593
dOhV4U	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0904031330801892	54	1
dOhV4U	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	64.577099908336	54	0.153569535205077
dOhV4U	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	64.5524536772375	53	0.132795220911455
dOhV4U	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	64.6223478880311	54	0.152656440549267
dOhV4U	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.114638642307508	54	1
dOhV4U	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	67.6526167860363	52	0.0711580379573223
dOhV4U	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	67.7356233214479	51	0.0583710302471044
dOhV4U	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	68.0165341099507	52	0.0671788684752547
dOhV4U	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.772360647346789	52	1
dPBX6A	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_L_int_imputed.txt_snps.txt	Maximum likelihood	76.7318192125191	46	0.00299207603241973
dPBX6A	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_L_int_imputed.txt_snps.txt	MR Egger	76.6672785911749	45	0.00225465719357296
dPBX6A	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_L_int_imputed.txt_snps.txt	Inverse variance weighted	76.7532032185431	46	0.00297755489997757
dPBX6A	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_L_int_imputed.txt_snps.txt	Unweighted regression	0.0659918258984343	46	1
dPBX6A	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_L_int_imputed.txt_snps.txt	Maximum likelihood	69.3841199112541	46	0.0145179419702013
dPBX6A	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_L_int_imputed.txt_snps.txt	MR Egger	69.2842806850154	45	0.0115089323976938
dPBX6A	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_L_int_imputed.txt_snps.txt	Inverse variance weighted	69.4124882470887	46	0.0144350710052451
dPBX6A	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_L_int_imputed.txt_snps.txt	Unweighted regression	0.0794654444857389	46	1
dPBX6A	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_L_int_imputed.txt_snps.txt	Maximum likelihood	38.4393531479511	45	0.744444241911435
dPBX6A	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_L_int_imputed.txt_snps.txt	MR Egger	36.4714948402202	44	0.782686577432342
dPBX6A	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_L_int_imputed.txt_snps.txt	Inverse variance weighted	38.4416429799121	45	0.744358091697028
dPBX6A	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_L_int_imputed.txt_snps.txt	Unweighted regression	0.165305015180181	45	1
DqEJHz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	70.7294687005862	48	0.0180427090869144
DqEJHz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_P_int_imputed.txt_snps.txt	MR Egger	70.0846495006704	47	0.0161228488419096
DqEJHz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	70.7399798370086	48	0.0180058846190637
DqEJHz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0512270430903572	48	1
DqEJHz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	63.1032224914183	48	0.0706861052051203
DqEJHz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_P_int_imputed.txt_snps.txt	MR Egger	62.9696190490309	47	0.0596555267388048
DqEJHz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	63.1246568355229	48	0.0704396376298071
DqEJHz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0878402937005341	48	1
DqEJHz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	61.3179346505457	47	0.0783709523230061
DqEJHz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_P_int_imputed.txt_snps.txt	MR Egger	56.5304515149368	46	0.137392560050587
DqEJHz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	61.3228525744666	47	0.0783087418879141
DqEJHz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.455057593968447	47	1
dT2sIA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	86.976541017265	66	0.0428545954792979
dT2sIA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_PL_int_imputed.txt_snps.txt	MR Egger	85.4337917182851	65	0.0455301856488318
dT2sIA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	87.0170603521179	66	0.0425876080149029
dT2sIA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0742171802118057	66	1
dT2sIA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	85.5727331962337	66	0.05302990813757
dT2sIA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_PL_int_imputed.txt_snps.txt	MR Egger	85.3513179598229	65	0.0461108360046247
dT2sIA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	85.6898208650778	66	0.0521094705436174
dT2sIA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.104070423309877	66	1
dT2sIA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	82.0773865241826	65	0.0747947735738082
dT2sIA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_PL_int_imputed.txt_snps.txt	MR Egger	76.3937368697007	64	0.137884639218076
dT2sIA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	82.0864709445014	65	0.0746984227202269
dT2sIA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.59621291306793	65	1
dUEtnJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	60.259713465079	43	0.0420146796376829
dUEtnJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_TG_int_imputed.txt_snps.txt	MR Egger	60.1397594058565	42	0.0343582984832144
dUEtnJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	60.2751830167769	43	0.0418951513070523
dUEtnJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0455663317427978	43	1
dUEtnJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	53.4298811432943	43	0.132339233711364
dUEtnJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_TG_int_imputed.txt_snps.txt	MR Egger	52.2247898081581	42	0.134027060068057
dUEtnJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	53.4301480789633	43	0.132333899987479
dUEtnJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0589883954530974	43	1
dUEtnJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	59.6219245533005	43	0.0472069305639037
dUEtnJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_TG_int_imputed.txt_snps.txt	MR Egger	59.0955242322163	42	0.0418254690073642
dUEtnJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	59.621939059582	43	0.0472068064422156
dUEtnJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.51746384963408	43	1
ECtbjA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Phe_int_imputed.txt_snps.txt	Maximum likelihood	8.08814477090022	5	0.151444235000678
ECtbjA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Phe_int_imputed.txt_snps.txt	MR Egger	7.87580573646595	4	0.0962350013806752
ECtbjA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Phe_int_imputed.txt_snps.txt	Inverse variance weighted	8.09207763379658	5	0.15123352553327
ECtbjA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Phe_int_imputed.txt_snps.txt	Unweighted regression	0.00457176043961389	5	0.999999924950394
ECtbjA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Phe_int_imputed.txt_snps.txt	Maximum likelihood	3.33850248640036	5	0.647952324631285
ECtbjA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Phe_int_imputed.txt_snps.txt	MR Egger	3.11232120202632	4	0.539207810832019
ECtbjA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Phe_int_imputed.txt_snps.txt	Inverse variance weighted	3.34584276257944	5	0.646830820608857
ECtbjA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Phe_int_imputed.txt_snps.txt	Unweighted regression	0.00434102819376346	5	0.999999934058769
ECtbjA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Phe_int_imputed.txt_snps.txt	Maximum likelihood	3.86041803960623	3	0.27693628163069
ECtbjA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Phe_int_imputed.txt_snps.txt	MR Egger	3.85182818264183	2	0.145742474018576
ECtbjA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Phe_int_imputed.txt_snps.txt	Inverse variance weighted	3.86563020145922	3	0.276343974868801
ECtbjA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Phe_int_imputed.txt_snps.txt	Unweighted regression	0.0108769640146253	3	0.999699279078735
EiP9Z5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	94.2717787863153	47	5.22579442947626e-05
EiP9Z5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	91.5342518101	46	7.49960138676934e-05
EiP9Z5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	94.2850948134386	47	5.20704985678935e-05
EiP9Z5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0871825456123	47	1
EiP9Z5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	93.0860472412712	47	7.18457450729357e-05
EiP9Z5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	88.6968827793848	46	0.000159097249328824
EiP9Z5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	93.086367905195	47	7.18395921462086e-05
EiP9Z5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.163082425505074	47	1
EiP9Z5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	55.0598874000305	44	0.122551661996141
EiP9Z5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	54.4273517819463	43	0.113542499338918
EiP9Z5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	55.2688355632389	44	0.11870501660976
EiP9Z5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.410192610491677	44	1
EiRUej	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	72.6483222965157	45	0.0056053402427559
EiRUej	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_C_pct_int_imputed.txt_snps.txt	MR Egger	72.6521399597791	44	0.00421536854486597
EiRUej	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	72.6705965351645	45	0.00557795473662641
EiRUej	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.076490230405039	45	1
EiRUej	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	75.2375316610579	45	0.0031364874923192
EiRUej	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_C_pct_int_imputed.txt_snps.txt	MR Egger	75.0331426924574	44	0.00243773792776702
EiRUej	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	75.2396215745245	45	0.00313498957283064
EiRUej	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.122007967798171	45	1
EiRUej	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	46.2082935249229	43	0.341180449044439
EiRUej	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_C_pct_int_imputed.txt_snps.txt	MR Egger	45.7187230438536	42	0.320373470735608
EiRUej	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	46.3843391667812	43	0.334582453519724
EiRUej	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.485252635976047	43	1
EWOi9i	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_C_int_imputed.txt_snps.txt	Maximum likelihood	79.3074423767217	55	0.0176260794133777
EWOi9i	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_C_int_imputed.txt_snps.txt	MR Egger	77.4309427442556	54	0.0199663324119973
EWOi9i	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	79.3365339264497	55	0.0175315577797718
EWOi9i	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0705003102267661	55	1
EWOi9i	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_C_int_imputed.txt_snps.txt	Maximum likelihood	69.3154395313613	55	0.0927338252936591
EWOi9i	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_C_int_imputed.txt_snps.txt	MR Egger	66.7721547957335	54	0.113785547644111
EWOi9i	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	69.3291641779853	55	0.0925476709505017
EWOi9i	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0719595702818094	55	1
EWOi9i	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_C_int_imputed.txt_snps.txt	Maximum likelihood	65.771883500125	54	0.130791099361646
EWOi9i	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_C_int_imputed.txt_snps.txt	MR Egger	61.6290189132094	53	0.194756805445818
EWOi9i	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	65.8288540284104	54	0.129773001289223
EWOi9i	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.507809060905729	54	1
eymStv	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_C_int_imputed.txt_snps.txt	Maximum likelihood	93.8752219110124	69	0.02492397636841
eymStv	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_C_int_imputed.txt_snps.txt	MR Egger	93.4409374050593	68	0.0220887514844483
eymStv	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	93.8999132395408	69	0.02482417742699
eymStv	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.110165372173042	69	1
eymStv	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_C_int_imputed.txt_snps.txt	Maximum likelihood	94.5778075540815	69	0.0222183945097884
eymStv	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_C_int_imputed.txt_snps.txt	MR Egger	94.5453087987381	68	0.0183593455392805
eymStv	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	94.6533208546374	69	0.0219436685433543
eymStv	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.190478377612057	69	1
eymStv	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_C_int_imputed.txt_snps.txt	Maximum likelihood	89.1221422828038	66	0.0305474021220217
eymStv	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_C_int_imputed.txt_snps.txt	MR Egger	88.5266016122905	65	0.0278385133376166
eymStv	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	89.2029778087652	66	0.0301512339544642
eymStv	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.722082785261001	66	1
f61ShK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	62.4838562616928	46	0.053103935408631
f61ShK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	62.3117003896252	45	0.0444946386041962
f61ShK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	62.4917460093625	46	0.0530313167255896
f61ShK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0455692855457074	46	1
f61ShK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	66.5209740460758	46	0.0254597565877968
f61ShK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	66.5065052731736	45	0.0201931135113773
f61ShK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	66.5215693201862	46	0.0254568693547647
f61ShK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0667366373261691	46	1
f61ShK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	57.1495287264738	46	0.125450743522788
f61ShK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	55.5098856644524	45	0.135492955673017
f61ShK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	57.1632551526126	46	0.125195371145618
f61ShK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.333473636718681	46	1
FAgZiR	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	78.0841211290054	46	0.00219335902495247
FAgZiR	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_FC_int_imputed.txt_snps.txt	MR Egger	75.4109381691368	45	0.00301445584178316
FAgZiR	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	78.2136370659151	46	0.00212844071471138
FAgZiR	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0461919717175496	46	1
FAgZiR	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	65.1896253428419	46	0.0326916917678165
FAgZiR	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_FC_int_imputed.txt_snps.txt	MR Egger	63.6166502181202	45	0.0350767930682647
FAgZiR	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	65.337963587148	46	0.0318050599842275
FAgZiR	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0609979575343174	46	1
FAgZiR	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	52.4075381983162	46	0.23943550765617
FAgZiR	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_FC_int_imputed.txt_snps.txt	MR Egger	47.844692648262	45	0.358023577951016
FAgZiR	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	52.5497783242296	46	0.235241886926738
FAgZiR	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.283843417001142	46	1
fFeMnW	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	72.0637864908654	43	0.00359537665968449
fFeMnW	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_CE_int_imputed.txt_snps.txt	MR Egger	72.0337460685164	42	0.00267509947074073
fFeMnW	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	72.0853419195418	43	0.00357757332123521
fFeMnW	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0822816948402656	43	1
fFeMnW	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	69.2858076035309	43	0.00672561900065783
fFeMnW	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_CE_int_imputed.txt_snps.txt	MR Egger	69.1883219921767	42	0.00517037406636451
fFeMnW	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	69.2942516097334	43	0.00671310587459267
fFeMnW	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.124142097190072	43	1
fFeMnW	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	37.265277843564	42	0.678630843666047
fFeMnW	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_CE_int_imputed.txt_snps.txt	MR Egger	34.4430583136878	41	0.75553682932597
fFeMnW	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	37.3454715608983	42	0.675234174573965
fFeMnW	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.24068590038539	42	1
FFJSuO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	59.9975204428008	45	0.0665940409653874
FFJSuO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_TG_int_imputed.txt_snps.txt	MR Egger	59.9283466190727	44	0.0551334985618595
FFJSuO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	60.0549523138348	45	0.0659503263582982
FFJSuO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0682457689605825	45	1
FFJSuO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	59.6025675326361	45	0.0711648072850534
FFJSuO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_TG_int_imputed.txt_snps.txt	MR Egger	59.5939551415341	44	0.0584533078761494
FFJSuO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	59.6179968543092	45	0.0709814571990917
FFJSuO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0938431620551489	45	1
FFJSuO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	56.9306586072583	43	0.0756050775327595
FFJSuO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_TG_int_imputed.txt_snps.txt	MR Egger	57.0095972536964	42	0.0610321062749029
FFJSuO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	57.0313174370228	43	0.0743308113536793
FFJSuO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.527723419120481	43	1
fjiaOq	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	116.383705787315	73	0.000941603944777674
fjiaOq	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_CE_int_imputed.txt_snps.txt	MR Egger	115.606366278465	72	0.000852097539135841
fjiaOq	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	116.399312115578	73	0.000938577441605921
fjiaOq	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.129817475050574	73	1
fjiaOq	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	122.021654406012	73	0.000283897605867783
fjiaOq	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_CE_int_imputed.txt_snps.txt	MR Egger	121.925339791368	72	0.000218224749899633
fjiaOq	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	122.075127873926	73	0.000280593253457171
fjiaOq	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.215012342661912	73	1
fjiaOq	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	92.6795582947313	69	0.0301991904839302
fjiaOq	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_CE_int_imputed.txt_snps.txt	MR Egger	92.4742481607135	68	0.0258887905806671
fjiaOq	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	92.7359122526765	69	0.0299302116829992
fjiaOq	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.725976551303993	69	1
fsSQ0j	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Lactate_int_imputed.txt_snps.txt	Maximum likelihood	35.8333612920308	5	1.02556494129887e-06
fsSQ0j	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Lactate_int_imputed.txt_snps.txt	MR Egger	35.496020311285	4	3.67360370800556e-07
fsSQ0j	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Lactate_int_imputed.txt_snps.txt	Inverse variance weighted	37.0941795708913	5	5.73465822049118e-07
fsSQ0j	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Lactate_int_imputed.txt_snps.txt	Unweighted regression	0.00974871866518999	5	0.999999502599974
fsSQ0j	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Lactate_int_imputed.txt_snps.txt	Maximum likelihood	31.1208152663099	5	8.86653092481823e-06
fsSQ0j	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Lactate_int_imputed.txt_snps.txt	MR Egger	31.7947993503211	4	2.10701157314458e-06
fsSQ0j	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Lactate_int_imputed.txt_snps.txt	Inverse variance weighted	32.465285976589	5	4.80488227557949e-06
fsSQ0j	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Lactate_int_imputed.txt_snps.txt	Unweighted regression	0.0120719170150329	5	0.999999151958027
fsSQ0j	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Lactate_int_imputed.txt_snps.txt	Maximum likelihood	8.65987560925293	5	0.123424150920708
fsSQ0j	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Lactate_int_imputed.txt_snps.txt	MR Egger	6.47189561097881	4	0.166569823105532
fsSQ0j	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Lactate_int_imputed.txt_snps.txt	Inverse variance weighted	8.68071204416017	5	0.122497463540962
fsSQ0j	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Lactate_int_imputed.txt_snps.txt	Unweighted regression	0.0176105496234296	5	0.999997824543743
fTCjCF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_C_int_imputed.txt_snps.txt	Maximum likelihood	59.2666244580722	37	0.0115089532952565
fTCjCF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_C_int_imputed.txt_snps.txt	MR Egger	58.6603075425725	36	0.0099066818792655
fTCjCF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	59.2968259769915	37	0.0114315896758828
fTCjCF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0508756425535456	37	1
fTCjCF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_C_int_imputed.txt_snps.txt	Maximum likelihood	52.1060055577145	37	0.0508300846824343
fTCjCF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_C_int_imputed.txt_snps.txt	MR Egger	51.2443064025529	36	0.0476748258063368
fTCjCF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	52.1624758009234	37	0.0502856778078135
fTCjCF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0831126131869404	37	1
fTCjCF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_C_int_imputed.txt_snps.txt	Maximum likelihood	36.6479479959368	35	0.392257257673373
fTCjCF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_C_int_imputed.txt_snps.txt	MR Egger	29.9857536114226	34	0.6648071039655
fTCjCF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	36.6800317147332	35	0.39083138866319
fTCjCF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.223957928807725	35	1
fWhUC1	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	70.8929732564511	56	0.0868148079820818
fWhUC1	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	70.2830030169078	55	0.0803301818335675
fWhUC1	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	70.9194969529423	56	0.0864765892287523
fWhUC1	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0774604732040075	56	1
fWhUC1	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	74.8407949305756	56	0.0470704906473533
fWhUC1	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	71.2114673263552	55	0.0697365039210611
fWhUC1	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	74.8407949305756	56	0.0470704906473533
fWhUC1	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.122091535586655	56	1
fWhUC1	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	56.2778012053455	54	0.389678170839881
fWhUC1	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	56.3871088414149	53	0.349489003203595
fWhUC1	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	56.4253055405302	54	0.384401717559914
fWhUC1	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.643581003902855	54	1
fZZIWQ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	53.8930761456294	49	0.292675168903357
fZZIWQ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_FC_int_imputed.txt_snps.txt	MR Egger	53.8541799303352	48	0.260359363454569
fZZIWQ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	53.9045945423073	49	0.292300238263875
fZZIWQ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.048716286731613	49	1
fZZIWQ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	45.4374022607638	49	0.618355351790635
fZZIWQ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_FC_int_imputed.txt_snps.txt	MR Egger	45.3963180046914	48	0.580151224713435
fZZIWQ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	45.4375928579821	49	0.618347640009677
fZZIWQ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0672140989461149	49	1
fZZIWQ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	49.7094659895753	48	0.405028734343125
fZZIWQ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_FC_int_imputed.txt_snps.txt	MR Egger	49.6588459193113	47	0.367777602024925
fZZIWQ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	49.7112527776379	48	0.404959762775434
fZZIWQ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.505103690645455	48	1
g1VgIB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	24.2176512953531	36	0.932767988558129
g1VgIB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	24.2821218283771	35	0.913026847237719
g1VgIB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	24.307924185328	36	0.930942643168398
g1VgIB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0308341441457329	36	1
g1VgIB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	24.9853826695619	36	0.916176288460252
g1VgIB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	25.0304940451498	35	0.893697369790999
g1VgIB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	25.0330824418598	36	0.915064739909164
g1VgIB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0489154426012162	36	1
g1VgIB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	50.3599525461464	35	0.0448021256678958
g1VgIB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	50.2690818151937	34	0.0357180737116875
g1VgIB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	50.376818505115	35	0.0446526444535183
g1VgIB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.486828475401441	35	1
G4tBx9	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_C_int_imputed.txt_snps.txt	Maximum likelihood	78.9456778407489	44	0.000952940500188842
G4tBx9	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_C_int_imputed.txt_snps.txt	MR Egger	78.9228768192184	43	0.000686987800105989
G4tBx9	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_C_int_imputed.txt_snps.txt	Inverse variance weighted	78.9467532263895	44	0.000952688404646588
G4tBx9	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_C_int_imputed.txt_snps.txt	Unweighted regression	0.089973364978287	44	1
G4tBx9	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_C_int_imputed.txt_snps.txt	Maximum likelihood	68.6955066153106	44	0.0100297293634528
G4tBx9	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_C_int_imputed.txt_snps.txt	MR Egger	68.6841935163828	43	0.00767476517811243
G4tBx9	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_C_int_imputed.txt_snps.txt	Inverse variance weighted	68.6962213944629	44	0.0100282102398184
G4tBx9	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_C_int_imputed.txt_snps.txt	Unweighted regression	0.118917014718478	44	1
G4tBx9	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_C_int_imputed.txt_snps.txt	Maximum likelihood	45.539895112969	42	0.326999857030967
G4tBx9	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_C_int_imputed.txt_snps.txt	MR Egger	41.0576232148692	41	0.468095829702572
G4tBx9	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_C_int_imputed.txt_snps.txt	Inverse variance weighted	45.5598477455548	42	0.326256906599248
G4tBx9	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_C_int_imputed.txt_snps.txt	Unweighted regression	0.241217060104901	42	1
g6TtQw	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	52.4958934159716	31	0.00929187685172988
g6TtQw	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_FC_int_imputed.txt_snps.txt	MR Egger	52.4988062005114	30	0.00672610620216175
g6TtQw	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	52.4993664187771	31	0.0092840746927732
g6TtQw	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0446629245593224	31	1
g6TtQw	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	39.2119971196803	31	0.147791397729109
g6TtQw	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_FC_int_imputed.txt_snps.txt	MR Egger	39.2211902982413	30	0.120850232968999
g6TtQw	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	39.2391876837811	31	0.147111182104248
g6TtQw	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0396995829586067	31	1
g6TtQw	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	44.3567361845172	30	0.0442552528221878
g6TtQw	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_FC_int_imputed.txt_snps.txt	MR Egger	43.4095326401679	29	0.0417104868487694
g6TtQw	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	44.3606756367114	30	0.0442185321092447
g6TtQw	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.226709244759582	30	1
gF47wS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_P_int_imputed.txt_snps.txt	Maximum likelihood	64.4506438367474	40	0.00845402245349827
gF47wS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_P_int_imputed.txt_snps.txt	MR Egger	63.8850126421561	39	0.00721120482162321
gF47wS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	64.4575796842198	40	0.00844098675151456
gF47wS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0668040981542598	40	1
gF47wS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_P_int_imputed.txt_snps.txt	Maximum likelihood	68.0166871268276	40	0.0037343036229458
gF47wS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_P_int_imputed.txt_snps.txt	MR Egger	67.5969075198958	39	0.00302420604360831
gF47wS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	68.0338885844665	40	0.00371919917844174
gF47wS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.11487462199928	40	1
gF47wS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_P_int_imputed.txt_snps.txt	Maximum likelihood	35.6088958891797	39	0.62534971618025
gF47wS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_P_int_imputed.txt_snps.txt	MR Egger	33.5567347916606	38	0.674971613554834
gF47wS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	35.7061465669949	39	0.620915587903362
gF47wS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.215922673524176	39	1
gFVDRT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	50.2349395403355	43	0.208605311793419
gFVDRT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	48.2988948134863	42	0.233432750905728
gFVDRT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	50.2618826855708	43	0.207854799220611
gFVDRT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0581306696173081	43	1
gFVDRT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	68.035772998896	43	0.00883512274181517
gFVDRT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	68.0018111385588	42	0.00674850500204881
gFVDRT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	68.0694064984459	43	0.00877116961080286
gFVDRT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.137836561910867	43	1
gFVDRT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	34.128064869285	42	0.8010272343392
gFVDRT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	27.716670520699	41	0.943894790828258
gFVDRT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	34.1285901791993	42	0.801008865190449
gFVDRT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.230233109546187	42	1
GjMwPt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	TG_by_PG_int_imputed.txt_snps.txt	Maximum likelihood	44.6117864844808	50	0.688691978636001
GjMwPt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	TG_by_PG_int_imputed.txt_snps.txt	MR Egger	43.518732122719	49	0.694183279849764
GjMwPt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	TG_by_PG_int_imputed.txt_snps.txt	Inverse variance weighted	44.6365659121569	50	0.687747256846976
GjMwPt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	TG_by_PG_int_imputed.txt_snps.txt	Unweighted regression	0.0449177214197594	50	1
GjMwPt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	TG_by_PG_int_imputed.txt_snps.txt	Maximum likelihood	41.9160819722489	50	0.784921263946761
GjMwPt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	TG_by_PG_int_imputed.txt_snps.txt	MR Egger	41.1755612741095	49	0.778912195909698
GjMwPt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	TG_by_PG_int_imputed.txt_snps.txt	Inverse variance weighted	41.9351044958875	50	0.784295678244347
GjMwPt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	TG_by_PG_int_imputed.txt_snps.txt	Unweighted regression	0.0879963335947168	50	1
GjMwPt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	TG_by_PG_int_imputed.txt_snps.txt	Maximum likelihood	51.6935471436855	50	0.407483250152756
GjMwPt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	TG_by_PG_int_imputed.txt_snps.txt	MR Egger	51.137800935831	49	0.389717486693742
GjMwPt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	TG_by_PG_int_imputed.txt_snps.txt	Inverse variance weighted	51.7976010055692	50	0.403544580769307
GjMwPt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	TG_by_PG_int_imputed.txt_snps.txt	Unweighted regression	0.744924505790552	50	1
gql6I5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Val_int_imputed.txt_snps.txt	Maximum likelihood	6.94470256797538	12	0.861246090672051
gql6I5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Val_int_imputed.txt_snps.txt	MR Egger	6.538736879869	11	0.835114022446973
gql6I5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Val_int_imputed.txt_snps.txt	Inverse variance weighted	6.98117931988492	12	0.858854792426404
gql6I5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Val_int_imputed.txt_snps.txt	Unweighted regression	0.00528546871073469	12	1
gql6I5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Val_int_imputed.txt_snps.txt	Maximum likelihood	9.45852199239508	12	0.663347466156206
gql6I5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Val_int_imputed.txt_snps.txt	MR Egger	9.49921466624071	11	0.575913563662413
gql6I5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Val_int_imputed.txt_snps.txt	Inverse variance weighted	9.50212484894575	12	0.659548709032912
gql6I5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Val_int_imputed.txt_snps.txt	Unweighted regression	0.0185103036964962	12	0.999999999999999
gql6I5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Val_int_imputed.txt_snps.txt	Maximum likelihood	7.74133521951632	12	0.805003441480146
gql6I5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Val_int_imputed.txt_snps.txt	MR Egger	6.45620925987024	11	0.841258866396571
gql6I5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Val_int_imputed.txt_snps.txt	Inverse variance weighted	7.74516750539642	12	0.804714181880208
gql6I5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Val_int_imputed.txt_snps.txt	Unweighted regression	0.0457352056132715	12	0.999999999999805
GsyjNc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_L_int_imputed.txt_snps.txt	Maximum likelihood	62.3173933242649	38	0.00770240690241817
GsyjNc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_L_int_imputed.txt_snps.txt	MR Egger	62.1496238017981	37	0.00594587173806352
GsyjNc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	62.3335836949077	38	0.00767399367197328
GsyjNc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0533654516891213	38	1
GsyjNc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_L_int_imputed.txt_snps.txt	Maximum likelihood	58.5126625365152	38	0.0178272195274013
GsyjNc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_L_int_imputed.txt_snps.txt	MR Egger	58.4022344387075	37	0.0139370712463964
GsyjNc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	58.550103976409	38	0.0176857990796504
GsyjNc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0860679660026611	38	1
GsyjNc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_L_int_imputed.txt_snps.txt	Maximum likelihood	35.8004925099598	36	0.478009453568357
GsyjNc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_L_int_imputed.txt_snps.txt	MR Egger	30.7694904307386	35	0.672550675792848
GsyjNc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	35.8792604900239	36	0.474307421833239
GsyjNc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.206250111907394	36	1
guBzRn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_FA_int_imputed.txt_snps.txt	Maximum likelihood	63.5968648048191	42	0.0173219111480433
guBzRn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_FA_int_imputed.txt_snps.txt	MR Egger	62.3036999591361	41	0.0175396264285995
guBzRn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_FA_int_imputed.txt_snps.txt	Inverse variance weighted	63.617937143143	42	0.0172471045636714
guBzRn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_FA_int_imputed.txt_snps.txt	Unweighted regression	0.0460741631253847	42	1
guBzRn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_FA_int_imputed.txt_snps.txt	Maximum likelihood	56.620608838745	42	0.0653399330882921
guBzRn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_FA_int_imputed.txt_snps.txt	MR Egger	56.5575142631881	41	0.0536356994261772
guBzRn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_FA_int_imputed.txt_snps.txt	Inverse variance weighted	56.6214087598029	42	0.0653308182531253
guBzRn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_FA_int_imputed.txt_snps.txt	Unweighted regression	0.0666625993020649	42	1
guBzRn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_FA_int_imputed.txt_snps.txt	Maximum likelihood	41.5110129123807	40	0.404681693358112
guBzRn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_FA_int_imputed.txt_snps.txt	MR Egger	39.941703148766	39	0.428102665301837
guBzRn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_FA_int_imputed.txt_snps.txt	Inverse variance weighted	41.5693913835561	40	0.402220641088487
guBzRn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_FA_int_imputed.txt_snps.txt	Unweighted regression	0.23752989746497	40	1
GuIIxO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	25.1569672630215	27	0.565665609317426
GuIIxO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	25.1338606680137	26	0.511408299235732
GuIIxO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	25.1635806521395	27	0.565295062268763
GuIIxO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0644149664099011	27	1
GuIIxO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	17.8827502068446	27	0.907062538787958
GuIIxO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	17.8846356263313	26	0.879930241545867
GuIIxO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	17.890659277713	27	0.906826127935832
GuIIxO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.049385111995427	27	1
GuIIxO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	26.4712659313589	26	0.437449298548537
GuIIxO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	26.2166509923385	25	0.396110318213376
GuIIxO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	26.4716577543886	26	0.437428188304713
GuIIxO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.272194569455958	26	1
GVOCV1	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	42.2869327188879	32	0.105522691897075
GVOCV1	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	39.6455435776679	31	0.137230371507453
GVOCV1	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	42.3254661541658	32	0.104794502698366
GVOCV1	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0678844106225241	32	1
GVOCV1	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	36.4231069338648	32	0.27032515824073
GVOCV1	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	35.7944202095588	31	0.253402663618087
GVOCV1	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	36.4322922679753	32	0.269977288105183
GVOCV1	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0803553737266825	32	1
GVOCV1	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	36.3476884218754	32	0.273192082480571
GVOCV1	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	35.4016439823246	31	0.268159700683845
GVOCV1	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	36.4402800681235	32	0.269675000598994
GVOCV1	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.477303522031024	32	1
gwzYon	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	70.6166622031214	46	0.0112895380508322
gwzYon	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_L_int_imputed.txt_snps.txt	MR Egger	70.472774799558	45	0.00896779852971444
gwzYon	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	70.659144641104	46	0.011190964651072
gwzYon	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0636151365779022	46	1
gwzYon	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	69.5126870125522	46	0.0141457879682523
gwzYon	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_L_int_imputed.txt_snps.txt	MR Egger	69.1376850681928	45	0.0118642848231204
gwzYon	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	69.5467418746596	46	0.014048672726354
gwzYon	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0942108555093356	46	1
gwzYon	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	49.8157457866675	45	0.287633576884467
gwzYon	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_L_int_imputed.txt_snps.txt	MR Egger	49.620716420045	44	0.259197123492205
gwzYon	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	49.8157852229189	45	0.287632253569615
gwzYon	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.374180222321325	45	1
Gxqfxo	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_C_int_imputed.txt_snps.txt	Maximum likelihood	68.1183000854703	45	0.0146251390009378
Gxqfxo	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_C_int_imputed.txt_snps.txt	MR Egger	67.9696550208192	44	0.0116859107690736
Gxqfxo	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	68.1271391438481	45	0.0145988810901407
Gxqfxo	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0711898665855934	45	1
Gxqfxo	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_C_int_imputed.txt_snps.txt	Maximum likelihood	54.4502811949663	45	0.157912155247344
Gxqfxo	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_C_int_imputed.txt_snps.txt	MR Egger	54.4573335358709	44	0.134189031425215
Gxqfxo	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	54.4575351677619	45	0.157749816609508
Gxqfxo	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.108374364959638	45	1
Gxqfxo	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_C_int_imputed.txt_snps.txt	Maximum likelihood	47.699580219699	42	0.252125526984878
Gxqfxo	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_C_int_imputed.txt_snps.txt	MR Egger	43.0044303601252	41	0.38542769877388
Gxqfxo	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	47.8462547200078	42	0.247464546111721
Gxqfxo	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.292526188088832	42	1
H1oBXR	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	67.1449675273097	42	0.00815384258376839
H1oBXR	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	66.6035618988581	41	0.00694239493408459
H1oBXR	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	67.1512346196291	42	0.00814264919936648
H1oBXR	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0799956810272594	42	1
H1oBXR	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	77.323134982929	42	0.000732515918589727
H1oBXR	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	74.9537983110244	41	0.000948805649138314
H1oBXR	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	77.3232349524604	42	0.000732497392168143
H1oBXR	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.218043121991458	42	1
H1oBXR	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	39.2822253791523	39	0.457231916314678
H1oBXR	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	37.5680643525813	38	0.489268458568435
H1oBXR	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	39.302381365568	39	0.456332560845624
H1oBXR	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.367283991115552	39	1
H3jPom	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	39.7361937731416	28	0.0697877742726244
H3jPom	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_CE_int_imputed.txt_snps.txt	MR Egger	36.3703195103266	27	0.10743393106169
H3jPom	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	39.7563559839652	28	0.0695020824960418
H3jPom	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.04060901480996	28	1
H3jPom	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	43.0305411156046	28	0.0345694290909523
H3jPom	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_CE_int_imputed.txt_snps.txt	MR Egger	42.0016960547753	27	0.0329026394806959
H3jPom	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	43.0315259290486	28	0.0345618477398217
H3jPom	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0661286412809052	28	1
H3jPom	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	31.5158884150475	27	0.250488007790103
H3jPom	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_CE_int_imputed.txt_snps.txt	MR Egger	31.3568002002845	26	0.2152484689195
H3jPom	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	31.5716878003817	27	0.248318470396613
H3jPom	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.253968549273221	27	1
h88W7m	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	63.2577898630496	46	0.0463728300481963
h88W7m	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	63.0403733102109	45	0.0389965935578177
h88W7m	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	63.2844323059667	46	0.0461548128684011
h88W7m	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0984292203600746	46	1
h88W7m	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	62.4461266939794	46	0.053452378830402
h88W7m	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	62.44197080307	45	0.0434651234145858
h88W7m	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	62.4461466938285	46	0.0534521936109506
h88W7m	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.131737029309554	46	1
h88W7m	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	44.9931138575772	41	0.308347324156719
h88W7m	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	42.8192658336521	40	0.351124809948742
h88W7m	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	45.0274930251744	41	0.307094170247817
h88W7m	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.448456026776093	41	1
HDFYLl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	56.0958917551048	49	0.22618078686089
HDFYLl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_TG_int_imputed.txt_snps.txt	MR Egger	55.8654528583132	48	0.203294845646078
HDFYLl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	56.1536630327081	49	0.2245814791022
HDFYLl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0329801146118628	49	1
HDFYLl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	56.0404001111363	49	0.227724056355696
HDFYLl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_TG_int_imputed.txt_snps.txt	MR Egger	55.7815644855375	48	0.205489471982203
HDFYLl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	56.0842102567162	49	0.226505083684774
HDFYLl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0523398612188973	49	1
HDFYLl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	49.8386817761997	47	0.361075796738454
HDFYLl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_TG_int_imputed.txt_snps.txt	MR Egger	49.4113595797568	46	0.338563498163203
HDFYLl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	49.9611831668608	47	0.356543896778254
HDFYLl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.368723268195384	47	1
hhSU2K	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	49.6148193839497	47	0.369427013778825
hhSU2K	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_TG_int_imputed.txt_snps.txt	MR Egger	49.065431896704	46	0.351246416571799
hhSU2K	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	49.6389031513353	47	0.36852431835638
hhSU2K	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0466801296851603	47	1
hhSU2K	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	51.3869763702094	47	0.30592418936014
hhSU2K	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_TG_int_imputed.txt_snps.txt	MR Egger	49.7108791064599	46	0.327773950576647
hhSU2K	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	51.4007613641482	47	0.305454945109183
hhSU2K	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0763084311865308	47	1
hhSU2K	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	46.7529615893557	46	0.441345183308311
hhSU2K	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_TG_int_imputed.txt_snps.txt	MR Egger	46.3971998191199	45	0.414514228674853
hhSU2K	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	46.7873065671225	46	0.439949745437264
hhSU2K	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.640362884249775	46	1
HmauXb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	100.802493144494	64	0.00227992517282914
HmauXb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	97.4797102830245	63	0.0034773931278265
HmauXb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	100.850126203979	64	0.00225771441825056
HmauXb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.144906946015835	64	1
HmauXb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	103.134619172661	64	0.00140188959108267
HmauXb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	102.13286685361	63	0.00132539609661706
HmauXb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	103.14408552313	64	0.00139908459917749
HmauXb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.214557991855012	64	1
HmauXb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	84.9405437956647	59	0.0151329142505487
HmauXb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	82.8556933282459	58	0.0177791268877667
HmauXb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	85.1153985138374	59	0.0146567466875179
HmauXb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.712784839372082	59	1
HsWinJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_L_int_imputed.txt_snps.txt	Maximum likelihood	65.2662021061571	42	0.0122262985180333
HsWinJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_L_int_imputed.txt_snps.txt	MR Egger	64.3614397593882	41	0.0113585383289974
HsWinJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	65.2951568740859	42	0.0121514574552463
HsWinJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0433657976447706	42	1
HsWinJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_L_int_imputed.txt_snps.txt	Maximum likelihood	55.0392527475936	42	0.0855663822645178
HsWinJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_L_int_imputed.txt_snps.txt	MR Egger	53.4918519711268	41	0.0914297599860548
HsWinJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	55.0560743916585	42	0.0853268061470744
HsWinJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0602274418570716	42	1
HsWinJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_L_int_imputed.txt_snps.txt	Maximum likelihood	46.6540529666077	42	0.286941180578399
HsWinJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_L_int_imputed.txt_snps.txt	MR Egger	44.4128537948829	41	0.329925261701236
HsWinJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	46.7633703468233	42	0.283172201487228
HsWinJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.3846071673488	42	1
I020nH	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LA_pct_int_imputed.txt_snps.txt	Maximum likelihood	26.4140798743947	18	0.0906601960360875
I020nH	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LA_pct_int_imputed.txt_snps.txt	MR Egger	26.3465970961257	17	0.0683731570486009
I020nH	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LA_pct_int_imputed.txt_snps.txt	Inverse variance weighted	26.4379153454291	18	0.0901586021926544
I020nH	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LA_pct_int_imputed.txt_snps.txt	Unweighted regression	0.016149447017515	18	1
I020nH	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LA_pct_int_imputed.txt_snps.txt	Maximum likelihood	26.7834013765589	18	0.0831486450830212
I020nH	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LA_pct_int_imputed.txt_snps.txt	MR Egger	26.7421702373534	17	0.0619590432535451
I020nH	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LA_pct_int_imputed.txt_snps.txt	Inverse variance weighted	26.7932185552569	18	0.0829564460544644
I020nH	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LA_pct_int_imputed.txt_snps.txt	Unweighted regression	0.023278599082999	18	1
I020nH	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LA_pct_int_imputed.txt_snps.txt	Maximum likelihood	21.8420603637989	18	0.239072710725252
I020nH	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LA_pct_int_imputed.txt_snps.txt	MR Egger	20.7907372748357	17	0.235790838207513
I020nH	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LA_pct_int_imputed.txt_snps.txt	Inverse variance weighted	21.8948693260507	18	0.23668607145064
I020nH	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LA_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0896615036134468	18	1
I3SdtY	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	73.5378223914966	60	0.112505028587999
I3SdtY	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	72.7089329018644	59	0.108228152641546
I3SdtY	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	73.5549967956733	60	0.112243616358234
I3SdtY	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0820833595454389	60	1
I3SdtY	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	85.1414091655299	60	0.0181066706037763
I3SdtY	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	83.6130190384699	59	0.0192264841767753
I3SdtY	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	85.1686067108502	60	0.0180191698291069
I3SdtY	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.15377129416261	60	1
I3SdtY	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	81.9627517179022	57	0.0168203203645233
I3SdtY	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	81.9585766861187	56	0.0134583576759323
I3SdtY	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	81.9673176436948	57	0.0168062645184524
I3SdtY	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.522091508334557	57	1
I8VwBC	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	67.8701003003294	58	0.17614179124181
I8VwBC	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_PL_int_imputed.txt_snps.txt	MR Egger	67.0814433250774	57	0.169716099641332
I8VwBC	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	67.8886326621856	58	0.175741145264348
I8VwBC	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0867911798150838	58	1
I8VwBC	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	47.4370557948988	58	0.837588717053415
I8VwBC	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_PL_int_imputed.txt_snps.txt	MR Egger	46.48270997382	57	0.838816870427802
I8VwBC	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	47.4499622644052	58	0.837251802209386
I8VwBC	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0773951564589564	58	1
I8VwBC	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	80.9355384280846	58	0.0250002327953567
I8VwBC	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_PL_int_imputed.txt_snps.txt	MR Egger	80.6978005350603	57	0.02114571134161
I8VwBC	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	80.9355384280846	58	0.0250002327953567
I8VwBC	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	1.11738779535057	58	1
i9hbTT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	54.4816851810493	54	0.456057203995741
i9hbTT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_TG_int_imputed.txt_snps.txt	MR Egger	52.9235861727143	53	0.47711631974903
i9hbTT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	54.4819248993233	54	0.45604812082939
i9hbTT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0623934792723893	54	1
i9hbTT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	49.8997672155968	54	0.633214009941265
i9hbTT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_TG_int_imputed.txt_snps.txt	MR Egger	48.046374471556	53	0.667011324203018
i9hbTT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	49.9024781126016	54	0.633110576440007
i9hbTT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.104543678126981	54	1
i9hbTT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	70.2572118887352	54	0.0677234923666589
i9hbTT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_TG_int_imputed.txt_snps.txt	MR Egger	70.1235572071378	53	0.0576338710653598
i9hbTT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	70.2651493550755	54	0.0676395786411218
i9hbTT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.808680985621304	54	1
Il6VXU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	69.3878718753302	52	0.0538147169765787
Il6VXU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_P_int_imputed.txt_snps.txt	MR Egger	66.864545864328	51	0.0672185545416422
Il6VXU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	69.3880149263888	52	0.0538134500091966
Il6VXU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0601226418877015	52	1
Il6VXU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	69.9546149751102	52	0.0489900502906955
Il6VXU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_P_int_imputed.txt_snps.txt	MR Egger	65.9704295774233	51	0.0774359156043258
Il6VXU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	69.9584282123679	52	0.0489588823725652
Il6VXU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0870664456387418	52	1
Il6VXU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	68.8045039107468	52	0.0591962742901294
Il6VXU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_P_int_imputed.txt_snps.txt	MR Egger	67.6624495110011	51	0.0590744259810134
Il6VXU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	68.8066893253071	52	0.0591752966358064
Il6VXU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.515538569787961	52	1
ioEGNj	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_6_by_Omega_3_int_imputed.txt_snps.txt	Maximum likelihood	28.0589276147813	23	0.213561466076409
ioEGNj	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_6_by_Omega_3_int_imputed.txt_snps.txt	MR Egger	28.0687520604264	22	0.173413881823064
ioEGNj	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_6_by_Omega_3_int_imputed.txt_snps.txt	Inverse variance weighted	28.0897321389713	23	0.212407404175844
ioEGNj	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_6_by_Omega_3_int_imputed.txt_snps.txt	Unweighted regression	0.0373296142951269	23	1
ioEGNj	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_6_by_Omega_3_int_imputed.txt_snps.txt	Maximum likelihood	25.6933441024642	23	0.315554940879153
ioEGNj	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_6_by_Omega_3_int_imputed.txt_snps.txt	MR Egger	25.4508444113854	22	0.276004525424348
ioEGNj	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_6_by_Omega_3_int_imputed.txt_snps.txt	Inverse variance weighted	25.7089612771317	23	0.314796713433294
ioEGNj	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_6_by_Omega_3_int_imputed.txt_snps.txt	Unweighted regression	0.0425334377364586	23	1
ioEGNj	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_6_by_Omega_3_int_imputed.txt_snps.txt	Maximum likelihood	29.6196838058441	21	0.099901045722598
ioEGNj	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_6_by_Omega_3_int_imputed.txt_snps.txt	MR Egger	29.4912807936387	20	0.0785267973015555
ioEGNj	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_6_by_Omega_3_int_imputed.txt_snps.txt	Inverse variance weighted	29.6484708374173	21	0.099282878594882
ioEGNj	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_6_by_Omega_3_int_imputed.txt_snps.txt	Unweighted regression	0.660425404642969	21	0.999999999999449
IT8QnL	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	75.0491926111583	39	0.000459020382379922
IT8QnL	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	74.351560023214	38	0.000382728652587935
IT8QnL	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	75.1226071701672	39	0.000450190061141185
IT8QnL	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0481158967536462	39	1
IT8QnL	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	55.4967831939243	39	0.0419746230101727
IT8QnL	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	55.4539334425994	38	0.0334620832438512
IT8QnL	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	55.5387641578702	39	0.0416384455139414
IT8QnL	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0612801252306463	39	1
IT8QnL	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	49.8934084354397	39	0.113472257119362
IT8QnL	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	44.8686603377742	38	0.206008251615443
IT8QnL	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	50.0269440919481	39	0.111026106018684
IT8QnL	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.330723500937569	39	1
iU8jfC	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	48.2767690924237	23	0.00154188728592464
iU8jfC	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	48.2535971907612	22	0.00100438389707797
iU8jfC	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	48.3666527085771	23	0.00150144006516405
iU8jfC	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0491113243261135	23	1
iU8jfC	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	38.7174466465273	23	0.02130396691281
iU8jfC	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	38.7061589713906	22	0.0152457228574212
iU8jfC	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	38.7371793509234	23	0.0211986570020595
iU8jfC	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0642834263121685	23	1
iU8jfC	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	28.1248925881177	20	0.106475712237809
iU8jfC	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	27.7950589599898	19	0.0874529109722465
iU8jfC	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	28.2232469000145	20	0.10421908984368
iU8jfC	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.281313907861528	20	0.999999999999999
JbAKGf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	41.5324963525987	23	0.0102859320709448
JbAKGf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	41.3119517630458	22	0.00756417815219581
JbAKGf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	41.5466671403009	23	0.0102472357191501
JbAKGf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0410299945333951	23	1
JbAKGf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	37.4787836155769	23	0.028948728790348
JbAKGf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	37.307833597665	22	0.0218797006174771
JbAKGf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	37.4806066305841	23	0.0289358562126506
JbAKGf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0530203380699104	23	1
JbAKGf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	26.1293609959653	22	0.246169375014449
JbAKGf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	26.230849918239	21	0.197783167457292
JbAKGf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	26.3772324473053	22	0.235838414916491
JbAKGf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.256802516795077	22	1
Jh1TBk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	40.827455815771	23	0.012391712615807
Jh1TBk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_C_pct_int_imputed.txt_snps.txt	MR Egger	39.8835583679185	22	0.0111553210503146
Jh1TBk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	40.8422602285359	23	0.0123436652250388
Jh1TBk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0467774860979519	23	1
Jh1TBk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	34.9965415631757	23	0.0520566971717676
Jh1TBk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_C_pct_int_imputed.txt_snps.txt	MR Egger	33.6672454517683	22	0.0530843556050786
Jh1TBk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	34.9972707525031	23	0.0520480215783638
Jh1TBk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0748008759245044	23	1
Jh1TBk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	27.6942448153642	21	0.149037851319495
Jh1TBk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_C_pct_int_imputed.txt_snps.txt	MR Egger	16.1927045567476	20	0.704599490053229
Jh1TBk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	27.7832981186342	21	0.146404970604922
Jh1TBk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.13074273099529	21	1
JhzxcX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Creatinine_int_imputed.txt_snps.txt	Maximum likelihood	42.7494771727286	34	0.144347847825776
JhzxcX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Creatinine_int_imputed.txt_snps.txt	MR Egger	41.926930870761	33	0.137105747591112
JhzxcX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Creatinine_int_imputed.txt_snps.txt	Inverse variance weighted	43.0928065313561	34	0.136402184439838
JhzxcX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Creatinine_int_imputed.txt_snps.txt	Unweighted regression	0.0187353849559	34	1
JhzxcX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Creatinine_int_imputed.txt_snps.txt	Maximum likelihood	40.0798048851769	34	0.218508336597286
JhzxcX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Creatinine_int_imputed.txt_snps.txt	MR Egger	39.1467945587024	33	0.21326469866263
JhzxcX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Creatinine_int_imputed.txt_snps.txt	Inverse variance weighted	40.2379714958282	34	0.213483747056918
JhzxcX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Creatinine_int_imputed.txt_snps.txt	Unweighted regression	0.0240997143172792	34	1
JhzxcX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Creatinine_int_imputed.txt_snps.txt	Maximum likelihood	28.1716803209805	34	0.748442591086797
JhzxcX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Creatinine_int_imputed.txt_snps.txt	MR Egger	27.5998584671313	33	0.732875041365871
JhzxcX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Creatinine_int_imputed.txt_snps.txt	Inverse variance weighted	28.2284439917723	34	0.745951581487303
JhzxcX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Creatinine_int_imputed.txt_snps.txt	Unweighted regression	0.0823489674316713	34	1
JiSoGO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Gly_int_imputed.txt_snps.txt	Maximum likelihood	37.2240456034047	30	0.170703909135188
JiSoGO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Gly_int_imputed.txt_snps.txt	MR Egger	34.3510512889321	29	0.22664183434688
JiSoGO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Gly_int_imputed.txt_snps.txt	Inverse variance weighted	37.2414200663399	30	0.170211850656936
JiSoGO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Gly_int_imputed.txt_snps.txt	Unweighted regression	0.0363361488069006	30	1
JiSoGO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Gly_int_imputed.txt_snps.txt	Maximum likelihood	39.6957026017454	30	0.110893762427
JiSoGO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Gly_int_imputed.txt_snps.txt	MR Egger	38.3074779168877	29	0.115649676941154
JiSoGO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Gly_int_imputed.txt_snps.txt	Inverse variance weighted	39.7526578809867	30	0.109744419757938
JiSoGO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Gly_int_imputed.txt_snps.txt	Unweighted regression	0.0740974435896165	30	1
JiSoGO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Gly_int_imputed.txt_snps.txt	Maximum likelihood	21.8896552328104	28	0.78637401802606
JiSoGO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Gly_int_imputed.txt_snps.txt	MR Egger	21.8926325364004	27	0.742813061677164
JiSoGO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Gly_int_imputed.txt_snps.txt	Inverse variance weighted	21.8933944747522	28	0.786202627323903
JiSoGO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Gly_int_imputed.txt_snps.txt	Unweighted regression	0.223851462723695	28	1
JMlYxD	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	50.6725323451728	39	0.0997870712334383
JMlYxD	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	49.1586284672184	38	0.106121460930037
JMlYxD	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	50.6843847505717	39	0.0995896444583813
JMlYxD	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0883952436602177	39	1
JMlYxD	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	54.4405409935914	39	0.0512444224877819
JMlYxD	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	53.7312807016468	38	0.0468062773073051
JMlYxD	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	54.4483649735937	39	0.0511697498567482
JMlYxD	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.128929677392735	39	1
JMlYxD	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	52.3105509341532	36	0.0386427778824632
JMlYxD	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	52.1621165670686	35	0.0310961520607094
JMlYxD	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	52.4076348406011	36	0.0379001412516672
JMlYxD	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.679818101734718	36	1
K16lZ2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	72.321047019058	41	0.00182201169360858
K16lZ2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_FC_int_imputed.txt_snps.txt	MR Egger	71.8435530508216	40	0.00147848859649087
K16lZ2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	72.3228477289779	41	0.00182121243166977
K16lZ2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0828373443778323	41	1
K16lZ2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	61.905091123565	41	0.0190417610622147
K16lZ2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_FC_int_imputed.txt_snps.txt	MR Egger	61.8863671465859	40	0.0147643920538721
K16lZ2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	61.9053006008629	41	0.0190409421025771
K16lZ2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.146026240887412	41	1
K16lZ2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	43.4433005257197	38	0.250620045949838
K16lZ2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_FC_int_imputed.txt_snps.txt	MR Egger	39.4486367038216	37	0.361002275981487
K16lZ2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	43.5634554764168	38	0.246633421366176
K16lZ2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.291426884699328	38	1
K8swj7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	65.2098058164856	43	0.0160187057322405
K8swj7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_L_int_imputed.txt_snps.txt	MR Egger	62.6453322191635	42	0.0210206597510584
K8swj7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	65.2333229344585	43	0.01594162831661
K8swj7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0646605339716199	43	1
K8swj7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	61.20520000135	43	0.0352313978620569
K8swj7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_L_int_imputed.txt_snps.txt	MR Egger	60.5492483328154	42	0.0317660950283567
K8swj7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	61.2458605979967	43	0.034962527782004
K8swj7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.104856075269963	43	1
K8swj7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	55.4348463087545	41	0.0655562638297905
K8swj7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_L_int_imputed.txt_snps.txt	MR Egger	47.2976828610367	40	0.199185502864091
K8swj7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	55.4752505510444	41	0.065091366097464
K8swj7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.358726260512358	41	1
KBKvT4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	62.5553568435863	54	0.198556732742818
KBKvT4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_P_int_imputed.txt_snps.txt	MR Egger	62.5491538821667	53	0.173379720147232
KBKvT4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	62.5592441197376	54	0.198462261578172
KBKvT4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0719598000197418	54	1
KBKvT4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	44.6721413149179	54	0.813268308294366
KBKvT4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_P_int_imputed.txt_snps.txt	MR Egger	44.6252470456361	53	0.786696489568859
KBKvT4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	44.676026708034	54	0.813154388539725
KBKvT4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0629187229344581	54	1
KBKvT4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	77.3706184126038	53	0.016134110791925
KBKvT4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_P_int_imputed.txt_snps.txt	MR Egger	77.3840752920216	52	0.0127461883880754
KBKvT4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	77.3841922450516	53	0.0160927361526012
KBKvT4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.764110119106485	53	1
KJzAlX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	67.0769932814356	56	0.147608222884244
KJzAlX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	63.1043757838656	55	0.211680420613558
KJzAlX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	67.0884858048547	56	0.147386274359573
KJzAlX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0645426625218886	56	1
KJzAlX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	67.6581251821938	56	0.136694619456013
KJzAlX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	66.6597455475323	55	0.134752843198662
KJzAlX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	67.6590303204115	56	0.136678109873826
KJzAlX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0999289077279501	56	1
KJzAlX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	64.6503489194956	55	0.175161250418248
KJzAlX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	63.877051815115	54	0.168213645363118
KJzAlX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	64.7493191520535	55	0.172986381428534
KJzAlX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.732940063585002	55	1
KNPiPV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	86.1703251429495	55	0.00458306664061647
KNPiPV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	83.7319258439876	54	0.00586022486036825
KNPiPV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	86.1814781859469	55	0.00457248279380903
KNPiPV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0687020221897223	55	1
KNPiPV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	89.7678833109456	55	0.00213237106301051
KNPiPV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	87.3452693309468	54	0.00273837261533986
KNPiPV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	89.7696785308859	55	0.00213153684327547
KNPiPV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.104725725371585	55	1
KNPiPV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	61.2436045508902	54	0.232205667309082
KNPiPV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	59.7739021260293	53	0.243221057071458
KNPiPV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	61.3835713856512	54	0.228447341968848
KNPiPV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.487808996850912	54	1
KpXG6A	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	64.8954785395652	54	0.147229997155069
KpXG6A	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_PL_int_imputed.txt_snps.txt	MR Egger	63.9632092865171	53	0.143904552971961
KpXG6A	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	64.958898331028	54	0.145990835803754
KpXG6A	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0513566132926976	54	1
KpXG6A	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	62.8365341255418	54	0.191803269450671
KpXG6A	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_PL_int_imputed.txt_snps.txt	MR Egger	62.6021561118768	53	0.172201675351744
KpXG6A	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	62.9207103431645	54	0.189812964033578
KpXG6A	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0802651087009048	54	1
KpXG6A	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	65.2070953915681	54	0.141216257189716
KpXG6A	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_PL_int_imputed.txt_snps.txt	MR Egger	59.4141194192875	53	0.253446635892266
KpXG6A	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	65.2254641997828	54	0.140867620230684
KpXG6A	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.445677523806454	54	1
KZ5Rf3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	77.4991007298024	55	0.0244772217918069
KZ5Rf3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_C_pct_int_imputed.txt_snps.txt	MR Egger	77.4789116921584	54	0.0197910720160026
KZ5Rf3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	77.5052131475244	55	0.0244505511399727
KZ5Rf3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0681685642720305	55	1
KZ5Rf3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	78.7965797714684	55	0.0193621340022999
KZ5Rf3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_C_pct_int_imputed.txt_snps.txt	MR Egger	78.6783895609416	54	0.0158332687233156
KZ5Rf3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	78.8016874347891	55	0.0193440451603317
KZ5Rf3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0815579694455916	55	1
KZ5Rf3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	60.5806435194073	53	0.221263677947653
KZ5Rf3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_C_pct_int_imputed.txt_snps.txt	MR Egger	60.28348016527	52	0.201197839700698
KZ5Rf3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	60.6430721208963	53	0.219620951889167
KZ5Rf3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.518778690824858	53	1
L2AgWa	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Phosphoglyc_int_imputed.txt_snps.txt	Maximum likelihood	109.979554536524	47	5.82760065227372e-07
L2AgWa	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Phosphoglyc_int_imputed.txt_snps.txt	MR Egger	106.297073657682	46	1.12493125364337e-06
L2AgWa	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Phosphoglyc_int_imputed.txt_snps.txt	Inverse variance weighted	109.982966333416	47	5.82161583063023e-07
L2AgWa	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Phosphoglyc_int_imputed.txt_snps.txt	Unweighted regression	0.0762200643156613	47	1
L2AgWa	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Phosphoglyc_int_imputed.txt_snps.txt	Maximum likelihood	94.5984643595042	47	4.7842639213609e-05
L2AgWa	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Phosphoglyc_int_imputed.txt_snps.txt	MR Egger	92.0012049159021	46	6.61419171224742e-05
L2AgWa	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Phosphoglyc_int_imputed.txt_snps.txt	Inverse variance weighted	94.6140396751343	47	4.76414190068691e-05
L2AgWa	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Phosphoglyc_int_imputed.txt_snps.txt	Unweighted regression	0.134825652110227	47	1
L2AgWa	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Phosphoglyc_int_imputed.txt_snps.txt	Maximum likelihood	60.869466709968	46	0.0698529219672975
L2AgWa	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Phosphoglyc_int_imputed.txt_snps.txt	MR Egger	60.8681395677613	45	0.0573828525504701
L2AgWa	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Phosphoglyc_int_imputed.txt_snps.txt	Inverse variance weighted	60.8810790501127	46	0.0697182534736947
L2AgWa	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Phosphoglyc_int_imputed.txt_snps.txt	Unweighted regression	0.391166552198328	46	1
L4lXvm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_C_int_imputed.txt_snps.txt	Maximum likelihood	96.3665998881773	58	0.00116121258911256
L4lXvm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_C_int_imputed.txt_snps.txt	MR Egger	94.5133081055228	57	0.00131774985917488
L4lXvm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	96.3689443932691	58	0.00116060984138552
L4lXvm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0990852766296464	58	1
L4lXvm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_C_int_imputed.txt_snps.txt	Maximum likelihood	78.8658767539084	58	0.0355800774626898
L4lXvm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_C_int_imputed.txt_snps.txt	MR Egger	78.273160560657	57	0.0322780496580839
L4lXvm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	78.8659825050943	58	0.0355794498965846
L4lXvm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0991470020632935	58	1
L4lXvm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_C_int_imputed.txt_snps.txt	Maximum likelihood	65.893906714353	55	0.149234548951928
L4lXvm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_C_int_imputed.txt_snps.txt	MR Egger	59.9373918493492	54	0.269186740310416
L4lXvm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	65.9650142902502	55	0.147842970165633
L4lXvm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.323246288554724	55	1
LTJxL7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	ApoB_by_ApoA1_int_imputed.txt_snps.txt	Maximum likelihood	82.1072913155771	49	0.00212188430596529
LTJxL7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	ApoB_by_ApoA1_int_imputed.txt_snps.txt	MR Egger	81.2924398397458	48	0.00190248595043977
LTJxL7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	ApoB_by_ApoA1_int_imputed.txt_snps.txt	Inverse variance weighted	82.5715824391809	49	0.00190888055269672
LTJxL7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	ApoB_by_ApoA1_int_imputed.txt_snps.txt	Unweighted regression	0.0706356061733743	49	1
LTJxL7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	ApoB_by_ApoA1_int_imputed.txt_snps.txt	Maximum likelihood	67.0511500648841	49	0.044233300020986
LTJxL7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	ApoB_by_ApoA1_int_imputed.txt_snps.txt	MR Egger	65.6550291574435	48	0.0459824369168787
LTJxL7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	ApoB_by_ApoA1_int_imputed.txt_snps.txt	Inverse variance weighted	67.289468845289	49	0.0424368164142585
LTJxL7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	ApoB_by_ApoA1_int_imputed.txt_snps.txt	Unweighted regression	0.0872959464927571	49	1
LTJxL7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	ApoB_by_ApoA1_int_imputed.txt_snps.txt	Maximum likelihood	54.8627494465485	48	0.23058712048011
LTJxL7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	ApoB_by_ApoA1_int_imputed.txt_snps.txt	MR Egger	44.0888823944744	47	0.593866152140079
LTJxL7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	ApoB_by_ApoA1_int_imputed.txt_snps.txt	Inverse variance weighted	55.0952169894489	48	0.22405375805744
LTJxL7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	ApoB_by_ApoA1_int_imputed.txt_snps.txt	Unweighted regression	0.295016209451046	48	1
lut1Tm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	68.9698880793726	52	0.0576263699082659
lut1Tm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_FC_int_imputed.txt_snps.txt	MR Egger	68.9763120364175	51	0.0474812661478282
lut1Tm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	68.9773379519934	52	0.0575564874890384
lut1Tm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0687816399223425	52	1
lut1Tm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	71.7850664081387	52	0.0358532475035622
lut1Tm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_FC_int_imputed.txt_snps.txt	MR Egger	71.0592294623833	51	0.0331027801711117
lut1Tm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	71.8076158302565	52	0.0357126782167921
lut1Tm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.10900423047632	52	1
lut1Tm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	71.7714098985644	51	0.0291468191103151
lut1Tm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_FC_int_imputed.txt_snps.txt	MR Egger	71.6684734052346	50	0.0238762772915802
lut1Tm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	71.7720444284841	51	0.0291434886169241
lut1Tm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.459902313831173	51	1
LZitjs	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_L_int_imputed.txt_snps.txt	Maximum likelihood	45.6630858358075	38	0.183689069054461
LZitjs	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_L_int_imputed.txt_snps.txt	MR Egger	42.1765019984489	37	0.257033843786759
LZitjs	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	45.6741200070741	38	0.183391808875988
LZitjs	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0264593424080273	38	1
LZitjs	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_L_int_imputed.txt_snps.txt	Maximum likelihood	43.7787324672051	38	0.239594259579511
LZitjs	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_L_int_imputed.txt_snps.txt	MR Egger	42.2711778960271	37	0.253798169822963
LZitjs	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	43.7870253993128	38	0.239325760079798
LZitjs	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0373883215827419	38	1
LZitjs	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_L_int_imputed.txt_snps.txt	Maximum likelihood	35.6449523568889	38	0.578855868065975
LZitjs	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_L_int_imputed.txt_snps.txt	MR Egger	35.6473524648874	37	0.532424617425451
LZitjs	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	35.7478376549019	38	0.574044102615115
LZitjs	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.222254049354916	38	1
lZkhIf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	63.5731494570897	59	0.318599996327893
lZkhIf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_L_int_imputed.txt_snps.txt	MR Egger	63.2922223834691	58	0.29505847391189
lZkhIf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	63.5735626388432	59	0.318587088567617
lZkhIf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.061316160168201	59	1
lZkhIf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	62.8779461395586	59	0.340700578528721
lZkhIf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_L_int_imputed.txt_snps.txt	MR Egger	62.8287131410643	58	0.309243403497635
lZkhIf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	62.8787850162195	59	0.34067345993599
lZkhIf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0924148657675025	59	1
lZkhIf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	76.9279239903142	58	0.0488182378466069
lZkhIf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_L_int_imputed.txt_snps.txt	MR Egger	76.9557061115263	57	0.040256873922315
lZkhIf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	76.9782591974188	58	0.048427360682377
lZkhIf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.690562892531624	58	1
M7Wwy4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	53.4012379445657	50	0.344922700757416
M7Wwy4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_TG_int_imputed.txt_snps.txt	MR Egger	49.690103558859	49	0.445627467650385
M7Wwy4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	53.4528352970046	50	0.343107586148459
M7Wwy4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0443888024369323	50	1
M7Wwy4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	51.6717466311267	50	0.408310317438001
M7Wwy4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_TG_int_imputed.txt_snps.txt	MR Egger	45.9771327298134	49	0.596427701631549
M7Wwy4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	51.7057712913422	50	0.407019772309522
M7Wwy4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0648180667884135	50	1
M7Wwy4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	53.3366128220471	50	0.347202798512365
M7Wwy4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_TG_int_imputed.txt_snps.txt	MR Egger	52.9006199892561	49	0.325994332083645
M7Wwy4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	53.5153575427812	50	0.340914546207713
M7Wwy4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.765986547023484	50	1
m8CJXX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	53.3143600884144	45	0.184880138426141
m8CJXX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_C_pct_int_imputed.txt_snps.txt	MR Egger	50.9346927171191	44	0.21950035206948
m8CJXX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	53.3145285300024	45	0.18487590913943
m8CJXX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0711662530800472	45	1
m8CJXX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	52.7616841718477	45	0.199129067148478
m8CJXX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_C_pct_int_imputed.txt_snps.txt	MR Egger	51.4621615312689	44	0.20477773313968
m8CJXX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	52.7624582528318	45	0.199108588330201
m8CJXX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0821657721368541	45	1
m8CJXX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	57.532456524577	42	0.0556224893650287
m8CJXX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_C_pct_int_imputed.txt_snps.txt	MR Egger	57.5422198379401	41	0.0447564982966382
m8CJXX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	57.578429404208	42	0.0551670084192831
m8CJXX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.584422217608593	42	1
m9OT58	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	49.9973415502802	35	0.0481228044189922
m9OT58	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	45.7230349764559	34	0.0863304873538049
m9OT58	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	50.0301960849079	35	0.0478133862162986
m9OT58	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0461491165808616	35	1
m9OT58	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	54.5970775158032	35	0.0185198827344741
m9OT58	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	51.3986264228313	34	0.0282115283858146
m9OT58	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	54.6263579802272	35	0.0184017596270594
m9OT58	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0610140959067908	35	1
m9OT58	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	26.9587499887834	34	0.799187215915557
m9OT58	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	26.4573691501535	33	0.782924123218551
m9OT58	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	26.9932195076356	34	0.797815760564498
m9OT58	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.253458763261254	34	1
mda6Zu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_L_int_imputed.txt_snps.txt	Maximum likelihood	120.399081370961	70	0.00017167433056361
mda6Zu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_L_int_imputed.txt_snps.txt	MR Egger	120.05355633302	69	0.00013786828142055
mda6Zu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	120.417480384128	70	0.000170958895087758
mda6Zu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.184288291354288	70	1
mda6Zu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_L_int_imputed.txt_snps.txt	Maximum likelihood	106.189160224341	70	0.00343084849218068
mda6Zu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_L_int_imputed.txt_snps.txt	MR Egger	106.055022593571	69	0.00276838630136855
mda6Zu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	106.221293168816	70	0.00340959036811745
mda6Zu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.26352304398897	70	1
mda6Zu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_L_int_imputed.txt_snps.txt	Maximum likelihood	75.9060055753042	66	0.189465096352752
mda6Zu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_L_int_imputed.txt_snps.txt	MR Egger	71.9908852799745	65	0.257700491329601
mda6Zu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	75.9512557929865	66	0.188495156959449
mda6Zu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.546455036293922	66	1
MMxFB1	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Ala_int_imputed.txt_snps.txt	Maximum likelihood	28.3439195242851	18	0.0570106997965665
MMxFB1	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Ala_int_imputed.txt_snps.txt	MR Egger	23.9133643456383	17	0.121808108491381
MMxFB1	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Ala_int_imputed.txt_snps.txt	Inverse variance weighted	28.3452379618665	18	0.0569920754057738
MMxFB1	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Ala_int_imputed.txt_snps.txt	Unweighted regression	0.0115880178511183	18	1
MMxFB1	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Ala_int_imputed.txt_snps.txt	Maximum likelihood	18.9872275338967	18	0.392610409137176
MMxFB1	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Ala_int_imputed.txt_snps.txt	MR Egger	17.1771787862736	17	0.44242604618257
MMxFB1	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Ala_int_imputed.txt_snps.txt	Inverse variance weighted	18.9901470056647	18	0.392430467246521
MMxFB1	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Ala_int_imputed.txt_snps.txt	Unweighted regression	0.0135004074789742	18	1
MMxFB1	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Ala_int_imputed.txt_snps.txt	Maximum likelihood	17.4423120764266	18	0.492918100376531
MMxFB1	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Ala_int_imputed.txt_snps.txt	MR Egger	9.88245134403527	17	0.908467147450768
MMxFB1	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Ala_int_imputed.txt_snps.txt	Inverse variance weighted	17.558465114944	18	0.485075599038337
MMxFB1	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Ala_int_imputed.txt_snps.txt	Unweighted regression	0.13393722966685	18	1
mwdca0	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	GlycA_int_imputed.txt_snps.txt	Maximum likelihood	73.9676766889924	28	5.09799176049555e-06
mwdca0	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	GlycA_int_imputed.txt_snps.txt	MR Egger	66.8779958130521	27	3.09177381140334e-05
mwdca0	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	GlycA_int_imputed.txt_snps.txt	Inverse variance weighted	73.9934857703343	28	5.05464815458488e-06
mwdca0	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	GlycA_int_imputed.txt_snps.txt	Unweighted regression	0.108267150039626	28	1
mwdca0	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	GlycA_int_imputed.txt_snps.txt	Maximum likelihood	60.319779362266	28	0.000370662720748882
mwdca0	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	GlycA_int_imputed.txt_snps.txt	MR Egger	56.4816650809229	27	0.00074801152469505
mwdca0	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	GlycA_int_imputed.txt_snps.txt	Inverse variance weighted	60.346801022354	28	0.000367717984411173
mwdca0	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	GlycA_int_imputed.txt_snps.txt	Unweighted regression	0.113717343621617	28	1
mwdca0	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	GlycA_int_imputed.txt_snps.txt	Maximum likelihood	24.4316898356954	27	0.606277804204692
mwdca0	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	GlycA_int_imputed.txt_snps.txt	MR Egger	24.433388862912	26	0.551198367218737
mwdca0	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	GlycA_int_imputed.txt_snps.txt	Inverse variance weighted	24.5466236041089	27	0.599853530202728
mwdca0	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	GlycA_int_imputed.txt_snps.txt	Unweighted regression	0.234844782913376	27	1
MXH8Ap	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	67.310344047147	50	0.0516673655030686
MXH8Ap	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	66.7540436441579	49	0.0465644028799753
MXH8Ap	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	67.3144799819119	50	0.0516314156397499
MXH8Ap	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.09978175141097	50	1
MXH8Ap	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	66.2263846748277	50	0.0618531476846719
MXH8Ap	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	64.7285776734805	49	0.0654317665264535
MXH8Ap	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	66.2344841620909	50	0.0617711826988041
MXH8Ap	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.132362274811575	50	1
MXH8Ap	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	47.147817420006	48	0.507693766001638
MXH8Ap	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	46.6436474436195	47	0.48722585628508
MXH8Ap	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	47.3368367451246	48	0.499924788928888
MXH8Ap	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.382614303676159	48	1
N2kfP4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	49.0531621298668	32	0.0274434310073456
N2kfP4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_FC_int_imputed.txt_snps.txt	MR Egger	47.4881283756235	31	0.029445233034643
N2kfP4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	49.164555166476	32	0.0267866356826133
N2kfP4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0297862816547552	32	1
N2kfP4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	41.5897024395418	32	0.119418216400879
N2kfP4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_FC_int_imputed.txt_snps.txt	MR Egger	41.6435647579022	31	0.0959896715932078
N2kfP4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	41.6581767251616	32	0.117992040847923
N2kfP4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0447060062224798	32	1
N2kfP4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	40.3627555594164	32	0.147356251513703
N2kfP4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_FC_int_imputed.txt_snps.txt	MR Egger	39.4646774178142	31	0.141562651590148
N2kfP4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	40.542579828774	32	0.142971999697311
N2kfP4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.46250118560759	32	1
N2zg1g	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_TG_int_imputed.txt_snps.txt	Maximum likelihood	63.4393227326764	51	0.113413972226048
N2zg1g	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_TG_int_imputed.txt_snps.txt	MR Egger	57.7309208022476	50	0.211158527503346
N2zg1g	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_TG_int_imputed.txt_snps.txt	Inverse variance weighted	63.4745982428808	51	0.112834620436696
N2zg1g	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0555901635038782	51	1
N2zg1g	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_TG_int_imputed.txt_snps.txt	Maximum likelihood	58.218361302112	51	0.226968180758201
N2zg1g	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_TG_int_imputed.txt_snps.txt	MR Egger	50.2677836057192	50	0.462780671912776
N2zg1g	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_TG_int_imputed.txt_snps.txt	Inverse variance weighted	58.2411138053023	51	0.226347481124399
N2zg1g	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0805957021988629	51	1
N2zg1g	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_TG_int_imputed.txt_snps.txt	Maximum likelihood	57.4352415884326	51	0.249011477301097
N2zg1g	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_TG_int_imputed.txt_snps.txt	MR Egger	57.3588714598006	50	0.22108036430367
N2zg1g	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_TG_int_imputed.txt_snps.txt	Inverse variance weighted	57.5623420024087	51	0.245344469951175
N2zg1g	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_TG_int_imputed.txt_snps.txt	Unweighted regression	0.753940887407443	51	1
NIZaOA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	68.5652875886337	50	0.0416949045977224
NIZaOA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_C_int_imputed.txt_snps.txt	MR Egger	66.8885632172839	49	0.0454961912951841
NIZaOA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	68.6645383894447	50	0.0409824012082211
NIZaOA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0430683301647117	50	1
NIZaOA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	59.6018946638886	50	0.165890390494447
NIZaOA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_C_int_imputed.txt_snps.txt	MR Egger	59.224520557565	49	0.150345218394951
NIZaOA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	59.7106153580551	50	0.163494815616508
NIZaOA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0609384669240333	50	1
NIZaOA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	64.9500915915007	50	0.0759583136760927
NIZaOA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_C_int_imputed.txt_snps.txt	MR Egger	55.9190165897747	49	0.231123962391462
NIZaOA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	65.0403995440508	50	0.0748796352230311
NIZaOA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.413687738522453	50	1
nli8n1	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	DHA_int_imputed.txt_snps.txt	Maximum likelihood	31.8936777891116	25	0.161111602889603
nli8n1	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	DHA_int_imputed.txt_snps.txt	MR Egger	29.0518819721039	24	0.218184395861563
nli8n1	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	DHA_int_imputed.txt_snps.txt	Inverse variance weighted	31.9025358027865	25	0.160851617931128
nli8n1	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	DHA_int_imputed.txt_snps.txt	Unweighted regression	0.037602954508664	25	1
nli8n1	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	DHA_int_imputed.txt_snps.txt	Maximum likelihood	19.0117931440845	25	0.79655473674782
nli8n1	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	DHA_int_imputed.txt_snps.txt	MR Egger	18.9309020374563	24	0.755664522462751
nli8n1	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	DHA_int_imputed.txt_snps.txt	Inverse variance weighted	19.0118665637418	25	0.796551212046424
nli8n1	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	DHA_int_imputed.txt_snps.txt	Unweighted regression	0.0398408083669332	25	1
nli8n1	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	DHA_int_imputed.txt_snps.txt	Maximum likelihood	25.4128434357012	23	0.329356376609161
nli8n1	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	DHA_int_imputed.txt_snps.txt	MR Egger	24.6003654430184	22	0.316564553191924
nli8n1	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	DHA_int_imputed.txt_snps.txt	Inverse variance weighted	25.4168255363751	23	0.329158042829307
nli8n1	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	DHA_int_imputed.txt_snps.txt	Unweighted regression	0.198561515621026	23	1
Nsxvon	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Albumin_int_imputed.txt_snps.txt	Maximum likelihood	20.5823092119295	18	0.30100713716362
Nsxvon	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Albumin_int_imputed.txt_snps.txt	MR Egger	20.5769616031471	17	0.24578634398832
Nsxvon	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Albumin_int_imputed.txt_snps.txt	Inverse variance weighted	20.5866391107054	18	0.300777974582931
Nsxvon	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Albumin_int_imputed.txt_snps.txt	Unweighted regression	0.0154826493194952	18	1
Nsxvon	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Albumin_int_imputed.txt_snps.txt	Maximum likelihood	16.4532616303408	18	0.560946078910309
Nsxvon	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Albumin_int_imputed.txt_snps.txt	MR Egger	16.4542074564506	17	0.491894477136583
Nsxvon	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Albumin_int_imputed.txt_snps.txt	Inverse variance weighted	16.4542144762738	18	0.560879786316795
Nsxvon	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Albumin_int_imputed.txt_snps.txt	Unweighted regression	0.0155361912246211	18	1
Nsxvon	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Albumin_int_imputed.txt_snps.txt	Maximum likelihood	19.4335217963448	18	0.365596672119074
Nsxvon	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Albumin_int_imputed.txt_snps.txt	MR Egger	19.4231680805048	17	0.304790110755412
Nsxvon	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Albumin_int_imputed.txt_snps.txt	Inverse variance weighted	19.4355744702262	18	0.365474782549314
Nsxvon	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Albumin_int_imputed.txt_snps.txt	Unweighted regression	0.145386926818808	18	1
o4c9h7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	86.7357277397616	57	0.00676003154664619
o4c9h7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_FC_int_imputed.txt_snps.txt	MR Egger	86.0235286725824	56	0.00608913961293403
o4c9h7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	86.8304605161358	57	0.00663391160051037
o4c9h7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.11860996229285	57	1
o4c9h7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	97.203013974017	57	0.000719717211565312
o4c9h7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_FC_int_imputed.txt_snps.txt	MR Egger	97.2793871551984	56	0.000523365377697886
o4c9h7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	97.3070452068314	57	0.000702808324008014
o4c9h7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.199395076594252	57	1
o4c9h7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	71.3336180468292	54	0.0571086831475153
o4c9h7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_FC_int_imputed.txt_snps.txt	MR Egger	69.6453910582095	53	0.0622341109820978
o4c9h7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	71.337034382698	54	0.057077365918695
o4c9h7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.807367609074121	54	1
O9k9I2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	53.1087700500341	39	0.0653934524663992
O9k9I2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_TG_int_imputed.txt_snps.txt	MR Egger	49.8034661127097	38	0.0951856566511858
O9k9I2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	53.2948478113566	39	0.0632368435339065
O9k9I2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.029752735864189	39	1
O9k9I2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	58.5514241779107	39	0.0228897214688454
O9k9I2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_TG_int_imputed.txt_snps.txt	MR Egger	57.209675231072	38	0.0234317078843577
O9k9I2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	58.9370408815582	39	0.0211398887708691
O9k9I2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0468709109612523	39	1
O9k9I2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	42.3916828794543	38	0.287254044889054
O9k9I2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_TG_int_imputed.txt_snps.txt	MR Egger	40.5711736051971	37	0.315797152789118
O9k9I2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	42.3970693125648	38	0.287058558286514
O9k9I2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.30653047917858	38	1
oDGC5J	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_L_int_imputed.txt_snps.txt	Maximum likelihood	61.107259661217	37	0.00757827142021319
oDGC5J	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_L_int_imputed.txt_snps.txt	MR Egger	60.1539387470338	36	0.00701303109572466
oDGC5J	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	61.107267787919	37	0.0075782572126
oDGC5J	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0537328320300117	37	1
oDGC5J	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_L_int_imputed.txt_snps.txt	Maximum likelihood	55.3473439793396	37	0.0267145609867214
oDGC5J	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_L_int_imputed.txt_snps.txt	MR Egger	53.8354156204369	36	0.028340733294378
oDGC5J	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	55.3539943670566	37	0.0266779587119947
oDGC5J	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0871922226093368	37	1
oDGC5J	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_L_int_imputed.txt_snps.txt	Maximum likelihood	39.0267480811934	35	0.293553293836034
oDGC5J	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_L_int_imputed.txt_snps.txt	MR Egger	32.080276646198	34	0.561980064417432
oDGC5J	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	39.0468573079829	35	0.292785384066841
oDGC5J	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.245875444369388	35	1
OgSOLw	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Glucose_int_imputed.txt_snps.txt	Maximum likelihood	6.16858860445858	7	0.520208017568145
OgSOLw	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Glucose_int_imputed.txt_snps.txt	MR Egger	1.56136969274977	6	0.955314257773505
OgSOLw	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Glucose_int_imputed.txt_snps.txt	Inverse variance weighted	6.23568076299492	7	0.512515604617882
OgSOLw	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Glucose_int_imputed.txt_snps.txt	Unweighted regression	0.00315395931134231	7	0.999999999986627
OgSOLw	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Glucose_int_imputed.txt_snps.txt	Maximum likelihood	6.02500845002827	7	0.53683229509126
OgSOLw	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Glucose_int_imputed.txt_snps.txt	MR Egger	3.48242123331375	6	0.746306986886498
OgSOLw	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Glucose_int_imputed.txt_snps.txt	Inverse variance weighted	6.11947176257729	7	0.525870682668707
OgSOLw	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Glucose_int_imputed.txt_snps.txt	Unweighted regression	0.003698690170864	7	0.99999999997665
OgSOLw	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Glucose_int_imputed.txt_snps.txt	Maximum likelihood	3.88191043386259	7	0.79327419777002
OgSOLw	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Glucose_int_imputed.txt_snps.txt	MR Egger	3.88298141537035	6	0.692508575532679
OgSOLw	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Glucose_int_imputed.txt_snps.txt	Inverse variance weighted	3.88330240416777	7	0.793116378539624
OgSOLw	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Glucose_int_imputed.txt_snps.txt	Unweighted regression	0.0136042256258571	7	0.99999999778021
OHqe6X	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	60.086833839249	40	0.021488363931662
OHqe6X	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	59.8919126069028	39	0.0173132549818681
OHqe6X	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	60.0959944174748	40	0.0214480941127568
OHqe6X	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0581248684012266	40	1
OHqe6X	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	58.7220141033608	40	0.0283014291310423
OHqe6X	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	58.5802943024948	39	0.0227543546936757
OHqe6X	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	58.7295722323777	40	0.0282589354095948
OHqe6X	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0785303119266658	40	1
OHqe6X	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	58.8898960793265	39	0.0213471709426524
OHqe6X	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	57.5241718523912	38	0.0219505674326262
OHqe6X	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	59.0491456997527	39	0.0206542433613157
OHqe6X	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.450013654802246	39	1
OJ6AdD	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	72.0421788400716	39	0.0010031941018961
OJ6AdD	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	71.3376630202423	38	0.000848590931381203
OJ6AdD	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	72.0703372040291	39	0.00099600340027134
OJ6AdD	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0543690493661145	39	1
OJ6AdD	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	52.0418022149036	39	0.0789891482715598
OJ6AdD	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	50.8187398494115	38	0.0798413033639583
OJ6AdD	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	52.068641350826	39	0.0786203705879762
OJ6AdD	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0640095876996766	39	1
OJ6AdD	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	65.8895898238371	37	0.0024080635257372
OJ6AdD	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	64.6176753081326	36	0.00237312712149454
OJ6AdD	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	65.9223120818947	37	0.00238856572000277
OJ6AdD	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.413858963277363	37	1
OML97c	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	54.7918486238591	46	0.175537565190795
OML97c	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_TG_int_imputed.txt_snps.txt	MR Egger	54.7286418754519	45	0.151771153004759
OML97c	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	54.8019609516034	46	0.175295445240128
OML97c	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.034560476644271	46	1
OML97c	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	48.4909335997716	46	0.372809313918989
OML97c	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_TG_int_imputed.txt_snps.txt	MR Egger	48.49208463281	45	0.334001590835141
OML97c	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	48.4937208862667	46	0.372703252691606
OML97c	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0530338143390995	46	1
OML97c	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	56.1722248740052	44	0.103154111402159
OML97c	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_TG_int_imputed.txt_snps.txt	MR Egger	56.0448111790996	43	0.0876178888591444
OML97c	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	56.1816587785737	44	0.103000741650745
OML97c	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.3987553548731	44	1
OMpKo5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	30.6923533697326	27	0.283957800963884
OMpKo5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	30.4553148781359	26	0.249178842622408
OMpKo5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	30.7074801743004	27	0.283318770992592
OMpKo5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0294357866796141	27	1
OMpKo5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	32.7954494138212	27	0.203904192699126
OMpKo5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	31.3668250709602	26	0.214890343902815
OMpKo5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	32.8257773753862	27	0.202880311048207
OMpKo5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.050902928802712	27	1
OMpKo5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	22.1247620255528	25	0.628529724165522
OMpKo5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	22.0903411809269	24	0.573874551811493
OMpKo5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	22.1268313260922	25	0.628409910398746
OMpKo5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.229417512336899	25	1
oo3fHm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	58.850569146879	50	0.183145592071812
oo3fHm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_TG_int_imputed.txt_snps.txt	MR Egger	58.8365529936036	49	0.158571757981176
oo3fHm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	58.8724583721554	50	0.182625459830947
oo3fHm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.106676282817289	50	1
oo3fHm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	59.6910413015279	50	0.163924237039537
oo3fHm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_TG_int_imputed.txt_snps.txt	MR Egger	59.2486383379559	49	0.149844528541974
oo3fHm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	59.6910587144927	50	0.163923854662692
oo3fHm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.124816549231989	50	1
oo3fHm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	63.8330321798543	49	0.0756224979294529
oo3fHm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_TG_int_imputed.txt_snps.txt	MR Egger	62.4455468997046	48	0.0786038893865053
oo3fHm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	63.9754387071346	49	0.0739192445760129
oo3fHm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.961934506251107	49	1
osiUqI	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	85.4154940185342	46	0.000370180368851072
osiUqI	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_PL_int_imputed.txt_snps.txt	MR Egger	81.6981883016065	45	0.000671111572890775
osiUqI	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	85.4430901959574	46	0.000367604000853201
osiUqI	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0694949777518352	46	1
osiUqI	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	76.8250848386581	46	0.00292922557827061
osiUqI	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_PL_int_imputed.txt_snps.txt	MR Egger	75.4859304679546	45	0.00296307291449954
osiUqI	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	76.8767124613605	46	0.0028949690018605
osiUqI	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.069516979790602	46	1
osiUqI	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	57.6977738117682	45	0.0970117139377178
osiUqI	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_PL_int_imputed.txt_snps.txt	MR Egger	49.691838671249	44	0.256939065279527
osiUqI	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	57.7234931496677	45	0.0966178983739529
osiUqI	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.349346529575678	45	1
OZqO9c	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	56.8901019515948	54	0.3679777548445
OZqO9c	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	56.6263515657093	53	0.341289878783565
OZqO9c	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	56.9934804497461	54	0.364368176228875
OZqO9c	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0635672029884004	54	1
OZqO9c	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	63.3223439782658	54	0.1805157197511
OZqO9c	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	62.2495182720276	53	0.180148376533509
OZqO9c	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	63.4285319458415	54	0.178112516310662
OZqO9c	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.106045611107515	54	1
OZqO9c	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	56.6986768951017	54	0.374703835251082
OZqO9c	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	56.6974786352138	53	0.338870837255214
OZqO9c	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	56.7001521973383	54	0.374651790900035
OZqO9c	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.469398901636189	54	1
pHQEww	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_6_pct_int_imputed.txt_snps.txt	Maximum likelihood	37.1194055376873	29	0.14319458364763
pHQEww	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_6_pct_int_imputed.txt_snps.txt	MR Egger	36.127348584664	28	0.139383513890543
pHQEww	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_6_pct_int_imputed.txt_snps.txt	Inverse variance weighted	37.1194134932208	29	0.143194383429327
pHQEww	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_6_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0318224655493331	29	1
pHQEww	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_6_pct_int_imputed.txt_snps.txt	Maximum likelihood	34.4069926965985	29	0.22467402214696
pHQEww	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_6_pct_int_imputed.txt_snps.txt	MR Egger	33.5005955652206	28	0.217800472205419
pHQEww	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_6_pct_int_imputed.txt_snps.txt	Inverse variance weighted	34.4179679269179	29	0.224289340294084
pHQEww	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_6_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0496782243361346	29	1
pHQEww	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_6_pct_int_imputed.txt_snps.txt	Maximum likelihood	38.0312898921884	29	0.121642028134944
pHQEww	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_6_pct_int_imputed.txt_snps.txt	MR Egger	38.11512444013	28	0.0962404893114586
pHQEww	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_6_pct_int_imputed.txt_snps.txt	Inverse variance weighted	38.1154800562237	29	0.119789691036388
pHQEww	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_6_pct_int_imputed.txt_snps.txt	Unweighted regression	0.424048419858903	29	1
PJtdmf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_FC_int_imputed.txt_snps.txt	Maximum likelihood	77.0996361762959	42	0.000775071615618537
PJtdmf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_FC_int_imputed.txt_snps.txt	MR Egger	77.0814443401832	41	0.000551370062827345
PJtdmf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_FC_int_imputed.txt_snps.txt	Inverse variance weighted	77.1000760458354	42	0.000774985591608899
PJtdmf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0865045699375658	42	1
PJtdmf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_FC_int_imputed.txt_snps.txt	Maximum likelihood	65.3567943745989	42	0.0119935307862671
PJtdmf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_FC_int_imputed.txt_snps.txt	MR Egger	65.3427384580984	41	0.00917848523560145
PJtdmf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_FC_int_imputed.txt_snps.txt	Inverse variance weighted	65.3761946873764	42	0.0119442129064356
PJtdmf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_FC_int_imputed.txt_snps.txt	Unweighted regression	0.113148215127807	42	1
PJtdmf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_FC_int_imputed.txt_snps.txt	Maximum likelihood	37.7615750424718	40	0.571469045555202
PJtdmf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_FC_int_imputed.txt_snps.txt	MR Egger	31.2944031319059	39	0.805311955706765
PJtdmf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_FC_int_imputed.txt_snps.txt	Inverse variance weighted	37.7791421971715	40	0.570668937372806
PJtdmf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_FC_int_imputed.txt_snps.txt	Unweighted regression	0.232554227672562	40	1
Pnvl72	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	SFA_int_imputed.txt_snps.txt	Maximum likelihood	54.2031663685822	38	0.04275566894504
Pnvl72	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	SFA_int_imputed.txt_snps.txt	MR Egger	50.8047458697745	37	0.0648532288507186
Pnvl72	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	SFA_int_imputed.txt_snps.txt	Inverse variance weighted	54.2215683265328	38	0.0426040833471113
Pnvl72	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	SFA_int_imputed.txt_snps.txt	Unweighted regression	0.0417213243867385	38	1
Pnvl72	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	SFA_int_imputed.txt_snps.txt	Maximum likelihood	51.12841011058	38	0.0755906617670539
Pnvl72	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	SFA_int_imputed.txt_snps.txt	MR Egger	49.3389835947159	37	0.0844349719131006
Pnvl72	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	SFA_int_imputed.txt_snps.txt	Inverse variance weighted	51.2157691839604	38	0.0744262198708476
Pnvl72	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	SFA_int_imputed.txt_snps.txt	Unweighted regression	0.0621961523634125	38	1
Pnvl72	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	SFA_int_imputed.txt_snps.txt	Maximum likelihood	39.0549342032532	36	0.334161315178076
Pnvl72	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	SFA_int_imputed.txt_snps.txt	MR Egger	37.8653056433617	35	0.339873660092177
Pnvl72	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	SFA_int_imputed.txt_snps.txt	Inverse variance weighted	39.1108253765135	36	0.331897888914366
Pnvl72	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	SFA_int_imputed.txt_snps.txt	Unweighted regression	0.164323058439148	36	1
PoeuP7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	54.2013727504521	56	0.543236859304308
PoeuP7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_C_int_imputed.txt_snps.txt	MR Egger	54.1909650114027	55	0.505514466287178
PoeuP7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	54.2018793935091	56	0.54321747374237
PoeuP7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0544571378115285	56	1
PoeuP7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	50.6907052898798	56	0.675415428645801
PoeuP7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_C_int_imputed.txt_snps.txt	MR Egger	50.6695814393542	55	0.640653999407743
PoeuP7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	50.6916409386282	56	0.675381464943819
PoeuP7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0835182511840387	56	1
PoeuP7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	66.9124688262494	54	0.11154482072263
PoeuP7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_C_int_imputed.txt_snps.txt	MR Egger	66.4875392280584	53	0.100891873642652
PoeuP7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	66.9334926503059	54	0.111212085013094
PoeuP7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.461424091648309	54	1
pUGzfc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_P_int_imputed.txt_snps.txt	Maximum likelihood	62.0852245640459	36	0.0044286082135046
pUGzfc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_P_int_imputed.txt_snps.txt	MR Egger	61.9796966845123	35	0.00329061657331119
pUGzfc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	62.0965321784047	36	0.00441651971404853
pUGzfc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0643034448602377	36	1
pUGzfc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_P_int_imputed.txt_snps.txt	Maximum likelihood	55.90643212095	36	0.018278679496685
pUGzfc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_P_int_imputed.txt_snps.txt	MR Egger	55.9100633851488	35	0.0138482945218104
pUGzfc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	55.9229529459701	36	0.0182134200715414
pUGzfc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.105451213770046	36	1
pUGzfc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_P_int_imputed.txt_snps.txt	Maximum likelihood	44.3368483160108	34	0.110431733542392
pUGzfc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_P_int_imputed.txt_snps.txt	MR Egger	38.4033493988418	33	0.237910887614278
pUGzfc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	44.4840221461427	34	0.107640073473815
pUGzfc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.355850377126529	34	1
pwUwt6	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	59.9314795307931	52	0.210113587864012
pwUwt6	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	59.8974247627254	51	0.184176406150384
pwUwt6	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	59.9350226232718	52	0.210022530992511
pwUwt6	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0920808117094588	52	1
pwUwt6	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	62.0775447278355	52	0.159830506913323
pwUwt6	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	59.6933853317563	51	0.18905056874763
pwUwt6	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	62.081491218052	52	0.159746927788247
pwUwt6	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.192408161868232	52	1
pwUwt6	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	50.624409752962	51	0.488499787258041
pwUwt6	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	48.0362590624081	50	0.552529987734498
pwUwt6	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	50.6462633397943	51	0.487633732291485
pwUwt6	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.551093955216476	51	1
py09mf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	62.8416409475991	37	0.00504974765926283
py09mf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_FC_int_imputed.txt_snps.txt	MR Egger	62.3653472994307	36	0.00413807560696849
py09mf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	62.8805572651057	37	0.00500330050970528
py09mf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0572634394087845	37	1
py09mf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	50.2503805515329	37	0.071755155222641
py09mf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_FC_int_imputed.txt_snps.txt	MR Egger	50.3070270983932	36	0.0570707442499777
py09mf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	50.308475825644	37	0.0710040698265459
py09mf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0843239472032899	37	1
py09mf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	38.1787117782213	34	0.285180950120422
py09mf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_FC_int_imputed.txt_snps.txt	MR Egger	36.2392614697884	33	0.319924916174019
py09mf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	38.2515841213361	34	0.282414724615039
py09mf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.183580226496234	34	1
q00ren	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	52.7291188435629	48	0.296244081007297
q00ren	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_TG_int_imputed.txt_snps.txt	MR Egger	51.5692075062877	47	0.299753639667831
q00ren	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	52.7302996435383	48	0.296204985685311
q00ren	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0530133822745713	48	1
q00ren	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	60.2910560399732	48	0.109770457830337
q00ren	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_TG_int_imputed.txt_snps.txt	MR Egger	58.6808459008183	47	0.118037604760882
q00ren	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	60.2923973005516	48	0.109748375528855
q00ren	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.103883751309168	48	1
q00ren	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	65.1403446849597	47	0.0409218595506726
q00ren	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_TG_int_imputed.txt_snps.txt	MR Egger	61.9223393694183	46	0.0584944380568242
q00ren	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	65.1911614838701	47	0.0405525365912001
q00ren	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.645464346501993	47	1
Q1zSbS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	70.2048546910642	53	0.0568809945649299
Q1zSbS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_CE_int_imputed.txt_snps.txt	MR Egger	70.1892563231449	52	0.0471034942491413
Q1zSbS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	70.2136350550328	53	0.0568001810466574
Q1zSbS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0785179879349822	53	1
Q1zSbS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	65.4458117310827	53	0.117216675543774
Q1zSbS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_CE_int_imputed.txt_snps.txt	MR Egger	65.3605430084507	52	0.100917292308065
Q1zSbS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	65.4564432465946	53	0.117040229916634
Q1zSbS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.124284815324321	53	1
Q1zSbS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	48.6294993940738	52	0.607242075860551
Q1zSbS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_CE_int_imputed.txt_snps.txt	MR Egger	47.9773283620316	51	0.594452408202268
Q1zSbS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	48.6532997588057	52	0.60630459202124
Q1zSbS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.804425277692809	52	1
qEtgMU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Gln_int_imputed.txt_snps.txt	Maximum likelihood	39.5119909310013	20	0.0057546572460888
qEtgMU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Gln_int_imputed.txt_snps.txt	MR Egger	36.4583509893968	19	0.00926734596089271
qEtgMU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Gln_int_imputed.txt_snps.txt	Inverse variance weighted	39.5833217100454	20	0.00563726414173707
qEtgMU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Gln_int_imputed.txt_snps.txt	Unweighted regression	0.0366916479596358	20	1
qEtgMU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Gln_int_imputed.txt_snps.txt	Maximum likelihood	35.0242155763056	20	0.0199756835988602
qEtgMU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Gln_int_imputed.txt_snps.txt	MR Egger	32.58695772634	19	0.0268130444903584
qEtgMU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Gln_int_imputed.txt_snps.txt	Inverse variance weighted	35.0553925572205	20	0.0198112349826483
qEtgMU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Gln_int_imputed.txt_snps.txt	Unweighted regression	0.0606864760799805	20	1
qEtgMU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Gln_int_imputed.txt_snps.txt	Maximum likelihood	26.8302335218822	19	0.108669965363922
qEtgMU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Gln_int_imputed.txt_snps.txt	MR Egger	22.4909362218372	18	0.210916305401005
qEtgMU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Gln_int_imputed.txt_snps.txt	Inverse variance weighted	26.844708132856	19	0.108322565412345
qEtgMU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Gln_int_imputed.txt_snps.txt	Unweighted regression	0.229213740239043	19	0.999999999999999
Qip8qD	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	116.918762048913	71	0.000493098572950156
Qip8qD	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_FC_int_imputed.txt_snps.txt	MR Egger	116.951394236174	70	0.000370644619198353
Qip8qD	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	116.951555235937	71	0.000489626961449724
Qip8qD	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.175012365888756	71	1
Qip8qD	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	110.446952501777	71	0.00189307113215815
Qip8qD	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_FC_int_imputed.txt_snps.txt	MR Egger	110.197699083493	70	0.00154797297502152
Qip8qD	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	110.508358614116	71	0.00186994772861763
Qip8qD	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.250853839253032	71	1
Qip8qD	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	72.8910704755503	66	0.261840422227499
Qip8qD	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_FC_int_imputed.txt_snps.txt	MR Egger	70.7988989095013	65	0.290369589154557
Qip8qD	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	72.9110093677286	66	0.261312270292818
Qip8qD	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.548775269301001	66	1
QQ4S5t	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	46.4923716824004	36	0.113070372595467
QQ4S5t	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	45.2655235647328	35	0.11466021967454
QQ4S5t	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	46.4971451855203	36	0.11297940469082
QQ4S5t	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.054931797771454	36	1
QQ4S5t	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	44.8334936097038	36	0.148357460821219
QQ4S5t	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	43.9400483380831	35	0.142913577195072
QQ4S5t	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	44.833579031419	36	0.148355448338929
QQ4S5t	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0755360482428154	36	1
QQ4S5t	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	36.677129963943	34	0.345705172751368
QQ4S5t	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	35.2387282080689	33	0.362682305404321
QQ4S5t	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	36.7016408957155	34	0.34466554373642
QQ4S5t	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.29932471243833	34	1
qTMZLy	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LA_int_imputed.txt_snps.txt	Maximum likelihood	84.4504394411662	43	0.000163681619710177
qTMZLy	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LA_int_imputed.txt_snps.txt	MR Egger	83.6576622085939	42	0.000139411095237355
qTMZLy	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LA_int_imputed.txt_snps.txt	Inverse variance weighted	84.5141275397853	43	0.000160921871011657
qTMZLy	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LA_int_imputed.txt_snps.txt	Unweighted regression	0.0614694120428859	43	1
qTMZLy	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LA_int_imputed.txt_snps.txt	Maximum likelihood	79.4487696095279	43	0.000601546700103264
qTMZLy	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LA_int_imputed.txt_snps.txt	MR Egger	78.537186897741	42	0.000537636900272125
qTMZLy	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LA_int_imputed.txt_snps.txt	Inverse variance weighted	79.4839493254087	43	0.000596208970874813
qTMZLy	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LA_int_imputed.txt_snps.txt	Unweighted regression	0.0875938231229864	43	1
qTMZLy	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LA_int_imputed.txt_snps.txt	Maximum likelihood	45.934266102755	41	0.275102379981674
qTMZLy	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LA_int_imputed.txt_snps.txt	MR Egger	42.4901294049028	40	0.364267593780259
qTMZLy	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LA_int_imputed.txt_snps.txt	Inverse variance weighted	45.9345510622182	41	0.275092653941914
qTMZLy	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LA_int_imputed.txt_snps.txt	Unweighted regression	0.251487983502793	41	1
qxpvkt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_L_int_imputed.txt_snps.txt	Maximum likelihood	69.2390664077126	40	0.0027926218419531
qxpvkt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_L_int_imputed.txt_snps.txt	MR Egger	68.9945034684916	39	0.00215283578631902
qxpvkt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	69.2412084942997	40	0.00279118754793864
qxpvkt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0769005408629285	40	1
qxpvkt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_L_int_imputed.txt_snps.txt	Maximum likelihood	57.4735349923098	40	0.0361471014182672
qxpvkt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_L_int_imputed.txt_snps.txt	MR Egger	57.4669274232263	39	0.0285263480238057
qxpvkt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	57.4738923915648	40	0.0361446061531437
qxpvkt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.134663272400748	40	1
qxpvkt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_L_int_imputed.txt_snps.txt	Maximum likelihood	47.2140994949624	37	0.121229556857421
qxpvkt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_L_int_imputed.txt_snps.txt	MR Egger	42.0795145035886	36	0.224426279756316
qxpvkt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	47.2946397488921	37	0.119634234447654
qxpvkt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.311723742357415	37	1
QyzJ1x	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	83.381884929806	43	0.00021738037165843
QyzJ1x	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_FC_int_imputed.txt_snps.txt	MR Egger	81.8329857063004	42	0.000227357164791523
QyzJ1x	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	83.4019958681556	43	0.00021622863734081
QyzJ1x	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0668124287139252	43	1
QyzJ1x	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	78.1959051459897	43	0.000824342628154498
QyzJ1x	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_FC_int_imputed.txt_snps.txt	MR Egger	77.4113965181303	42	0.000716332086022409
QyzJ1x	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	78.2314378415559	43	0.000817060691973315
QyzJ1x	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.108790210950359	43	1
QyzJ1x	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	43.2808499282942	41	0.374209509831987
QyzJ1x	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_FC_int_imputed.txt_snps.txt	MR Egger	36.0933600499343	40	0.646771673298275
QyzJ1x	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	43.3282449225601	41	0.372301142306214
QyzJ1x	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.281269787568654	41	1
QZDpA5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	62.7580148435021	45	0.0410527164833613
QZDpA5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_CE_int_imputed.txt_snps.txt	MR Egger	61.0985107825055	44	0.0447524019475701
QZDpA5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	62.8059871719597	45	0.0406968834017626
QZDpA5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0628063828303303	45	1
QZDpA5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	59.2575196254516	45	0.0753692139603444
QZDpA5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_CE_int_imputed.txt_snps.txt	MR Egger	58.283896341794	44	0.0731345056004465
QZDpA5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	59.2827441649863	45	0.0750550280455251
QZDpA5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.119185093975169	45	1
QZDpA5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	55.1385834688813	43	0.10147651762879
QZDpA5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_CE_int_imputed.txt_snps.txt	MR Egger	54.9645215317295	42	0.0866373897497578
QZDpA5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	55.1760308864144	43	0.100870851404408
QZDpA5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.407010625619873	43	1
r2N7ZX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	75.6618176704534	48	0.00661641144260873
r2N7ZX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	75.4983898034852	47	0.00522911463104603
r2N7ZX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	75.6704395337876	48	0.00660432132227014
r2N7ZX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0653261088179659	48	1
r2N7ZX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	66.8276390338079	48	0.0373876525987814
r2N7ZX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	65.6666659819443	47	0.0372346012594826
r2N7ZX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	66.8358993639683	48	0.0373324376272831
r2N7ZX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0946592495307701	48	1
r2N7ZX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	62.2851341904572	48	0.0806421698349872
r2N7ZX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	62.2274066526569	47	0.0675402888326
r2N7ZX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	62.4296744042468	48	0.0788036640393836
r2N7ZX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.514482191036823	48	1
r8W3wN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	47.8881163203659	28	0.0110172061165888
r8W3wN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_FC_int_imputed.txt_snps.txt	MR Egger	46.6106685978199	27	0.0109265458460491
r8W3wN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	47.9059993121627	28	0.0109685607910406
r8W3wN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0298459305034235	28	1
r8W3wN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	37.7416444513568	28	0.103387083485878
r8W3wN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_FC_int_imputed.txt_snps.txt	MR Egger	37.3422414819241	27	0.0888545368756607
r8W3wN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	37.7597093491162	28	0.103031696376301
r8W3wN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0438654857387871	28	1
r8W3wN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	26.0169752707056	28	0.572111433155544
r8W3wN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_FC_int_imputed.txt_snps.txt	MR Egger	22.9890838697785	27	0.685598774344483
r8W3wN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	26.0568028789504	28	0.569922144623272
r8W3wN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.290532300855351	28	1
rAi1N4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	61.7264727924118	34	0.0025074474994191
rAi1N4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_FC_int_imputed.txt_snps.txt	MR Egger	60.5024964450492	33	0.00243161337853526
rAi1N4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	61.7838446264282	34	0.00247102397499184
rAi1N4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0621271982026545	34	1
rAi1N4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	57.2751666513656	34	0.00751449826520732
rAi1N4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_FC_int_imputed.txt_snps.txt	MR Egger	57.2604883626159	33	0.00550140977852067
rAi1N4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	57.3289153917857	34	0.00741900287329065
rAi1N4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.102005243816834	34	1
rAi1N4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	28.0631398707763	33	0.711475639396941
rAi1N4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_FC_int_imputed.txt_snps.txt	MR Egger	27.597615972253	32	0.689109916030898
rAi1N4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	28.1721606878935	33	0.706360607676973
rAi1N4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.218872120918894	33	1
Rbayxz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	36.0269360662747	48	0.898298906913094
Rbayxz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_TG_int_imputed.txt_snps.txt	MR Egger	35.4109285789691	47	0.8925734413328
Rbayxz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	36.030135994805	48	0.898228550949254
Rbayxz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0489392308454169	48	1
Rbayxz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	43.6930740722149	48	0.649816844566598
Rbayxz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_TG_int_imputed.txt_snps.txt	MR Egger	40.8319260421388	47	0.724664164062727
Rbayxz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	43.6931632456121	48	0.649813257983979
Rbayxz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0910507486282514	48	1
Rbayxz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	59.6162169375929	48	0.121332517656686
Rbayxz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_TG_int_imputed.txt_snps.txt	MR Egger	59.033547969252	47	0.111959589380776
Rbayxz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	59.6202199870843	48	0.121261238615017
Rbayxz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.720665909857094	48	1
Rds5KE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	68.5658777235489	54	0.0876776625666798
Rds5KE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_CE_int_imputed.txt_snps.txt	MR Egger	68.7039031120381	53	0.0721934408633112
Rds5KE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	68.7044918891442	54	0.0858802082068151
Rds5KE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0687495407835273	54	1
Rds5KE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	62.6136453725094	54	0.197143417202316
Rds5KE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_CE_int_imputed.txt_snps.txt	MR Egger	62.6916527949469	53	0.170225590467829
Rds5KE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	62.6937839128052	54	0.195211676807002
Rds5KE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.110810053493442	54	1
Rds5KE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	78.7824079101831	52	0.00967314637405405
Rds5KE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_CE_int_imputed.txt_snps.txt	MR Egger	76.9027113162427	51	0.0110134347670251
Rds5KE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	78.7830574060801	52	0.00967189186490908
Rds5KE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.774283080783204	52	1
rGbfoD	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_C_int_imputed.txt_snps.txt	Maximum likelihood	115.224030532821	79	0.00490440779812497
rGbfoD	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_C_int_imputed.txt_snps.txt	MR Egger	113.629022316695	78	0.00526036326977428
rGbfoD	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	115.263137486508	79	0.00487002606191273
rGbfoD	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.157196214891645	79	1
rGbfoD	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_C_int_imputed.txt_snps.txt	Maximum likelihood	117.999419168109	79	0.00294892099922714
rGbfoD	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_C_int_imputed.txt_snps.txt	MR Egger	118.023026121099	78	0.00233102242548166
rGbfoD	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	118.077481338468	79	0.00290623564507144
rGbfoD	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.252657148845625	79	1
rGbfoD	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_C_int_imputed.txt_snps.txt	Maximum likelihood	71.7185931542311	74	0.553502918253055
rGbfoD	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_C_int_imputed.txt_snps.txt	MR Egger	69.6558331966281	73	0.589276966951911
rGbfoD	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	71.724642415741	74	0.553302328508791
rGbfoD	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.613854856519185	74	1
RIXMfl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_C_int_imputed.txt_snps.txt	Maximum likelihood	46.9797705085183	26	0.00707324333148395
RIXMfl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_C_int_imputed.txt_snps.txt	MR Egger	46.8913908288091	25	0.00504970531731651
RIXMfl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	47.0662448490561	26	0.00691476269933639
RIXMfl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.062446446083795	26	1
RIXMfl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_C_int_imputed.txt_snps.txt	Maximum likelihood	47.1630346973065	26	0.00674131495754659
RIXMfl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_C_int_imputed.txt_snps.txt	MR Egger	47.0213941421273	25	0.00487475598580355
RIXMfl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	47.1792555517374	26	0.00671264809950509
RIXMfl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0804943101322877	26	1
RIXMfl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_C_int_imputed.txt_snps.txt	Maximum likelihood	32.1211445385352	23	0.0976501211225063
RIXMfl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_C_int_imputed.txt_snps.txt	MR Egger	32.1802616032637	22	0.0743742770651122
RIXMfl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	32.199232039817	23	0.0960704676192318
RIXMfl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.284856534695168	23	1
rJa2wz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_C_int_imputed.txt_snps.txt	Maximum likelihood	56.4721871700363	37	0.0211246787952838
rJa2wz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_C_int_imputed.txt_snps.txt	MR Egger	55.9527280234201	36	0.0180963370016743
rJa2wz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	56.4884267380073	37	0.0210523208878123
rJa2wz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0519013316065979	37	1
rJa2wz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_C_int_imputed.txt_snps.txt	Maximum likelihood	53.806668607009	37	0.0364986013952341
rJa2wz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_C_int_imputed.txt_snps.txt	MR Egger	52.9004703065173	36	0.0343203074436395
rJa2wz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	53.8300083489968	37	0.0363295073012688
rJa2wz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.086230331903304	37	1
rJa2wz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_C_int_imputed.txt_snps.txt	Maximum likelihood	38.4874907787743	35	0.314585712245356
rJa2wz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_C_int_imputed.txt_snps.txt	MR Egger	35.6926613534766	34	0.38874827839249
rJa2wz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	38.5719537863668	35	0.311236067224264
rJa2wz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.239614310074084	35	1
rQaSAV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Clinical_LDL_C_int_imputed.txt_snps.txt	Maximum likelihood	57.8388992072156	35	0.00891387088036046
rQaSAV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Clinical_LDL_C_int_imputed.txt_snps.txt	MR Egger	57.766097133726	34	0.00668308711179922
rQaSAV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Clinical_LDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	57.8633745890386	35	0.0088632901166683
rQaSAV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Clinical_LDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.053568216749669	35	1
rQaSAV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Clinical_LDL_C_int_imputed.txt_snps.txt	Maximum likelihood	53.236607550229	35	0.0248242502122622
rQaSAV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Clinical_LDL_C_int_imputed.txt_snps.txt	MR Egger	53.2456696418228	34	0.0189289299383715
rQaSAV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Clinical_LDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	53.2563121061271	35	0.0247206486968508
rQaSAV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Clinical_LDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0897849770984624	35	1
rQaSAV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Clinical_LDL_C_int_imputed.txt_snps.txt	Maximum likelihood	29.9502734675718	34	0.666508914921542
rQaSAV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Clinical_LDL_C_int_imputed.txt_snps.txt	MR Egger	27.7473209061922	33	0.726125344393657
rQaSAV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Clinical_LDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	30.0650927781946	34	0.660994298843967
rQaSAV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Clinical_LDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.242637805712382	34	1
rzale4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	78.5527964739504	50	0.00609777852822361
rzale4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	78.5523964334698	49	0.00466522848388432
rzale4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	78.5601712014785	50	0.00608833062146262
rzale4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0732294777802472	50	1
rzale4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	74.65417258396	50	0.0134867209211179
rzale4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	74.6431406497329	49	0.0105774104991446
rzale4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	74.6560254201407	50	0.0134818043750948
rzale4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.122225438432979	50	1
rzale4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	60.5687983588586	49	0.124304844236076
rzale4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	59.6448328283498	48	0.120823693611007
rzale4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	60.6433407929531	49	0.122969728035974
rzale4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.410439531319748	49	1
RzfJ2j	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	65.3547660408725	45	0.0252679101977273
RzfJ2j	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_PL_int_imputed.txt_snps.txt	MR Egger	64.4040219104029	44	0.0240334468729969
RzfJ2j	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	65.3816055889231	45	0.0251377824770926
RzfJ2j	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0487306399157539	45	1
RzfJ2j	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	66.7349581570607	45	0.0193025745021273
RzfJ2j	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_PL_int_imputed.txt_snps.txt	MR Egger	66.7028062559287	44	0.0151850537909653
RzfJ2j	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	66.7667909397569	45	0.0191813281408121
RzfJ2j	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0828884256257366	45	1
RzfJ2j	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	53.0668236252315	44	0.164252871763093
RzfJ2j	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_PL_int_imputed.txt_snps.txt	MR Egger	47.1603458935092	43	0.306313978185267
RzfJ2j	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	53.1068581113635	44	0.163322848023338
RzfJ2j	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.421191163086488	44	1
S3LOqr	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	51.6810731222054	50	0.40795641064423
S3LOqr	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_PL_int_imputed.txt_snps.txt	MR Egger	51.5161486686124	49	0.375594982756401
S3LOqr	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	51.6824716138461	50	0.407903353043326
S3LOqr	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.05301430526683	50	1
S3LOqr	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	52.088916123123	50	0.392598432930207
S3LOqr	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_PL_int_imputed.txt_snps.txt	MR Egger	51.9450012363342	49	0.359868824483891
S3LOqr	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	52.0890581731153	50	0.392593125213716
S3LOqr	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.090272980384176	50	1
S3LOqr	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	44.3803600169608	49	0.660647768047745
S3LOqr	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_PL_int_imputed.txt_snps.txt	MR Egger	44.4026768699477	48	0.621036429016605
S3LOqr	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	44.406354610113	49	0.659621200689088
S3LOqr	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.496762038389479	49	1
S59Wjp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	61.6544603850844	46	0.0612251373926588
S59Wjp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_FC_int_imputed.txt_snps.txt	MR Egger	61.6483935209114	45	0.0500692352306779
S59Wjp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	61.6549436162009	46	0.0612201162052165
S59Wjp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0432385887861288	46	1
S59Wjp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	55.5539555857753	46	0.15796173023235
S59Wjp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_FC_int_imputed.txt_snps.txt	MR Egger	55.0871025528523	45	0.144128559817032
S59Wjp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	55.5543020672946	46	0.157954046764133
S59Wjp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0606297878313184	46	1
S59Wjp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	59.2057403460308	45	0.0760175691788488
S59Wjp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_FC_int_imputed.txt_snps.txt	MR Egger	55.9948337473024	44	0.106072154148323
S59Wjp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	59.226246411576	45	0.0757602518805278
S59Wjp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.42328802122581	45	1
s7g54o	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	75.6944854022979	45	0.00282446267532788
s7g54o	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	75.0650680315802	44	0.00241959604847834
s7g54o	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	75.7000891496217	45	0.00282082364644106
s7g54o	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0969688785176444	45	1
s7g54o	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	63.8151813459201	45	0.0338086271859612
s7g54o	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	63.2991928599919	44	0.0297381365800234
s7g54o	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	63.8188854170229	45	0.0337853537256103
s7g54o	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.123326252890194	45	1
s7g54o	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	59.4453347316469	41	0.0311491380759955
s7g54o	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	59.2612184072172	40	0.0254084485994643
s7g54o	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	59.4926975453613	41	0.0308630070720032
s7g54o	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.535778334468859	41	1
SeeCbk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_P_int_imputed.txt_snps.txt	Maximum likelihood	55.9732788079283	45	0.126488972479824
SeeCbk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_P_int_imputed.txt_snps.txt	MR Egger	56.0126261007619	44	0.105776536607073
SeeCbk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	56.0187848735763	45	0.125630346850384
SeeCbk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0344914013525982	45	1
SeeCbk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_P_int_imputed.txt_snps.txt	Maximum likelihood	54.4004567743362	45	0.159030538470875
SeeCbk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_P_int_imputed.txt_snps.txt	MR Egger	54.4373258055453	44	0.134589542861213
SeeCbk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	54.4715986959238	45	0.157435437807589
SeeCbk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0545573196049151	45	1
SeeCbk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_P_int_imputed.txt_snps.txt	Maximum likelihood	56.4253433069421	45	0.118158791845886
SeeCbk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_P_int_imputed.txt_snps.txt	MR Egger	54.794758904113	44	0.127571639841854
SeeCbk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	56.5043031620067	45	0.116748885574622
SeeCbk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.432907879868035	45	1
SMtyhy	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	72.0267072157407	51	0.0278335986729323
SMtyhy	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_FC_int_imputed.txt_snps.txt	MR Egger	71.1517095504249	50	0.0262677721328822
SMtyhy	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	72.0381693968066	51	0.027775883276727
SMtyhy	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.061892410891834	51	1
SMtyhy	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	66.1423488898544	51	0.0753775997340636
SMtyhy	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_FC_int_imputed.txt_snps.txt	MR Egger	65.0469464602301	50	0.0748019303095761
SMtyhy	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	66.1657550773253	51	0.0751008898211064
SMtyhy	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0687069231297563	51	1
SMtyhy	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	67.8998775479295	49	0.0381204763606341
SMtyhy	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_FC_int_imputed.txt_snps.txt	MR Egger	64.9780802578601	48	0.0516801906692976
SMtyhy	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	67.9465506556219	49	0.0378067260783072
SMtyhy	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.453428624080223	49	1
SR6TTl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	77.1427907801142	38	0.00017883616611332
SR6TTl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_C_pct_int_imputed.txt_snps.txt	MR Egger	77.0004417120831	37	0.000125326788470413
SR6TTl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	77.1448119724705	38	0.000178736269278243
SR6TTl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.10890538704391	38	1
SR6TTl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	61.0141759190745	37	0.00774263403483675
SR6TTl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_C_pct_int_imputed.txt_snps.txt	MR Egger	60.7067679197097	36	0.00615742479055378
SR6TTl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	61.0149811088718	37	0.00774119823132157
SR6TTl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.127965965458107	37	1
SR6TTl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	46.611148953167	35	0.0907187983154887
SR6TTl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_C_pct_int_imputed.txt_snps.txt	MR Egger	46.3238574483666	34	0.0773247205600496
SR6TTl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	46.6223425777327	35	0.0905382725610516
SR6TTl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.546070166764495	35	1
sYgrCa	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_L_int_imputed.txt_snps.txt	Maximum likelihood	85.2023798604479	66	0.0560320908980463
sYgrCa	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_L_int_imputed.txt_snps.txt	MR Egger	84.9779696256743	65	0.0488189837483041
sYgrCa	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	85.2305531798469	66	0.0557987941420109
sYgrCa	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0718185399887742	66	1
sYgrCa	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_L_int_imputed.txt_snps.txt	Maximum likelihood	86.4634040332311	66	0.046361650966218
sYgrCa	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_L_int_imputed.txt_snps.txt	MR Egger	86.5300029021327	65	0.0383868003089446
sYgrCa	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	86.5406872896179	66	0.0458182896426686
sYgrCa	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.101007985681509	66	1
sYgrCa	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_L_int_imputed.txt_snps.txt	Maximum likelihood	81.2968156532326	65	0.0834611075127641
sYgrCa	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_L_int_imputed.txt_snps.txt	MR Egger	79.6163630524861	64	0.0901904119140002
sYgrCa	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	81.3191680273355	65	0.0832020839276665
sYgrCa	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.58573299451092	65	1
tCcZw8	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_3_pct_int_imputed.txt_snps.txt	Maximum likelihood	29.2025859243502	22	0.139167245255796
tCcZw8	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_3_pct_int_imputed.txt_snps.txt	MR Egger	29.133834835939	21	0.110825269602251
tCcZw8	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_3_pct_int_imputed.txt_snps.txt	Inverse variance weighted	29.2112246438089	22	0.138928457020106
tCcZw8	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_3_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0298528453148183	22	1
tCcZw8	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_3_pct_int_imputed.txt_snps.txt	Maximum likelihood	22.1169267800443	22	0.452928297011537
tCcZw8	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_3_pct_int_imputed.txt_snps.txt	MR Egger	22.1068885660631	21	0.393372857397009
tCcZw8	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_3_pct_int_imputed.txt_snps.txt	Inverse variance weighted	22.1179313121828	22	0.452868665120317
tCcZw8	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_3_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0313585764951531	22	1
tCcZw8	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_3_pct_int_imputed.txt_snps.txt	Maximum likelihood	37.8753380889983	22	0.0189206568547778
tCcZw8	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_3_pct_int_imputed.txt_snps.txt	MR Egger	37.61315770372	21	0.0143005703560283
tCcZw8	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_3_pct_int_imputed.txt_snps.txt	Inverse variance weighted	37.8801346734259	22	0.018897288219466
tCcZw8	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_3_pct_int_imputed.txt_snps.txt	Unweighted regression	0.527696687214128	22	0.999999999999991
Ti31zJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	58.743246992565	52	0.242155168848215
Ti31zJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_FC_int_imputed.txt_snps.txt	MR Egger	58.7445681306735	51	0.212899853057832
Ti31zJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	58.7521129832871	52	0.241905034636992
Ti31zJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0496737877625994	52	1
Ti31zJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	47.4047869835081	52	0.654933872935922
Ti31zJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_FC_int_imputed.txt_snps.txt	MR Egger	47.2956478320411	51	0.621561450951582
Ti31zJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	47.4051382944043	52	0.654920383169643
Ti31zJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0649388188964314	52	1
Ti31zJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	59.9356575748763	51	0.183273067809867
Ti31zJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_FC_int_imputed.txt_snps.txt	MR Egger	59.6985759908797	50	0.163758841291217
Ti31zJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	59.935726751827	51	0.183271436196119
Ti31zJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.543745034758635	51	1
tiLTX8	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	65.4503989779699	42	0.0117572817813855
tiLTX8	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_C_int_imputed.txt_snps.txt	MR Egger	64.7269123110099	41	0.010496452391107
tiLTX8	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	65.4969715295597	42	0.0116413286644245
tiLTX8	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0618350667592612	42	1
tiLTX8	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	55.7272394942879	42	0.0762083634190144
tiLTX8	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_C_int_imputed.txt_snps.txt	MR Egger	55.106796162691	41	0.0694352977503931
tiLTX8	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	55.7518324326168	42	0.0758902100157049
tiLTX8	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0913097240576105	42	1
tiLTX8	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	52.2408686938747	39	0.076287771552921
tiLTX8	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_C_int_imputed.txt_snps.txt	MR Egger	51.6536174788164	38	0.0688134627072682
tiLTX8	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	52.272034044471	39	0.0758718891108849
tiLTX8	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.363440073911206	39	1
tjBvyr	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	58.7083657074739	49	0.161361610046842
tjBvyr	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_P_int_imputed.txt_snps.txt	MR Egger	58.4374966719377	48	0.143769242479854
tjBvyr	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	58.7213894543175	49	0.161076527333757
tjBvyr	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0696338715499369	49	1
tjBvyr	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	46.4811699147847	49	0.575829435416215
tjBvyr	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_P_int_imputed.txt_snps.txt	MR Egger	46.4972233531783	48	0.534553085692528
tjBvyr	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	46.497232089837	49	0.575171772511118
tjBvyr	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.079988321779273	49	1
tjBvyr	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	51.230572659994	48	0.34814425910943
tjBvyr	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_P_int_imputed.txt_snps.txt	MR Egger	51.2635785328616	47	0.310142542483741
tjBvyr	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	51.2980677871583	48	0.345712606323539
tjBvyr	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.618738640449493	48	1
TjVKqz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	63.2611599938258	40	0.0109849531416018
TjVKqz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_CE_int_imputed.txt_snps.txt	MR Egger	63.1930191938417	39	0.0084313772196059
TjVKqz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	63.3376630089337	40	0.0108032807396208
TjVKqz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0462953720704933	40	1
TjVKqz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	57.7819303267439	40	0.0340493728079716
TjVKqz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_CE_int_imputed.txt_snps.txt	MR Egger	57.8617860497486	39	0.0263451126609804
TjVKqz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	57.8827095702165	40	0.0333874705268092
TjVKqz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0669133793405194	40	1
TjVKqz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	47.6244203546827	40	0.190213679716005
TjVKqz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_CE_int_imputed.txt_snps.txt	MR Egger	46.923301196306	39	0.179550552714719
TjVKqz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	47.7158660926961	40	0.187754944125022
TjVKqz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.414297641761429	40	1
tjYDe3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Leu_int_imputed.txt_snps.txt	Maximum likelihood	9.6155732747155	9	0.382493063517276
tjYDe3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Leu_int_imputed.txt_snps.txt	MR Egger	9.58527322050522	8	0.295348416438065
tjYDe3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Leu_int_imputed.txt_snps.txt	Inverse variance weighted	9.6159596463423	9	0.382460016481455
tjYDe3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Leu_int_imputed.txt_snps.txt	Unweighted regression	0.0132087685985613	9	0.999999999997062
tjYDe3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Leu_int_imputed.txt_snps.txt	Maximum likelihood	13.7428433315928	9	0.131771330637271
tjYDe3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Leu_int_imputed.txt_snps.txt	MR Egger	13.7472847535123	8	0.0885948322405529
tjYDe3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Leu_int_imputed.txt_snps.txt	Inverse variance weighted	13.7588799179197	9	0.131164558100076
tjYDe3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Leu_int_imputed.txt_snps.txt	Unweighted regression	0.02292253244367	9	0.999999999965036
tjYDe3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Leu_int_imputed.txt_snps.txt	Maximum likelihood	3.5051606109665	9	0.940870754292179
tjYDe3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Leu_int_imputed.txt_snps.txt	MR Egger	2.9707022684378	8	0.936182646991303
tjYDe3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Leu_int_imputed.txt_snps.txt	Inverse variance weighted	3.50620408305189	9	0.940815335594187
tjYDe3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Leu_int_imputed.txt_snps.txt	Unweighted regression	0.0296313204853755	9	0.999999999889306
tqGDEz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	64.5672470344347	59	0.288363071714674
tqGDEz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	58.5443845812431	58	0.45529734513306
tqGDEz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	64.6652801289286	59	0.285472269189726
tqGDEz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0711413227620693	59	1
tqGDEz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	63.2980240115552	59	0.327255622872475
tqGDEz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	59.3143306822004	58	0.427416230081115
tqGDEz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	63.4099531096958	59	0.323719696354547
tqGDEz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0999906975537389	59	1
tqGDEz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	52.3931036592932	56	0.612190884388122
tqGDEz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	51.6417027661884	55	0.6037299027872
tqGDEz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	52.5360462990172	56	0.606781047536699
tqGDEz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.534547711220976	56	1
tqgHSF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	ApoA1_int_imputed.txt_snps.txt	Maximum likelihood	81.3435333650258	56	0.0151024221373017
tqgHSF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	ApoA1_int_imputed.txt_snps.txt	MR Egger	75.621323081325	55	0.0339940694011396
tqgHSF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	ApoA1_int_imputed.txt_snps.txt	Inverse variance weighted	81.3536766184623	56	0.0150738999722719
tqgHSF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	ApoA1_int_imputed.txt_snps.txt	Unweighted regression	0.0771488396917929	56	1
tqgHSF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	ApoA1_int_imputed.txt_snps.txt	Maximum likelihood	89.2441146713066	56	0.00313093971653312
tqgHSF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	ApoA1_int_imputed.txt_snps.txt	MR Egger	82.8535585994368	55	0.00895870848712382
tqgHSF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	ApoA1_int_imputed.txt_snps.txt	Inverse variance weighted	89.255654865183	56	0.00312331135586426
tqgHSF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	ApoA1_int_imputed.txt_snps.txt	Unweighted regression	0.121365681748019	56	1
tqgHSF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	ApoA1_int_imputed.txt_snps.txt	Maximum likelihood	71.3926043516234	53	0.0467964791000608
tqgHSF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	ApoA1_int_imputed.txt_snps.txt	MR Egger	66.1868545723912	52	0.0892073736021313
tqgHSF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	ApoA1_int_imputed.txt_snps.txt	Inverse variance weighted	71.3947174202028	53	0.0467799990386523
tqgHSF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	ApoA1_int_imputed.txt_snps.txt	Unweighted regression	0.503819549881301	53	1
trst1c	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	62.3079008414951	50	0.113587173100039
trst1c	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_L_int_imputed.txt_snps.txt	MR Egger	61.1628766094465	49	0.113971430812255
trst1c	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	62.3129044893703	50	0.113504044101979
trst1c	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0669398353487796	50	1
trst1c	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	60.8779608504401	50	0.139355382903595
trst1c	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_L_int_imputed.txt_snps.txt	MR Egger	58.4515431858604	49	0.167059186333013
trst1c	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	60.8855829034171	50	0.139207130268272
trst1c	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0976712993225044	50	1
trst1c	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	60.7107766903183	50	0.142637340176596
trst1c	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_L_int_imputed.txt_snps.txt	MR Egger	60.5960941987852	49	0.123814656695848
trst1c	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	60.7386652930329	50	0.142085849329293
trst1c	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.74928025310407	50	1
TsaTvK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	77.2922544174021	53	0.0163748527651664
TsaTvK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_C_int_imputed.txt_snps.txt	MR Egger	71.7047968801856	52	0.0363575532874882
TsaTvK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	77.3175388112524	53	0.0162968253891928
TsaTvK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.061695309996351	53	1
TsaTvK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	73.586621660338	53	0.0321578216752277
TsaTvK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_C_int_imputed.txt_snps.txt	MR Egger	69.4345122576721	52	0.0534029743519069
TsaTvK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	73.6113666640613	53	0.0320186461982634
TsaTvK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.093070372798969	53	1
TsaTvK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	61.1577603701139	53	0.206387813753168
TsaTvK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_C_int_imputed.txt_snps.txt	MR Egger	56.4766399614283	52	0.311378299766995
TsaTvK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	61.2066839029544	53	0.205158758360875
TsaTvK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.435159609724481	53	1
TzvLoK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	64.5081026488202	56	0.203614409245171
TzvLoK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_TG_int_imputed.txt_snps.txt	MR Egger	63.4247546132711	55	0.203717421780709
TzvLoK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	64.5516046436846	56	0.202558211601382
TzvLoK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0662687911328328	56	1
TzvLoK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	68.2870360839762	56	0.125583613921464
TzvLoK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_TG_int_imputed.txt_snps.txt	MR Egger	68.1640718965534	55	0.109450187791149
TzvLoK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	68.3145468767884	56	0.125113885363111
TzvLoK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.099195205000311	56	1
TzvLoK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	62.7556265940046	54	0.193729953462005
TzvLoK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_TG_int_imputed.txt_snps.txt	MR Egger	62.8215225540533	53	0.167387265282906
TzvLoK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	62.8513717762573	54	0.191451388215054
TzvLoK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.537712154602833	54	1
uBEYhN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	73.083025839327	52	0.0285058039259838
uBEYhN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	72.7765135671529	51	0.0242738479981075
uBEYhN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	73.1215762862073	52	0.0283095051448005
uBEYhN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0884724768727347	52	1
uBEYhN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	74.1194883054436	52	0.0236264907286121
uBEYhN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	74.094983482227	51	0.0189846185394431
uBEYhN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	74.1245353440862	52	0.0236046684209776
uBEYhN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.125080646602052	52	1
uBEYhN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	46.7638907684675	51	0.642485211404929
uBEYhN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	46.9424727423132	50	0.596827090802898
uBEYhN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	46.9479637651283	51	0.635268984999638
uBEYhN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.481572414944951	51	1
UbNGXu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	45.9061787869624	36	0.124691374455192
UbNGXu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_PL_int_imputed.txt_snps.txt	MR Egger	45.6324811546575	35	0.107678017825964
UbNGXu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	45.9632386136406	36	0.123520463944156
UbNGXu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0285162024154784	36	1
UbNGXu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	47.4530758278603	36	0.0959090343766492
UbNGXu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_PL_int_imputed.txt_snps.txt	MR Egger	47.4327224466305	35	0.0782327412610432
UbNGXu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	47.5641805586713	36	0.0940687211394426
UbNGXu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0566906489041648	36	1
UbNGXu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	35.2880927586448	36	0.502257770426399
UbNGXu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_PL_int_imputed.txt_snps.txt	MR Egger	35.110337937472	35	0.46297488982793
UbNGXu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	35.3305771829301	36	0.500237458893392
UbNGXu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.334349500537351	36	1
UHxAsh	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	34.3754956447836	35	0.498078813548609
UHxAsh	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_C_pct_int_imputed.txt_snps.txt	MR Egger	33.8662115976358	34	0.474191588812827
UHxAsh	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	34.3793129253131	35	0.497894895084681
UHxAsh	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0435274044571922	35	1
UHxAsh	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	45.2108142527289	35	0.115731430469271
UHxAsh	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_C_pct_int_imputed.txt_snps.txt	MR Egger	41.8825667603117	34	0.165984750206358
UHxAsh	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	45.2133521907637	35	0.11568156207987
UHxAsh	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.103021597393325	35	1
UHxAsh	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	44.9456933770626	33	0.0803094078187372
UHxAsh	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_C_pct_int_imputed.txt_snps.txt	MR Egger	44.7890653858292	32	0.0660738792118881
UHxAsh	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	44.9514348314394	33	0.0802236056348897
UHxAsh	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.344776388640779	33	1
uKOLUZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	PUFA_pct_int_imputed.txt_snps.txt	Maximum likelihood	38.4966863827339	26	0.0544194685741388
uKOLUZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	PUFA_pct_int_imputed.txt_snps.txt	MR Egger	37.4069157401079	25	0.0527986495532907
uKOLUZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	PUFA_pct_int_imputed.txt_snps.txt	Inverse variance weighted	38.5002092143097	26	0.0543779108366627
uKOLUZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	PUFA_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0341126211842486	26	1
uKOLUZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	PUFA_pct_int_imputed.txt_snps.txt	Maximum likelihood	36.561287377964	26	0.0818193689694563
uKOLUZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	PUFA_pct_int_imputed.txt_snps.txt	MR Egger	35.9915957253247	25	0.0717274794941177
uKOLUZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	PUFA_pct_int_imputed.txt_snps.txt	Inverse variance weighted	36.5613087310543	26	0.0818190118544456
uKOLUZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	PUFA_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0541360809785972	26	1
uKOLUZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	PUFA_pct_int_imputed.txt_snps.txt	Maximum likelihood	36.8740509085134	26	0.0767273826151606
uKOLUZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	PUFA_pct_int_imputed.txt_snps.txt	MR Egger	36.6726008019006	25	0.0619958270852036
uKOLUZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	PUFA_pct_int_imputed.txt_snps.txt	Inverse variance weighted	36.9927036908375	26	0.0748669931136376
uKOLUZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	PUFA_pct_int_imputed.txt_snps.txt	Unweighted regression	0.372335072757611	26	1
USJJHa	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Phosphatidylc_int_imputed.txt_snps.txt	Maximum likelihood	68.3993975822644	45	0.0138107470325641
USJJHa	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Phosphatidylc_int_imputed.txt_snps.txt	MR Egger	65.0012673083545	44	0.0213746989280212
USJJHa	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Phosphatidylc_int_imputed.txt_snps.txt	Inverse variance weighted	68.3995423319381	45	0.0138103384945669
USJJHa	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Phosphatidylc_int_imputed.txt_snps.txt	Unweighted regression	0.0681834498303581	45	1
USJJHa	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Phosphatidylc_int_imputed.txt_snps.txt	Maximum likelihood	62.0642523064981	45	0.046508280167991
USJJHa	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Phosphatidylc_int_imputed.txt_snps.txt	MR Egger	61.0841744315063	44	0.0448685980205071
USJJHa	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Phosphatidylc_int_imputed.txt_snps.txt	Inverse variance weighted	62.0648196761002	45	0.0465035747733397
USJJHa	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Phosphatidylc_int_imputed.txt_snps.txt	Unweighted regression	0.13819236220749	45	1
USJJHa	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Phosphatidylc_int_imputed.txt_snps.txt	Maximum likelihood	68.504797018955	44	0.0104426660319187
USJJHa	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Phosphatidylc_int_imputed.txt_snps.txt	MR Egger	68.4669051313841	43	0.00804694447834237
USJJHa	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Phosphatidylc_int_imputed.txt_snps.txt	Inverse variance weighted	68.5150183433582	44	0.0104201450658837
USJJHa	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Phosphatidylc_int_imputed.txt_snps.txt	Unweighted regression	0.420725707843744	44	1
UTtYXS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Tyr_int_imputed.txt_snps.txt	Maximum likelihood	19.7947381740905	14	0.136746824023797
UTtYXS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Tyr_int_imputed.txt_snps.txt	MR Egger	19.5491489348964	13	0.107036394842827
UTtYXS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Tyr_int_imputed.txt_snps.txt	Inverse variance weighted	19.7947381740905	14	0.136746824023797
UTtYXS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Tyr_int_imputed.txt_snps.txt	Unweighted regression	0.0130046969881141	14	1
UTtYXS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Tyr_int_imputed.txt_snps.txt	Maximum likelihood	17.6176502346764	14	0.22475352801329
UTtYXS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Tyr_int_imputed.txt_snps.txt	MR Egger	17.5133343199189	13	0.17688695215672
UTtYXS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Tyr_int_imputed.txt_snps.txt	Inverse variance weighted	17.6176893530489	14	0.224751631740912
UTtYXS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Tyr_int_imputed.txt_snps.txt	Unweighted regression	0.0221363517119216	14	1
UTtYXS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Tyr_int_imputed.txt_snps.txt	Maximum likelihood	21.1282055157241	13	0.0704312727009515
UTtYXS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Tyr_int_imputed.txt_snps.txt	MR Egger	20.563689765401	12	0.0571463619083207
UTtYXS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Tyr_int_imputed.txt_snps.txt	Inverse variance weighted	21.1590699096372	13	0.0698414113921553
UTtYXS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Tyr_int_imputed.txt_snps.txt	Unweighted regression	0.176900391439138	13	0.999999999929508
UVQyns	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	111.83387365717	71	0.00143096437492424
UVQyns	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_PL_int_imputed.txt_snps.txt	MR Egger	110.8888496864	70	0.00134399362617005
UVQyns	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	111.846996750825	71	0.00142714807764107
UVQyns	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.147668878294591	71	1
UVQyns	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	105.149262256916	71	0.00527109871298555
UVQyns	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_PL_int_imputed.txt_snps.txt	MR Egger	105.138234720266	70	0.0041979063592104
UVQyns	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	105.150560183844	71	0.00526982394229606
UVQyns	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.229532780516558	71	1
UVQyns	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	82.0430743385177	67	0.102054936909902
UVQyns	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_PL_int_imputed.txt_snps.txt	MR Egger	76.7107989154159	66	0.172727576609923
UVQyns	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	82.0994891996392	67	0.101298509222385
UVQyns	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.557790678539061	67	1
UZeUWf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	PUFA_by_MUFA_int_imputed.txt_snps.txt	Maximum likelihood	43.4211114075701	38	0.251360775001643
UZeUWf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	PUFA_by_MUFA_int_imputed.txt_snps.txt	MR Egger	42.7508598712077	37	0.237808942930653
UZeUWf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	PUFA_by_MUFA_int_imputed.txt_snps.txt	Inverse variance weighted	43.42144725311	38	0.251349553145103
UZeUWf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	PUFA_by_MUFA_int_imputed.txt_snps.txt	Unweighted regression	0.0400016268411457	38	1
UZeUWf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	PUFA_by_MUFA_int_imputed.txt_snps.txt	Maximum likelihood	35.390969772816	38	0.590722121823971
UZeUWf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	PUFA_by_MUFA_int_imputed.txt_snps.txt	MR Egger	34.0895550379826	37	0.606235216989124
UZeUWf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	PUFA_by_MUFA_int_imputed.txt_snps.txt	Inverse variance weighted	35.3979037686759	38	0.590398454808892
UZeUWf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	PUFA_by_MUFA_int_imputed.txt_snps.txt	Unweighted regression	0.048141102868515	38	1
UZeUWf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	PUFA_by_MUFA_int_imputed.txt_snps.txt	Maximum likelihood	42.6040714195473	37	0.242629853950697
UZeUWf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	PUFA_by_MUFA_int_imputed.txt_snps.txt	MR Egger	42.5305822648773	36	0.210402126570739
UZeUWf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	PUFA_by_MUFA_int_imputed.txt_snps.txt	Inverse variance weighted	42.6059110873691	37	0.242569040817741
UZeUWf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	PUFA_by_MUFA_int_imputed.txt_snps.txt	Unweighted regression	0.316019561404432	37	1
Vd7xTH	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	87.7517275517149	50	0.000772543762977466
Vd7xTH	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	86.5072825393574	49	0.000759084233092003
Vd7xTH	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	87.7517275570676	50	0.000772543761992986
Vd7xTH	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.073585807980371	50	1
Vd7xTH	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	82.6151733361253	50	0.00252742583872464
Vd7xTH	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	79.8558611708171	49	0.00351098785799582
Vd7xTH	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	82.6305652626926	50	0.00251875789592525
Vd7xTH	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.10927820573383	50	1
Vd7xTH	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	69.3650894606315	49	0.0292857855771167
Vd7xTH	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	68.7152990112513	48	0.0264798103162822
Vd7xTH	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	69.543775930609	49	0.0283425034191227
Vd7xTH	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.540801834080188	49	1
VocmdP	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	56.3611682384662	52	0.31517543227814
VocmdP	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	53.5321166967433	51	0.37733524431284
VocmdP	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	56.3622023574902	52	0.315141316147355
VocmdP	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.061988841063597	52	1
VocmdP	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	57.6007907769189	52	0.275753367891683
VocmdP	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	56.3350632299579	51	0.282174414637657
VocmdP	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	57.601186952103	52	0.275741253143953
VocmdP	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.112933517781543	52	1
VocmdP	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	49.3315810742425	49	0.459858520569015
VocmdP	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	48.286868631279	48	0.461246105353268
VocmdP	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	49.3906428368566	49	0.457505371915515
VocmdP	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.469061291502449	49	1
vtOzIZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	MUFA_pct_int_imputed.txt_snps.txt	Maximum likelihood	56.6605288195288	45	0.113998272956351
vtOzIZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	MUFA_pct_int_imputed.txt_snps.txt	MR Egger	56.2456739648534	44	0.101964842489889
vtOzIZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	MUFA_pct_int_imputed.txt_snps.txt	Inverse variance weighted	56.6614077485713	45	0.113982943599826
vtOzIZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	MUFA_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0469220561620283	45	1
vtOzIZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	MUFA_pct_int_imputed.txt_snps.txt	Maximum likelihood	53.3687194961033	45	0.183518840692571
vtOzIZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	MUFA_pct_int_imputed.txt_snps.txt	MR Egger	53.1679232455197	44	0.161911751650374
vtOzIZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	MUFA_pct_int_imputed.txt_snps.txt	Inverse variance weighted	53.3763769276818	45	0.18332765542335
vtOzIZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	MUFA_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0672411228124807	45	1
vtOzIZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	MUFA_pct_int_imputed.txt_snps.txt	Maximum likelihood	54.7497628469484	44	0.128439199968231
vtOzIZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	MUFA_pct_int_imputed.txt_snps.txt	MR Egger	50.4622280505446	43	0.202332440054665
vtOzIZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	MUFA_pct_int_imputed.txt_snps.txt	Inverse variance weighted	54.7523082513009	44	0.128390001027683
vtOzIZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	MUFA_pct_int_imputed.txt_snps.txt	Unweighted regression	0.404114738474046	44	1
vtrB1V	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	66.2035892300128	53	0.105151392439889
vtrB1V	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_CE_int_imputed.txt_snps.txt	MR Egger	64.8098817641072	52	0.109379508371573
vtrB1V	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	66.2245224322715	53	0.10483258632545
vtrB1V	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0622855403613029	53	1
vtrB1V	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	71.1383215994303	53	0.0488163049989153
vtrB1V	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_CE_int_imputed.txt_snps.txt	MR Egger	70.1150190442103	52	0.0476935290407591
vtrB1V	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	71.1411112964797	53	0.0487937478714009
vtrB1V	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.112421723693726	53	1
vtrB1V	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	73.3973099453215	52	0.0269398953321794
vtrB1V	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_CE_int_imputed.txt_snps.txt	MR Egger	68.6710417941785	51	0.0499853437105829
vtrB1V	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	73.3994256583543	52	0.0269296166320039
vtrB1V	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.714805114420996	52	1
VvDY1C	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	MUFA_int_imputed.txt_snps.txt	Maximum likelihood	55.1760114124268	40	0.0556471299346178
VvDY1C	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	MUFA_int_imputed.txt_snps.txt	MR Egger	53.3136936288329	39	0.0630218175140607
VvDY1C	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	MUFA_int_imputed.txt_snps.txt	Inverse variance weighted	55.1813913757053	40	0.0555925742449
VvDY1C	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	MUFA_int_imputed.txt_snps.txt	Unweighted regression	0.0658982099118953	40	1
VvDY1C	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	MUFA_int_imputed.txt_snps.txt	Maximum likelihood	55.0181213110111	40	0.0572686916961
VvDY1C	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	MUFA_int_imputed.txt_snps.txt	MR Egger	53.0876972385572	39	0.0656415504219054
VvDY1C	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	MUFA_int_imputed.txt_snps.txt	Inverse variance weighted	55.0268378023483	40	0.0571781329160321
VvDY1C	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	MUFA_int_imputed.txt_snps.txt	Unweighted regression	0.0830646563092629	40	1
VvDY1C	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	MUFA_int_imputed.txt_snps.txt	Maximum likelihood	54.0103247787487	38	0.0443726293216787
VvDY1C	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	MUFA_int_imputed.txt_snps.txt	MR Egger	53.9878742480821	37	0.035203758412163
VvDY1C	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	MUFA_int_imputed.txt_snps.txt	Inverse variance weighted	54.0125031654155	38	0.0443540711856328
VvDY1C	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	MUFA_int_imputed.txt_snps.txt	Unweighted regression	0.396735723411705	38	1
vyPE4F	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	76.4486399838781	55	0.0294614026468365
vyPE4F	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	76.4412969344583	54	0.0239050914825433
vyPE4F	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	76.4546961620562	55	0.0294302805267416
vyPE4F	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0705653822582681	55	1
vyPE4F	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	76.8914516881478	55	0.0272606811065442
vyPE4F	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	75.8210872182875	54	0.0267118387663151
vyPE4F	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	76.9019040515429	55	0.0272105336829104
vyPE4F	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.105159835218727	55	1
vyPE4F	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	52.1634400738923	54	0.545530937440458
vyPE4F	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	52.2475450959418	53	0.503409663387577
vyPE4F	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	52.2614993822833	54	0.541708022271932
vyPE4F	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.443528697010263	54	1
W0rGP4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Sphingomyelins_int_imputed.txt_snps.txt	Maximum likelihood	89.8432653573539	47	0.000168679732547301
W0rGP4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Sphingomyelins_int_imputed.txt_snps.txt	MR Egger	89.8544567009244	46	0.000117338615371824
W0rGP4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Sphingomyelins_int_imputed.txt_snps.txt	Inverse variance weighted	89.8677736077475	47	0.000167611375049752
W0rGP4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Sphingomyelins_int_imputed.txt_snps.txt	Unweighted regression	0.0971801563238742	47	1
W0rGP4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Sphingomyelins_int_imputed.txt_snps.txt	Maximum likelihood	72.4037016378322	47	0.0100822259867676
W0rGP4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Sphingomyelins_int_imputed.txt_snps.txt	MR Egger	72.4136502235577	46	0.00774601186170027
W0rGP4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Sphingomyelins_int_imputed.txt_snps.txt	Inverse variance weighted	72.4268060568527	47	0.0100341836885507
W0rGP4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Sphingomyelins_int_imputed.txt_snps.txt	Unweighted regression	0.117508906424591	47	1
W0rGP4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Sphingomyelins_int_imputed.txt_snps.txt	Maximum likelihood	66.515405118731	46	0.0254867814186269
W0rGP4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Sphingomyelins_int_imputed.txt_snps.txt	MR Egger	56.8025632161778	45	0.111542069898354
W0rGP4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Sphingomyelins_int_imputed.txt_snps.txt	Inverse variance weighted	66.5180795927587	46	0.0254737995804775
W0rGP4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Sphingomyelins_int_imputed.txt_snps.txt	Unweighted regression	0.39602012802326	46	1
wBn7Ly	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Citrate_int_imputed.txt_snps.txt	Maximum likelihood	23.0797200698201	18	0.187545217775125
wBn7Ly	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Citrate_int_imputed.txt_snps.txt	MR Egger	17.7684828055426	17	0.403585479488651
wBn7Ly	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Citrate_int_imputed.txt_snps.txt	Inverse variance weighted	23.0894285193209	18	0.187176933861037
wBn7Ly	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Citrate_int_imputed.txt_snps.txt	Unweighted regression	0.0118969647167097	18	1
wBn7Ly	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Citrate_int_imputed.txt_snps.txt	Maximum likelihood	30.2862700868187	18	0.0347545695387931
wBn7Ly	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Citrate_int_imputed.txt_snps.txt	MR Egger	25.3255727068658	17	0.087655937169438
wBn7Ly	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Citrate_int_imputed.txt_snps.txt	Inverse variance weighted	30.3128774640456	18	0.0345134482860398
wBn7Ly	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Citrate_int_imputed.txt_snps.txt	Unweighted regression	0.0213516612109126	18	1
wBn7Ly	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Citrate_int_imputed.txt_snps.txt	Maximum likelihood	12.2446995211654	18	0.834349923719391
wBn7Ly	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Citrate_int_imputed.txt_snps.txt	MR Egger	12.2017753206681	17	0.787767873536362
wBn7Ly	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Citrate_int_imputed.txt_snps.txt	Inverse variance weighted	12.2480266906391	18	0.834171243066961
wBn7Ly	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Citrate_int_imputed.txt_snps.txt	Unweighted regression	0.108873217966103	18	1
WBtn8D	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_C_int_imputed.txt_snps.txt	Maximum likelihood	57.3282413083991	39	0.0293296909011585
WBtn8D	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_C_int_imputed.txt_snps.txt	MR Egger	57.3613447541382	38	0.0227065791169886
WBtn8D	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	57.3810671969936	39	0.0290213595772252
WBtn8D	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0401296006503151	39	1
WBtn8D	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_C_int_imputed.txt_snps.txt	Maximum likelihood	43.3430211067719	39	0.291331156356864
WBtn8D	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_C_int_imputed.txt_snps.txt	MR Egger	43.3375426840412	38	0.254163122198625
WBtn8D	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	43.3933187759858	39	0.289515688259922
WBtn8D	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0450499752107761	39	1
WBtn8D	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_C_int_imputed.txt_snps.txt	Maximum likelihood	37.9252062970518	38	0.472895291303066
WBtn8D	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_C_int_imputed.txt_snps.txt	MR Egger	34.7263054058482	37	0.576101364738093
WBtn8D	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	38.0612995111609	38	0.4666936284115
WBtn8D	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.221704989457473	38	1
wCZ3P0	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_P_int_imputed.txt_snps.txt	Maximum likelihood	80.851199793777	55	0.0131970992113832
wCZ3P0	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_P_int_imputed.txt_snps.txt	MR Egger	76.7848514948359	54	0.0224657299471053
wCZ3P0	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	80.8526029030583	55	0.0131935795555002
wCZ3P0	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.076298182681403	55	1
wCZ3P0	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_P_int_imputed.txt_snps.txt	Maximum likelihood	73.1440251334452	55	0.0513772881968736
wCZ3P0	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_P_int_imputed.txt_snps.txt	MR Egger	68.6178627855856	54	0.0870000156197622
wCZ3P0	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	73.1486532779722	55	0.0513387962678614
wCZ3P0	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0944443854045801	55	1
wCZ3P0	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_P_int_imputed.txt_snps.txt	Maximum likelihood	60.8768854174068	52	0.186764197582674
wCZ3P0	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_P_int_imputed.txt_snps.txt	MR Egger	57.9309590064423	51	0.234904892883271
wCZ3P0	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	60.8821757013939	52	0.186638879511273
wCZ3P0	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.413790568304381	52	1
WGYTZT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	79.6358427920556	60	0.045814242684311
WGYTZT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_C_int_imputed.txt_snps.txt	MR Egger	79.0467896841678	59	0.0418222439042314
WGYTZT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	79.6449051180921	60	0.0457483284869094
WGYTZT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0961968840616195	60	1
WGYTZT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	66.9946499553963	60	0.249644842898938
WGYTZT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_C_int_imputed.txt_snps.txt	MR Egger	66.0199983104397	59	0.247274231462957
WGYTZT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	67.0144398934998	60	0.249112517404058
WGYTZT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.116300371126663	60	1
WGYTZT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	71.5614564007083	60	0.145864377420776
WGYTZT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_C_int_imputed.txt_snps.txt	MR Egger	71.5457781066078	59	0.126657659035961
WGYTZT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	71.5699390161154	60	0.145706892249477
WGYTZT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	1.27786859362177	60	1
WLQNXb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	bOHbutyrate_int_imputed.txt_snps.txt	Maximum likelihood	15.6646560045534	8	0.0474392801527244
WLQNXb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	bOHbutyrate_int_imputed.txt_snps.txt	MR Egger	13.4221027322193	7	0.062467833269268
WLQNXb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	bOHbutyrate_int_imputed.txt_snps.txt	Inverse variance weighted	15.7051983761341	8	0.046799325433205
WLQNXb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	bOHbutyrate_int_imputed.txt_snps.txt	Unweighted regression	0.0176706693892004	8	0.999999999747877
WLQNXb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	bOHbutyrate_int_imputed.txt_snps.txt	Maximum likelihood	11.5823477736777	8	0.170833688409741
WLQNXb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	bOHbutyrate_int_imputed.txt_snps.txt	MR Egger	9.70208856425545	7	0.20609372725082
WLQNXb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	bOHbutyrate_int_imputed.txt_snps.txt	Inverse variance weighted	11.628935509614	8	0.168543473724859
WLQNXb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	bOHbutyrate_int_imputed.txt_snps.txt	Unweighted regression	0.018218045303182	8	0.999999999715219
WLQNXb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	bOHbutyrate_int_imputed.txt_snps.txt	Maximum likelihood	13.2292648049828	8	0.104201016627657
WLQNXb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	bOHbutyrate_int_imputed.txt_snps.txt	MR Egger	12.4530646365616	7	0.0866099149344008
WLQNXb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	bOHbutyrate_int_imputed.txt_snps.txt	Inverse variance weighted	13.2405527133867	8	0.103836614159373
WLQNXb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	bOHbutyrate_int_imputed.txt_snps.txt	Unweighted regression	0.107977327104695	8	0.999999660954165
WPdkcL	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_6_int_imputed.txt_snps.txt	Maximum likelihood	74.397651778668	45	0.0037958568330666
WPdkcL	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_6_int_imputed.txt_snps.txt	MR Egger	74.3833382913512	44	0.00283599777096299
WPdkcL	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_6_int_imputed.txt_snps.txt	Inverse variance weighted	74.4136541140222	45	0.00378216485909287
WPdkcL	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_6_int_imputed.txt_snps.txt	Unweighted regression	0.0550358836468651	45	1
WPdkcL	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_6_int_imputed.txt_snps.txt	Maximum likelihood	71.343399384574	45	0.00744548521654276
WPdkcL	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_6_int_imputed.txt_snps.txt	MR Egger	71.1072965980904	44	0.00595244769998672
WPdkcL	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_6_int_imputed.txt_snps.txt	Inverse variance weighted	71.362623311799	45	0.00741473596077628
WPdkcL	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_6_int_imputed.txt_snps.txt	Unweighted regression	0.07732073192766	45	1
WPdkcL	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_6_int_imputed.txt_snps.txt	Maximum likelihood	50.8727573703732	43	0.191337319765003
WPdkcL	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_6_int_imputed.txt_snps.txt	MR Egger	41.7626843548351	42	0.481291393068761
WPdkcL	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_6_int_imputed.txt_snps.txt	Inverse variance weighted	50.8963813064314	43	0.190717694351128
WPdkcL	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_6_int_imputed.txt_snps.txt	Unweighted regression	0.325316977898766	43	1
wQDE5n	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	112.447270665839	79	0.00800209892163115
wQDE5n	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_CE_int_imputed.txt_snps.txt	MR Egger	111.819788295079	78	0.00725143053278605
wQDE5n	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	112.468962382416	79	0.00797216768056475
wQDE5n	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.142334206141827	79	1
wQDE5n	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	110.655442922171	79	0.0108588703855784
wQDE5n	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_CE_int_imputed.txt_snps.txt	MR Egger	110.699078294948	78	0.00880891845335543
wQDE5n	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	110.705056629135	79	0.0107687037100276
wQDE5n	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.204543315691789	79	1
wQDE5n	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	76.9632467747113	74	0.383976015135453
wQDE5n	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_CE_int_imputed.txt_snps.txt	MR Egger	72.6304643104403	73	0.490187754080423
wQDE5n	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	76.9640590245069	74	0.38395119043918
wQDE5n	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.585325916718656	74	1
wQwZZw	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	88.2462222696183	53	0.00169649301201371
wQwZZw	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_C_pct_int_imputed.txt_snps.txt	MR Egger	86.8402072611944	52	0.00174302753637222
wQwZZw	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	88.2898246607596	53	0.00168001133873506
wQwZZw	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.111976352818984	53	1
wQwZZw	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	86.8220106124448	53	0.0023266379769074
wQwZZw	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_C_pct_int_imputed.txt_snps.txt	MR Egger	86.0579492557921	52	0.0020766150012408
wQwZZw	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	86.8331374441393	53	0.00232095684905538
wQwZZw	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.146092515074722	53	1
wQwZZw	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	38.5777353575247	51	0.899635865905852
wQwZZw	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_C_pct_int_imputed.txt_snps.txt	MR Egger	38.7262888595316	50	0.876422220168747
wQwZZw	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	38.7302208608741	51	0.896399086735655
wQwZZw	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.393705352211117	51	1
WSaKEs	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	42.9601894364427	32	0.093375650101292
WSaKEs	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	42.6001909492747	31	0.0801800865195537
WSaKEs	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	42.982232410055	32	0.0929981867783484
WSaKEs	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0520042225708245	32	1
WSaKEs	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	43.7856499025863	32	0.0800747394111864
WSaKEs	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	43.4052822273427	31	0.0686181323001537
WSaKEs	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	43.8260546538346	32	0.0794664427215084
WSaKEs	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0736195052914864	32	1
WSaKEs	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	34.3564094227443	31	0.310002116545376
WSaKEs	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	34.364309265133	30	0.266503222070086
WSaKEs	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	34.3718245412089	31	0.309358542643963
WSaKEs	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.293094394019789	31	1
wwd99R	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	77.1743691030424	46	0.0027046825837779
wwd99R	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	76.2742491017026	45	0.00247044269727192
wwd99R	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	77.2358216589363	46	0.00266688847393942
wwd99R	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0773231701600906	46	1
wwd99R	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	70.6175364026085	46	0.0112875016511865
wwd99R	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	69.8498586029751	45	0.0102271996177078
wwd99R	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	70.6186926411658	46	0.0112848087723112
wwd99R	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.115841244432468	46	1
wwd99R	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	41.6740564633453	44	0.571814507029884
wwd99R	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	41.599284275066	43	0.532100754937675
wwd99R	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	41.9191072172443	44	0.561193080863629
wwd99R	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.412494012645777	44	1
x4eTAm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	61.530126144076	51	0.148368910503516
x4eTAm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_PL_int_imputed.txt_snps.txt	MR Egger	61.5575555810886	50	0.126601890288551
x4eTAm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	61.5575834272778	51	0.147814495293502
x4eTAm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0533881434192481	51	1
x4eTAm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	50.361671322776	51	0.498934740719298
x4eTAm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_PL_int_imputed.txt_snps.txt	MR Egger	49.9922252097474	50	0.473707629696419
x4eTAm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	50.3692365528719	51	0.498633727220924
x4eTAm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0779239528588577	51	1
x4eTAm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	62.8676269195636	51	0.123131673409345
x4eTAm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_PL_int_imputed.txt_snps.txt	MR Egger	62.8008591649875	50	0.105624451573246
x4eTAm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	62.8851190660619	51	0.122825063430378
x4eTAm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.758568681686197	51	1
xJwlqu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Acetone_int_imputed.txt_snps.txt	Maximum likelihood	0.340191255678608	2	0.843584142610277
xJwlqu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Acetone_int_imputed.txt_snps.txt	MR Egger	0.276009153107258	1	0.599328970210971
xJwlqu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Acetone_int_imputed.txt_snps.txt	Inverse variance weighted	0.344924774599815	2	0.841589942686591
xJwlqu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Acetone_int_imputed.txt_snps.txt	Unweighted regression	0.000802686323158334	2	0.999598737365814
xJwlqu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Acetone_int_imputed.txt_snps.txt	Maximum likelihood	1.19690328050085	2	0.549662052146545
xJwlqu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Acetone_int_imputed.txt_snps.txt	MR Egger	1.20577748545612	1	0.272169995335578
xJwlqu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Acetone_int_imputed.txt_snps.txt	Inverse variance weighted	1.22335228784232	2	0.54244089765282
xJwlqu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Acetone_int_imputed.txt_snps.txt	Unweighted regression	0.00501494040997843	2	0.997495670872491
xJwlqu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Acetone_int_imputed.txt_snps.txt	Maximum likelihood	1.2378265038816	2	0.538529365445223
xJwlqu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Acetone_int_imputed.txt_snps.txt	MR Egger	0.672194642989115	1	0.412287499476487
xJwlqu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Acetone_int_imputed.txt_snps.txt	Inverse variance weighted	1.25049661837948	2	0.535128534687438
xJwlqu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Acetone_int_imputed.txt_snps.txt	Unweighted regression	0.0165907154735179	2	0.991738953802186
xm1YnK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	94.2770954730063	60	0.00312000791844224
xm1YnK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_CE_int_imputed.txt_snps.txt	MR Egger	91.6741430021973	59	0.00411919465585978
xm1YnK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	94.3079811596903	60	0.00310020190372522
xm1YnK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.084314978512723	60	1
xm1YnK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	81.1169052814823	60	0.0360656689233063
xm1YnK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_CE_int_imputed.txt_snps.txt	MR Egger	75.9686847455826	59	0.0676657474881367
xm1YnK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	81.1259905319454	60	0.0360118995768128
xm1YnK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0912910554870281	60	1
xm1YnK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	69.8279369360589	58	0.137351595488451
xm1YnK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_CE_int_imputed.txt_snps.txt	MR Egger	66.4090779743005	57	0.184427462157563
xm1YnK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	69.8698012958693	58	0.136598574138249
xm1YnK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.502531564384998	58	1
xmV50Z	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Unsaturation_int_imputed.txt_snps.txt	Maximum likelihood	28.3781962291068	28	0.44454775294091
xmV50Z	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Unsaturation_int_imputed.txt_snps.txt	MR Egger	28.0995884403501	27	0.40585252738107
xmV50Z	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Unsaturation_int_imputed.txt_snps.txt	Inverse variance weighted	28.3892645457839	28	0.443969875561565
xmV50Z	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Unsaturation_int_imputed.txt_snps.txt	Unweighted regression	0.0454818888273807	28	1
xmV50Z	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Unsaturation_int_imputed.txt_snps.txt	Maximum likelihood	24.5548397071066	28	0.651941229929242
xmV50Z	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Unsaturation_int_imputed.txt_snps.txt	MR Egger	24.5583390957069	27	0.59919827488553
xmV50Z	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Unsaturation_int_imputed.txt_snps.txt	Inverse variance weighted	24.5610793783666	28	0.651605285135359
xmV50Z	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Unsaturation_int_imputed.txt_snps.txt	Unweighted regression	0.0571860051863388	28	1
xmV50Z	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Unsaturation_int_imputed.txt_snps.txt	Maximum likelihood	43.4344198058977	27	0.0236343403182744
xmV50Z	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Unsaturation_int_imputed.txt_snps.txt	MR Egger	40.2071859336351	26	0.0372235555740775
xmV50Z	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Unsaturation_int_imputed.txt_snps.txt	Inverse variance weighted	43.4349317027435	27	0.0236314999081728
xmV50Z	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Unsaturation_int_imputed.txt_snps.txt	Unweighted regression	0.69095769121307	27	1
xN30Js	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_size_int_imputed.txt_snps.txt	Maximum likelihood	23.2565702065332	16	0.107046028142069
xN30Js	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_size_int_imputed.txt_snps.txt	MR Egger	23.2590409194913	15	0.0787926747013843
xN30Js	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_size_int_imputed.txt_snps.txt	Inverse variance weighted	23.260017151694	16	0.106958462340745
xN30Js	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_size_int_imputed.txt_snps.txt	Unweighted regression	0.0238121870412473	16	1
xN30Js	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_size_int_imputed.txt_snps.txt	Maximum likelihood	19.4356529493545	16	0.246719968851486
xN30Js	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_size_int_imputed.txt_snps.txt	MR Egger	17.8224342561955	15	0.272115789575115
xN30Js	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_size_int_imputed.txt_snps.txt	Inverse variance weighted	19.4356534154696	16	0.246719946068102
xN30Js	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_size_int_imputed.txt_snps.txt	Unweighted regression	0.0257592589045327	16	1
xN30Js	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_size_int_imputed.txt_snps.txt	Maximum likelihood	30.7128265026424	16	0.0146382214291734
xN30Js	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_size_int_imputed.txt_snps.txt	MR Egger	27.7570568262608	15	0.0231402015334347
xN30Js	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_size_int_imputed.txt_snps.txt	Inverse variance weighted	30.7150583442886	16	0.0146286738342227
xN30Js	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_size_int_imputed.txt_snps.txt	Unweighted regression	0.313489863645593	16	0.999999999992137
XPJNHb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_BCAA_int_imputed.txt_snps.txt	Maximum likelihood	9.39780048579626	10	0.494812175548993
XPJNHb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_BCAA_int_imputed.txt_snps.txt	MR Egger	7.96911966815467	9	0.537261195991395
XPJNHb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_BCAA_int_imputed.txt_snps.txt	Inverse variance weighted	9.4007172040935	10	0.494542473296415
XPJNHb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_BCAA_int_imputed.txt_snps.txt	Unweighted regression	0.00597977238039642	10	0.999999999999998
XPJNHb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_BCAA_int_imputed.txt_snps.txt	Maximum likelihood	10.6605321166918	10	0.38456979543667
XPJNHb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_BCAA_int_imputed.txt_snps.txt	MR Egger	10.2841029049192	9	0.327978937326377
XPJNHb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_BCAA_int_imputed.txt_snps.txt	Inverse variance weighted	10.6662508303163	10	0.38410421739117
XPJNHb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_BCAA_int_imputed.txt_snps.txt	Unweighted regression	0.0173794221341203	10	0.99999999999959
XPJNHb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_BCAA_int_imputed.txt_snps.txt	Maximum likelihood	3.21169929683383	10	0.975993807624525
XPJNHb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_BCAA_int_imputed.txt_snps.txt	MR Egger	2.86057302998476	9	0.969566973583382
XPJNHb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_BCAA_int_imputed.txt_snps.txt	Inverse variance weighted	3.21169930549737	10	0.975993807383611
XPJNHb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_BCAA_int_imputed.txt_snps.txt	Unweighted regression	0.0285018692686654	10	0.99999999999516
Xt5dXX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Cholines_int_imputed.txt_snps.txt	Maximum likelihood	82.5208459111914	45	0.000546597997105487
Xt5dXX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Cholines_int_imputed.txt_snps.txt	MR Egger	80.682509725485	44	0.000618827908195588
Xt5dXX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Cholines_int_imputed.txt_snps.txt	Inverse variance weighted	82.529306700109	45	0.000545440144945728
Xt5dXX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Cholines_int_imputed.txt_snps.txt	Unweighted regression	0.0772807797937663	45	1
Xt5dXX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Cholines_int_imputed.txt_snps.txt	Maximum likelihood	77.7570354951124	45	0.00174546843704993
Xt5dXX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Cholines_int_imputed.txt_snps.txt	MR Egger	76.6428772542246	44	0.00166590991853408
Xt5dXX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Cholines_int_imputed.txt_snps.txt	Inverse variance weighted	77.7598052075895	45	0.0017443249922566
Xt5dXX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Cholines_int_imputed.txt_snps.txt	Unweighted regression	0.129957401561142	45	1
Xt5dXX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Cholines_int_imputed.txt_snps.txt	Maximum likelihood	67.5416376855643	43	0.00982549727183238
Xt5dXX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Cholines_int_imputed.txt_snps.txt	MR Egger	67.266884964503	42	0.00793861839103765
Xt5dXX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Cholines_int_imputed.txt_snps.txt	Inverse variance weighted	67.5658260122595	43	0.0097747378161597
Xt5dXX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Cholines_int_imputed.txt_snps.txt	Unweighted regression	0.487489039046894	43	1
XVKabO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	His_int_imputed.txt_snps.txt	Maximum likelihood	14.0492158767702	10	0.170758533779854
XVKabO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	His_int_imputed.txt_snps.txt	MR Egger	13.9567256732015	9	0.123872927926267
XVKabO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	His_int_imputed.txt_snps.txt	Inverse variance weighted	14.0585436219526	10	0.17033796288437
XVKabO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	His_int_imputed.txt_snps.txt	Unweighted regression	0.012077414470711	10	0.999999999999933
XVKabO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	His_int_imputed.txt_snps.txt	Maximum likelihood	12.5571129816627	10	0.249498445693668
XVKabO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	His_int_imputed.txt_snps.txt	MR Egger	12.564421349834	9	0.183326202424848
XVKabO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	His_int_imputed.txt_snps.txt	Inverse variance weighted	12.5765644000358	10	0.248319103272956
XVKabO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	His_int_imputed.txt_snps.txt	Unweighted regression	0.0178481006132666	10	0.999999999999532
XVKabO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	His_int_imputed.txt_snps.txt	Maximum likelihood	12.7328944913399	10	0.238991777474862
XVKabO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	His_int_imputed.txt_snps.txt	MR Egger	11.9866983073426	9	0.214060230368671
XVKabO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	His_int_imputed.txt_snps.txt	Inverse variance weighted	12.7629957894891	10	0.237226537316852
XVKabO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	His_int_imputed.txt_snps.txt	Unweighted regression	0.10363938149552	10	0.999999997017707
YAb2Ep	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_P_int_imputed.txt_snps.txt	Maximum likelihood	59.2608701377334	42	0.0405563526200359
YAb2Ep	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_P_int_imputed.txt_snps.txt	MR Egger	57.7592688360982	41	0.0429800177185528
YAb2Ep	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	59.2939395003912	42	0.0403065882758389
YAb2Ep	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0312622997066812	42	1
YAb2Ep	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_P_int_imputed.txt_snps.txt	Maximum likelihood	49.2103633955353	42	0.206803081636176
YAb2Ep	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_P_int_imputed.txt_snps.txt	MR Egger	48.3175712753619	41	0.201255482861647
YAb2Ep	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	49.2499490542486	42	0.205695909752309
YAb2Ep	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0526544985649037	42	1
YAb2Ep	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_P_int_imputed.txt_snps.txt	Maximum likelihood	55.801450175362	42	0.0752516723941105
YAb2Ep	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_P_int_imputed.txt_snps.txt	MR Egger	52.423465692704	41	0.108885344423138
YAb2Ep	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	55.9387930097241	42	0.073507434355449
YAb2Ep	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.505410708647166	42	1
YeCRAk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	DHA_pct_int_imputed.txt_snps.txt	Maximum likelihood	17.9975762011549	18	0.455812289653616
YeCRAk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	DHA_pct_int_imputed.txt_snps.txt	MR Egger	17.9299984676045	17	0.39326993339594
YeCRAk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	DHA_pct_int_imputed.txt_snps.txt	Inverse variance weighted	17.9976015510635	18	0.455810619433308
YeCRAk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	DHA_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0376548280126146	18	1
YeCRAk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	DHA_pct_int_imputed.txt_snps.txt	Maximum likelihood	19.1272975155857	18	0.384024205047444
YeCRAk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	DHA_pct_int_imputed.txt_snps.txt	MR Egger	18.3847433857614	17	0.364966689859462
YeCRAk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	DHA_pct_int_imputed.txt_snps.txt	Inverse variance weighted	19.1309961337916	18	0.383798795470041
YeCRAk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	DHA_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0557398773527546	18	1
YeCRAk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	DHA_pct_int_imputed.txt_snps.txt	Maximum likelihood	23.3923988877856	16	0.103640637453985
YeCRAk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	DHA_pct_int_imputed.txt_snps.txt	MR Egger	17.679357091746	15	0.279897683049463
YeCRAk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	DHA_pct_int_imputed.txt_snps.txt	Inverse variance weighted	23.3928318368238	16	0.103629930255529
YeCRAk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	DHA_pct_int_imputed.txt_snps.txt	Unweighted regression	0.588286879316404	16	0.999999998929492
yEkV7X	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	22.0623735594371	18	0.229227719537648
yEkV7X	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	20.9162659769899	17	0.230058170318375
yEkV7X	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	22.0775831796568	18	0.22855890108725
yEkV7X	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0379421663211885	18	1
yEkV7X	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	17.6001826326507	18	0.482268595981662
yEkV7X	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	16.6471353700948	17	0.478509625672149
yEkV7X	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	17.6025782598504	18	0.482107564277627
yEkV7X	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0390130801691368	18	1
yEkV7X	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	15.8977582693922	17	0.531094228356839
yEkV7X	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	15.4044286399081	16	0.495240685334566
yEkV7X	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	15.925270671877	17	0.529138655495472
yEkV7X	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.220385367422444	17	0.999999999999945
YJKXWo	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Ile_int_imputed.txt_snps.txt	Maximum likelihood	5.09676892620451	6	0.531463127367871
YJKXWo	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Ile_int_imputed.txt_snps.txt	MR Egger	4.09065897898181	5	0.536438566104083
YJKXWo	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Ile_int_imputed.txt_snps.txt	Inverse variance weighted	5.1043535390031	6	0.530500459455044
YJKXWo	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Ile_int_imputed.txt_snps.txt	Unweighted regression	0.00197354086279634	6	0.999999999839979
YJKXWo	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Ile_int_imputed.txt_snps.txt	Maximum likelihood	4.19191116977433	6	0.650723514204697
YJKXWo	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Ile_int_imputed.txt_snps.txt	MR Egger	3.68076970623787	5	0.596228302329305
YJKXWo	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Ile_int_imputed.txt_snps.txt	Inverse variance weighted	4.19191679318059	6	0.650722754855311
YJKXWo	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Ile_int_imputed.txt_snps.txt	Unweighted regression	0.00178027759270828	6	0.999999999882529
YJKXWo	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Ile_int_imputed.txt_snps.txt	Maximum likelihood	3.79684173049402	6	0.704146656781764
YJKXWo	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Ile_int_imputed.txt_snps.txt	MR Egger	3.41279491163998	5	0.63662196819235
YJKXWo	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Ile_int_imputed.txt_snps.txt	Inverse variance weighted	3.80423388142705	6	0.703148808480683
YJKXWo	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Ile_int_imputed.txt_snps.txt	Unweighted regression	0.0100947262239371	6	0.999999978649966
yOwevo	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	63.3291394541614	39	0.00817725185416366
yOwevo	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_TG_int_imputed.txt_snps.txt	MR Egger	63.1907848599399	38	0.00630107455973912
yOwevo	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	63.3394531225983	39	0.00815828827789205
yOwevo	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0560400215355853	39	1
yOwevo	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	61.0836376503092	39	0.0134213196740885
yOwevo	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_TG_int_imputed.txt_snps.txt	MR Egger	60.9752387684612	38	0.0104260306312294
yOwevo	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	61.0836676098203	39	0.0134212327671004
yOwevo	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.128168922497607	39	1
yOwevo	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	53.4427923772305	39	0.0615654124195958
yOwevo	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_TG_int_imputed.txt_snps.txt	MR Egger	50.9611671106767	38	0.077862277501359
yOwevo	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	53.4561474666961	39	0.0614163908907557
yOwevo	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.508141451893431	39	1
YthXcn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	23.0964862500884	17	0.146135813698439
YthXcn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	22.8895091875951	16	0.116720265224425
YthXcn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	23.099622563136	17	0.146035442968477
YthXcn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0280950865726635	17	1
YthXcn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	13.9682588910113	17	0.669347490782105
YthXcn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	13.9667192340443	16	0.601193282475339
YthXcn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	13.9704909213956	17	0.669189668929019
YthXcn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0267567378268808	17	1
YthXcn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	21.3283223955382	15	0.126663213335607
YthXcn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	21.3508491396493	14	0.0929736465917897
YthXcn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	21.3522198080102	15	0.125948203665216
YthXcn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.142299897829247	15	0.999999999999835
YxA7nb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	57.2830435696927	43	0.0712221244360131
YxA7nb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_C_pct_int_imputed.txt_snps.txt	MR Egger	54.8638392560402	42	0.0880976424656302
YxA7nb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	57.2830524357919	43	0.0712220168841695
YxA7nb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0719475486889558	43	1
YxA7nb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	58.7948880113938	43	0.0547555511000168
YxA7nb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_C_pct_int_imputed.txt_snps.txt	MR Egger	58.224359566151	42	0.049096587721617
YxA7nb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	58.7965852563047	43	0.0547390615868837
YxA7nb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.102245257274128	43	1
YxA7nb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	42.1204403143005	41	0.422241461270049
YxA7nb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_C_pct_int_imputed.txt_snps.txt	MR Egger	42.1864060609331	40	0.376600371804657
YxA7nb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	42.2564320737685	41	0.416491455892918
YxA7nb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.417302102433708	41	1
z5ylGX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	79.2644933060171	61	0.0580326773806711
z5ylGX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	79.2315847302877	60	0.0488382971671938
z5ylGX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	79.2764357877164	61	0.0579272839582649
z5ylGX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0668378658191447	61	1
z5ylGX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	83.9632284685091	61	0.027276649321437
z5ylGX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	82.7372430704793	60	0.027512410925235
z5ylGX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	83.9632284685091	61	0.0272766493214369
z5ylGX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.119116279528592	61	1
z5ylGX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	77.1820837845939	59	0.0562141851872401
z5ylGX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	77.2611707005332	58	0.0462797351433358
z5ylGX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	77.2629259458469	59	0.0555129989319189
z5ylGX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.817772999239937	59	1
Z90uYG	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	87.7197083470493	56	0.00430636873624875
Z90uYG	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_C_pct_int_imputed.txt_snps.txt	MR Egger	84.7211448699604	55	0.00616879053483371
Z90uYG	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	87.7847236080944	56	0.00424882313805562
Z90uYG	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.128991676658455	56	1
Z90uYG	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	74.0225054178672	56	0.053709181931435
Z90uYG	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_C_pct_int_imputed.txt_snps.txt	MR Egger	73.7430071104492	55	0.0465953700696725
Z90uYG	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	74.0246396563788	56	0.0536908842165608
Z90uYG	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.167075993006678	56	1
Z90uYG	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	71.3010694713361	53	0.0475151601634049
Z90uYG	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_C_pct_int_imputed.txt_snps.txt	MR Egger	70.3108573716379	52	0.0461505292815361
Z90uYG	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	71.4941325952376	53	0.0460102501489254
Z90uYG	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.746964575534953	53	1
zaeG1L	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	103.353955318246	44	1.11081420668168e-06
zaeG1L	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	103.276892686395	43	7.18463816330803e-07
zaeG1L	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	103.355512855267	44	1.11029039271668e-06
zaeG1L	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0883479350934418	44	1
zaeG1L	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	83.4932863674727	44	0.000302191366347277
zaeG1L	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	83.4793892157858	43	0.000211850929484537
zaeG1L	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	83.4936748089085	44	0.000302160982226741
zaeG1L	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.121783700160072	44	1
zaeG1L	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	62.5971445035168	41	0.0165031350132518
zaeG1L	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	62.6042197477326	40	0.0126641046115082
zaeG1L	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	62.604811352719	41	0.016476813634308
zaeG1L	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.368409912921136	41	1
